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1     ABSTRACT 
 
 
The purpose of this study was to develop methods for quantitative analysis of Eustachian 
tube (ET) function to supplement video endoscopy and to apply the knowledge gained to 
the creation of new surgical procedures to treat refractory dilatory or patulous 
dysfunction of the ET. 
Prospective studies were performed on adult normal subjects and patients with otitis 
media with effusion (OME) or patulous ETs in tertiary medical centers and on human 
cadaver heads.  Timing and metric parameters were measured from the endoscopic 
videos. Analyses of endoscopy with simultaneous sonotubometry were conducted in 
normal subjects. Patients with refractory OME underwent laser Eustachian tuboplasty 
(LETP) procedures to vaporize mucosa, submucosa, and cartilage, thinning the postero-
medial wall of the ET.  The feasibility and safety of an alternative procedure, balloon 
dilation of the ET was investigated in cadavers and then performed on patients with 
refractory OME. Patients with patulous ETs underwent surgical augmentation of the 
concave defect found in the antero-lateral wall. 
Diagnostic analyses were done on 27 normal, 13 OME and 15 patulous subjects.   
Mean values for normals:  angle of torus tubarius rotation 34.2° (SD 14.3) and excursion 
of the antero-lateral wall 35.5 % of torus tubarius height (SD 16.3).  Lateral excursion 
wall was significantly less in patulous ET (18.7%, SD 15.1, p=0.001) and in OME 
(23.9%, SD 21.7, p=0.048).  During sonotubometery, all showed normal endoscopy and 
appeared to open, but only 11/17 opened by objective criteria of 5 dB increase in signal 
with swallows (ave. duration 0.43 s) and 13/17 with yawns (ave.2.03s).  LETP in 
conjunction with tympanostomy tube was performed in 13 patients and eliminated OME 
in 4/11 at 6 months, 3/10 at 1 year, and 3/8 at 2 years.  Balloon dilation catheters 
successfully dilated all cadaver ETs without significant adverse effects and average tubal 
volume increased from 0.16 to 0.49 cm3 (SD 0.12). In 11 patients undergoing balloon 
dilation, all cases successfully dilated.  11/11 could autoinsufflate by Valsalva (p<0.001); 
tympanograms were A: 4/11, C: 1/11, or open (perforation or tube): 6/11.  All atelectases 
resolved.  There were no complications related to the dilation.    14 patients underwent 
patulous ET reconstruction; 1 had complete relief, 5 had significant improvement and 
were satisfied, 7 improved but were dissatisfied, and 1 was unchanged.  There were no 
complications. 
The ET contains a functional valve within the cartilaginous segment and its failure may 
leads to middle ear disorders.  On video endoscopy, lateral excursion of the antero-lateral 
wall was reduced in OME and patulous ETs.  This parameter can now be further studied 
in the search for pathophysiology of tubal dysfunction. Sonotubometry failed to record 
tubal opening in all subjects, but when it occurred it was more accurately determined than 
by endoscopy.  The combined technology provides complimentary information and is 
promising for future use. 
LETP was safe, without significant complications, and could improve severely refractory 
OME. It is promising for expanded indications in ET surgery.  Alternatively, balloon 
dilation was shown to be safe, technically feasible and with some reasonable possibility 
for clinical efficacy.  Randomized clinical trials of the procedure are indicated. Patulous 
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ET reconstruction was successful in relieving symptoms and future work is needed to 
improve the instrumentation and graft materials.   
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2     ABBREVIATIONS 
 
CCD  Charge Coupled Device  
cm centimeter 
CO2 Carbon Dioxide 
CT Computed Tomographic 
dB decibel 
DV Digital Video 
EAC External Auditory Canal 
ET Eustachian Tube 
H2 blocker Histamine receptor type 2 antagonist 
KTP Potassium-titanyl-phosphate  
LETP Laser Eustachian Tuboplasty 
LVP Levator Veli Palatini 
mg milligram 
mmHg Millimeters of mercury 
MPR Multi Planar Reconstruction 
N2 Nitrogen 
OME Otitis Media with Effusion 
O2 Oxygen 
PETR Patulous Eustachian Tube Reconstruction 
PTA Pure Tone Average 
RMS Root Mean Square 
SCD     Semicircular Canal Dehiscence 
SPSS Statistical Package for Social Sciences 
s-VHS Super Video Home System 
TVP Tensor Veli Palatini 
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4     INTRODUCTION 
 
The Eustachian tube connects the middle ear cavity with the naso-pharynx, performs the 
critical roles of aeration and drainage of the middle ear cavity and protects the middle ear 
from reflux of sound and material from the nasopharynx. The first known mention of the 
Eustachian tube was in the writings of Alcmaeon of Sparta in 400 B.C., (Bluestone and 
Bluestone 2005) but Bartolomeus Eustachius is credited with its discovery in 1562 when 
he published a detailed description of its anatomy and physiologic function. (Eustachius 
1944)  Valsalva later described the Eustachian tube as having cartilaginous and osseous 
parts and he was the first to recognize the importance of the tensor veli palatini muscle in 
opening the Eustachian tube. (Canalis 1990)  Additionally, he described the Valsalva 
maneuver, which remains clinically relevant to this day.  Toynbee furthered our 
understanding of the Eustachian tube through extensive investigations of the peri-tubal 
muscles (Toynbee 1853) and Politzer made important contributions in recognizing the 
role of the Eustachian tube in middle ear pathology. (Bluestone and Bluestone 2005)   
 
Eustachian tube dysfunction is believed to be the leading cause of otitis media, but the 
nature of the pathology remains undetermined.  Previous work has principally focused on 
studying the limitations of tubal fluid dynamics through the bony-cartilaginous isthmus, 
which is the narrowest portion of the lumen.  Despite the extensive analyses that have 
resulted from these efforts, tests to measure various aspects of tubal flow and pressure 
have failed to consistently correlate with clinical findings.  Surgical treatments to widen 
the isthmus have not been beneficial.  There is evidence that acute otitis media and otitis 
media with effusion are associated with inflammatory and anatomical changes in the 
cartilaginous portion of the Eustachian tube.  We have proposed a hypothesis that the 
cartilaginous portion of the Eustachian tube functions as a valve and that malfunction of 
the valve can result in pathology or symptoms in the middle ear.  Pathological changes in 
the tubal orifice and valve have been demonstrated to correlate closely with the presence 
of middle ear atelectasis or middle ear effusion.  Therapy directed toward correction of 
the valve’s function should be expected to improve otitis media and alleviate middle ear 
symptoms.  Initial attempts to surgically widen the valve as a treatment for dilatory 
dysfunction and to narrow it for patulous dysfunction have met with some preliminary 
success. 
 
Endoscopy of the Eustachian tube has greatly aided in the recognition of pathological 
changes within the cartilaginous portion.  Mucosal inflammation, edema, excessive 
mucous secretions and external compression from the adenoid may cause functional 
obstruction.  Dynamic dysfunction due to muscle weakness, hypercontraction, or lack of 
coordination between muscles can also cause functional obstruction. (Poe, Abou-Halawa 
et al. 2001) These observations have been made qualitatively, but the means for 
quantification of abnormalities is lacking.    
 
The purpose of this study was two-fold.  First, a method was sought to make quantified 
measurements of tubal function in conjunction with transnasal video endoscopy to 
determine whether the information would be useful for clinical or research purposes in 
elucidating the pathophysiology of dysfunction in patients.  Identification or 
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quantification of pathology should aid in staging severity of disease and in planning for 
clinical treatment.  Second, a hypothesis was proposed that dysfunction of the Eustachian 
tube most commonly involves a failure of its functional valve.  The test of this hypothesis 
would be that the surgical methods developed to repair observed defects in the valve 
would result in clinical improvement of symptoms or signs of middle ear complaints.   
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5     REVIEW OF THE LITERATURE 
 
5.1 EUSTACHIAN TUBE 
 
5.1.1     Eustachian tube Anatomy 
 
The Eustachian tube is a dynamic conduit between the middle ear and the nasopharynx.  
It performs aeration and drainage of the middle ear cavity and protects the middle ear 
material from the nasopharynx.  This tubular organ performs secretory, ciliary, and 
dilatory functions that are required for optimal conduction of sound through the middle 
ear cavity.(Bluestone and Bluestone 2005)  
 
The Eustachian tube measures approximately 31 to 38 mm in length in the normal adult. 
(Proctor 1973)  It contains a physiological functional valve, which is closed in the passive 
resting position and is dilated open by active muscular exertion.  Although there is no 
consensus on the definition of Eustachian tube dysfunction, it is taken to imply that the 
tubal functional valve fails to dilate open sufficiently widely or frequently to adequately 
ventilate the middle ear cavity.  Failure of valve dilation may lead to numerous 
consequences within the middle ear with the most common of these being otitis media. 
(Bluestone, Paradise et al. 1972) Insufficient dilation of the functional valve should be 
more properly referred to as dilatory dysfunction to distinguish it from failure of the 
valve to close, which is the etiology of the patulous Eustachian tube. (Poe, Abou-Halawa 
et al. 2001) 
 
 
As the direction of mucociliary clearance within the Eustachian tube flows from the ear 
to the nasopharyngeal orifice, the anatomy will be described with “proximal” referring to 
the middle ear end and “distal” referring toward the nasopharyngeal orifice.  A cross 
section through the tubal lumen can be divided into superior and inferior halves and 
anterolateral and posteromedial halves. 
 
The proximal one-third of the tubal length is, in effect, a bony funnel-shaped extension of 
the middle ear which becomes narrowest at the isthmus, the smallest aperture in the entire 
tube. (Sudo, Sando et al. 1997)The osseus portion is lined with a thin layer of cuboidal 
respiratory epithelium (Honjo, Hayashi et al. 1985) (Sando, Takahashi et al. 1994) and is 
a fixed conduit that is normally patent. (Hopf, Linnarz et al. 1991) 
 
The distal 2/3 of the Eustachian tube is the pharyngeal portion, which is composed of a 
cartilaginous skeleton to which is attached a complex arrangement of peritubal muscles 
capable of a wide range of dynamic movements.  The lumen is lined with respiratory 
epithelium that is taller, more columnar, and more ciliated inferiorly than the cuboidal 
epithelium in the superior one-half.  (Honjo, Hayashi et al. 1985) (Sando, Takahashi et al. 
1994) A submucosal layer of lymphatics and fat add to the thickness of the lining within 
the tubal lumen. The cartilaginous portion is normally closed in the resting position due 
to apposition of the mucosal walls.  Closure occurs over a variable length (5-10mm 
segment) just a few millimeters distal to the bony isthmus where the cartilaginous 
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skeleton becomes flexible.(Poe, Abou-Halawa et al. 2001)  This portion that 
intermittently dilates to the open position is termed the “functional valve,” because it 
serves such a purpose. (Poe, Pyykko et al. 2000) 
 
There are four peritubular muscles, the levator veli palatini (LVP), the 
salpingopharyngeus, the tensor tympani, and the tensor veli palatini (TVP). The TVP 
muscle is thought to be the principal dilator of the tubal lumen.  (Figure 1a-c) (Rood and 
Doyle 1978) 
 
 
 
Figure 1a.  Fixed cadaver dissection with a longitudinal cut through a right Eustachian 
tube orifice.  The antero-lateral wall has been resected and the figure is oriented with 
superior upward.  The bony orifice is labelled 1, isthmus 3, and torus tubarius 7.  Scale 
unit marks are in mm. 
14 
 
 
 
Figure 1b.  Diagram of a left Eustachian tube seen from the nasopharyngeal orifice.  LVP 
= Levator Veli Palatini muscle,  TVP = Tensor Veli Palatini muscle.  Posterior cushion = 
Torus tubarius.  Artwork courtesy of Dr. Oskar Kujawski 
 
 
 
15 
 
 
 
 
Figure 1c Fixed cadaver dissection of the nasal cavity and left Eustachian tube orifice.  
MCL = Medial cartilaginous lamina within the torus tubarius.  Reproduced courtesy of 
Laryngoscope, 113:583-591,2003. 
 
The LVP is a round-bellied muscle that looks like a sling running from the base of the 
temporal bone along the bony Eustachian tube and passing under a groove in the inferior 
aspect of the medial cartilaginous lamina and membranous floor of the Eustachian tube to 
insert into the palatal musculature.  Contraction of the LVP raises the soft palate and 
medially rotates the medial cartilaginous lamina. (Rich 1920; Proctor 1973) 
 
The TVP is a flat, fan shaped muscle with broad origins from the basisphenoid and 
includes dilator tubae muscle fibers originating from the membranous anterolateral wall 
of the Eustachian tube.  It courses longitudinally to follow the length of the cartilaginous 
Eustachian tube and tapers to run under the hamulus of the palatal bone, finally inserting 
into the soft palate. (Proctor 1973) The relaxed bulk of the TVP contributes to the bulge 
in the anterolateral wall that protrudes into the lumen of the Eustachian tube and aids in 
its closure.(Ishijima, Sando et al. 2002; Takasaki, Sando et al. 2002)  Contraction of the 
TVP muscle tenses the anterolateral membranous wall and distracts it laterally to dilate 
the tubal valve into the open position.(Rood and Doyle 1978) 
 
 
5.1.2    Physiology of tubal dilation 
Intermittent brief tubal dilation is most likely the principal mechanism for equilibration of 
middle ear pressure with the ambient atmosphere.  Involuntary dilation of the Eustachian 
tube occurs throughout the day, typically occurring with a swallow or yawn, but it does 
not accompany every swallow or yawn.  Barometric and chemical receptors within the 
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middle ear are thought to provide autonomic nervous system feedback that influences the 
frequency of involuntary tubal opening. (Eden and Gannon 1987; Rockley and Hawke 
1992) Tubal dilation occurs in normal subjects approximately 1.4 times per minute 
during daytime with the duration of opening averaging 0.4 seconds. (Mondain, Vidal et 
al. 1997) During sleep, the frequency of tubal opening is substantially reduced. 
 
 Experiments with electrical stimulation in monkey models has shown that sequential 
muscular contractions initiate rotational movements of the cartilaginous framework and 
create tension within the anterolateral wall, which causes the effacement of its resting 
bulge.  This effacement is the primary action that opens the lumen to the middle ear. 
(Bluestone and Bluestone 2005) Tubal dilation begins with the action of the LVP muscle 
to medially rotate the cartilaginous skeleton, primarily its mobile distal half of the medial 
cartilaginous lamina. (Cantekin, Doyle et al. 1979) TVP muscle contraction follows 
causing the resting convexity of the anterolateral wall to become effaced or even concave 
as the final step to transiently open the lumen. (Cantekin, Doyle et al. 1979; Honjo, 
Okazaki et al. 1979; Honjo, Ushiro et al. 1983; Ghadiali, Swarts et al. 2003) 
 
 It is believed that intermittent brief dilation of the tube is the principal mechanism for 
equilibration of middle ear pressure with the ambient atmosphere. (Sade 1984; Honjo 
1988; Hergils and Magnuson 1998)  Middle ear and mastoid gas exchange is an ongoing 
process that continually generates a net absorption of gases resulting in an increasingly 
negative pressure between tubal dilations. (Felding, Rasmussen et al. 1987; Ostfeld and 
Silberberg 1991; Ars and Ars-Piret 1994; Doyle and Seroky 1994) There is a gradient of 
partial pressures of gases between the middle ear gases and the venous capillary soluble 
gases that drives the net absorption of gas into the circulation over time as seen in table 1.   
 
Table 1 
 
Partial pressures (in mmHg) measured in humans – table adapted from Sadé (Sade and Ar 
1997) 
 
 Atmosphere Nasopharynx Middle Ear Venous Blood 
Total 760 760 760 704 
N2 563 578 623 575 
O2 150 99 40 38 
H2O  47 47 47 47 
CO2 0.3 36 50 44 
 
 
CO2 has the highest coefficient of diffusion and is most rapidly exchanged with the net 
exchange passing from the venous blood to the middle ear.  The next most rapid diffusion 
occurs with O2, passing from the middle ear into the blood.  Diffusing much more slowly 
into the circulation is N2, the predominant partial pressure in both air and blood and the 
source of the largest gradient.  It is the slow absorption of N2 that causes the increasing 
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relative vacuum between ambient air and the middle ear cavity over time. (Tideholm 
2003; Pau, Sievert et al. 2008) Failure to dilate for an extended period of time can lead to 
pathologically severe negative pressure and consequences of tympanic membrane 
retraction, atelectasis, and otitis media with effusion (OME).(Falk and Magnuson 1984; 
Doyle and Seroky 1994; Bluestone and Bluestone 2005)  Indeed, intermittent dilation 
with opening of the middle ear may principally serve to regulate nitrogen balance.(Ars 
and Ars-Piret 1994) 
 
Tubal dilation is likely naturally facilitated by the presence of surface tension lowering 
substances that are found in its mucus.  Surfactants are produced within the tubal mucosa 
and probably aid in reducing the surface tension of the lumen, which reduces the work 
required to dilate the tube. (Birken and Brookler 1972)  Although treatment with 
surfactants has produced reduction of passive opening pressures in Eustachian tubes and 
even reduced the time to resolve acute otitis media in animal models, these results have 
not yet been reproduced successfully in humans.(Grace, Kwok et al. 1987; Passali and 
Zavattini 1987; Kobayashi T 1993; Chandrasekhar and Mautone 2004) 
 
 Fluid and secretions in the middle ear are cleared by a combination of muscular pumping 
action that occurs with the tubal closing process (Honjo, Hayashi et al. 1985) and by 
mucociliary activity. (Bluestone CD 1996) Reflux of nasopharyngeal secretions into the 
middle ear is limited or prevented by the closed position of the resting pharyngeal 
Eustachian tube and by the trapped volume of gas in the middle ear and mastoid bone 
which creates a "gas cushion."  Reflux of the sounds of breathing and vocalization are 
similarly blocked by the closed resting position of the pharyngeal Eustachian 
tube.(Bluestone CD 1996)  
 
5.2    TESTING OF THE EUSTACHIAN TUBE 
 
5.2.1     Eustachian tube function tests 
 
A number of tests have been employed applying either positive or negative pressure 
through the external auditory canal or nasopharynx to assess Eustachian tube function.  
Unfortunately, none of these tests have gained widespread use as they are all lacking in 
clinical significance. The forced response test measures the pressure needed to passively 
open the Eustachian Tube and it requires a patent ventilation tube or tympanic membrane 
perforation.  The external auditory canal is sealed and using a tympanometry probe, the 
pressure is increased until the Eustachian tube opens resulting in a sudden 
decompression.  The inflation-deflation test uses a tympanometry probe to record and 
vary pressure as the patient swallows in an attempt to open the Eustachian tube.   
(Bluestone CD 2005) 
 
 Both the forced response test and the inflation-deflation test were used to evaluate 
pediatric patients prior to tympanoplasty in one study.  Although good Eustachian tube 
function correlated with a favorable outcome for tympanoplasty, poor Eustachian tube 
function did not correlate with worse outcomes for tympanoplasty.(Manning, Cantekin et 
al. 1987; Choi, Han et al. 2009) 
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Sonotubometry takes measurements of the Eustachian tube opening using a speaker that 
produces a tone inside the nose and mouth.  A microphone is placed within the external 
auditory canal such that opening of the Eustachian tube can be detected as an increase in 
the amplitude of sound received from the nasopharynx. (van der Avoort, van Heerbeek et 
al. 2005; van der Avoort, Heerbeek et al. 2006; van der Avoort, van Heerbeek et al. 2007)  
Difficulties with signal to noise ratio, false negatives and positives, artefacts and 
waveforms of uncertain importance have limited its clinical use. Sonotubometry has not 
necessarily predicted the presence or absence of middle ear ventilation in all cases.  False 
negatives are a particular problem as some subjects with normal ears and no history of 
tubal dysfunction may fail to open with sonotubometry. (Sumi, Tsunoda et al. 2007; van 
Heerbeek, van der Avoort et al. 2007) 
  
Most recently, tubomanometry has become available using impedance tympanometry 
measurements of the external auditory canal during swallowing.  During a swallow, the 
mouth is closed and the nose is sealed with a probe that causes a ramp increase in 
nasopharyngeal pressure.  The pressure stimulus is not physiologic and may take some 
practice for patients to learn to swallow against the rising nasopharyngeal pressure.  
Investigators have correlated higher tubal opening pressures with middle ear pathology, 
but its clinical utility remains limited.(Martin C 1999) 
 
 
5.2.2     Eustachian tube endoscopy 
 
Efforts have been made to observe the functioning of the Eustachian tube in a 
minimally invasive fashion using endoscopic techniques.   Endoscopy of the human 
Eustachian tube has substantially increased our understanding of the functional processes 
in both normal and pathological cases.  Initial work done by the insertion of microfiber-
optic instruments into the tubal lumen yielded only limited information since the bony 
isthmus is only about 1.0-1.5 mm in horizontal diameter and 2 to 3 mm in vertical 
diameter. (Schuknecht and Gulya 1986)  In order to pass through the narrow isthmus, 
endoscope diameters must be restricted to 1 mm or less, which significantly compromises 
the resolution of images.  Only gross structures within the middle ear, such as ossicles, 
are recognizable and fine structures or details of movements cannot be appreciated.  
Direct contact of the endoscope lens with secretions and mucosal folds obscures the view 
within the lumen to such a degree that most reports have only been able to describe gross 
observations such as the presence of lesions or degree of patency. (Kimura, Yamaguchi et 
al. 1989; Chays, Cohen et al. 1995; Takahashi, Honjo et al. 1996; Klug, Fabinyi et al. 
1999)  Importantly, microendoscopy has demonstrated that the lumen of the osseus 
Eustachian tube may be patent in cases of active otitis media with effusion, suggesting 
that the pathophysiology is for reasons other than obstruction within the bony portion. 
(Hopf, Linnarz et al. 1991) 
 
Larger diameter (≥ 3 mm) fiber-optic nasopharyngoscopes or rigid Hopkins rod 
endoscopes have been used for more detailed studies of the lumen of the cartilaginous 
portion of the Eustachian tube.  The endoscopes were carefully positioned in the 
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nasopharyngeal orifice with the view directed superiorly 45 degrees and laterally 45 
degrees into the lumen.  This angle allowed for observation along the longitudinal axis of 
most of the pharyngeal portion of the tube as it rotated into the dilated position during the 
opening sequence.  Careful observation of tubal dynamics became possible with high-
resolution optics.   Avoidance of direct contact with the mucosa prevented interference 
with the dilating mechanism and limited problems with fogging of the lens.  Video 
recordings were made and replayed in slow motion for meticulous analysis of the dilation 
process and for study of normal physiology and pathophysiology.(Poe, Pyykko et al. 
2000; Poe, Abou-Halawa et al. 2001; Mathew, Kuruvilla et al. 2007) 
 
Eustachian tube endoscopy generally yielded views proximally well into the valve area 
during the time of maximal active dilation.  The opening process was observed to begin 
at the nasopharyngeal orifice and to progressively dilate the lumen proximally toward the 
isthmus, generally straightening the resting curvature of the lumen and bringing it into 
full view of the endoscope.  Although valve dilation was observed in detail, true opening 
of the lumen to communicate with the middle ear cannot be substantiated by visual means 
alone.  Normal subjects and patients with tubal dysfunction have been studied using these 
techniques to establish some observed patterns of normal dynamic physiology and 
pathophysiology. (Poe, Pyykko et al. 2000; Poe, Abou-Halawa et al. 2001) 
 
 
5.2.3     Technique of Eustachian tube video endoscopy  
 
Patients were examined in the sitting position in an office setting.  Topical spray 
anesthetic and decongestant, lidocaine (4%) topical mixed with equal parts of 
phenylepherine HCl 0.5% solution, was applied to both nasal cavities while the patient 
sniffed. Endoscopes were introduced into the nasal cavity and advanced along the floor 
and below inferior turbinate up to the nasopharyngeal orifice of the Eustachian tube. It is 
located just posterior to the inferior turbinate and identified by the torus tubarius (or 
posterior cushion).  It was observed to be important to positively identify the torus 
tubarius and not pass it, resulting in viewing the fossa of Rosenmüller and mistaking it 
for Eustachian tube orifice. 
 
The initial endoscopic (Poe, Pyykko et al. 2000)exam was done with a 3.7 mm diameter 
steerable flexible fiber-optic nasopharyngoscope EMF-P3 (Olympus, Tokyo, Japan).  
Careful inspection of the nasal cavity, nasopharynx, hypopharynx, and larynx was done 
to look for mucosal inflammation or lesions, especially if there was any evidence for 
laryngo-pharyngeal reflux or allergic disease.  If the adenoid was enlarged, its proximity 
to the torus tubarius of the Eustachian tube was noted.  Contact of the adenoid with the 
torus tubarius has been demonstrated to correlate with tubal dilatory dysfunction that 
improves following adenoidectomy. (Nguyen, Manoukian et al. 2004)  Lastly, the 
Eustachian tube was closely examined.  The optimal fiber-optic view brought the tip into 
the proper angle to view up the long axis of the Eustachian tube as it dilated.  This angle 
of introduction could be obtained either from the ipsilateral nasal cavity or by introducing 
the endoscope along the floor of the contralateral nasal cavity and passing the tip behind 
the vomer.   
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 For a more detailed examination or if slow-motion recording (Poe, Pyykko et al. 
2000)was desired, rigid endoscopes were preferred, generally using a 4-mm diameter, 30 
or 45 degree view angle, Hopkins rod rigid sinus surgery endoscope (Karl Storz, Culver 
City CU Alber City, CA) The rod endoscopes have high-resolution images, but the fiber-
optic endoscopes are easier to pass and can be steered deeper into the Eustachian tube 
lumen if desired. 
 
The 30 or 45-degree rigid endoscope was introduced with the view angle looking directly 
laterally and passed along the nasal floor, following the inferior turbinate.  After passing 
the posterior aspect of the inferior turbinate, the next landmark encountered was the 
anterior cushion of the Eustachian tube’s nasopharyngeal orifice.  Once at the orifice, the 
endoscope was rotated slightly to look superiorly into the long axis of the tubal lumen.   
The rigid endoscope was used with a Charge Coupled Device (CCD) camera in place and 
images are viewed on a video monitor.  Video recordings were made with an s-VHS 
video or DV recorder. 
 
The patient was initially asked to vocalize the letters "K,” “K,” “K," repeatedly to view 
the isolated action of the LVP.  The "Ks” stimulated palatal elevation and medial rotation 
of the torus tubarius and posteromedial wall of the Eustachian tube.  Swallows were done 
to induce normal physiological tubal dilations, and forced yawns were performed to 
cause maximal sustained dilations.  The Eustachian tube was not expected to open with 
every swallow and yawn and patients were coached to feel the muscular contractions in 
the back of their throats to generate some dilatory efforts.  Water was often provided if 
there were difficulties with swallowing.  The procedure was repeated for the contralateral 
Eustachian tube orifice.   
 
The video of tubal dilations was then reviewed and analyzed in normal time, slow 
motion, and even stepping through single frames that were captured at a rate of 29.97 
frames per second. (Poe, Pyykko et al. 2000; Poe, Abou-Halawa et al. 2001) 
 
 
5.2.4     Endoscopy of the normal Eustachian tube  
 
Although the technique for endoscopy has been available for decades only a few studies 
have systematically tried to visualize the dynamic events in the normal Eustachian tube 
function. The dilation process was initially studied endoscopically in thirty normal 
subjects (Poe, Pyykko et al. 2000). Dilation and opening were observed to have four 
consistent sequential phases during a normal swallow:  
 
1.  The soft palate elevated with simultaneous medial rotation of the torus tubarius and 
posteromedial wall.  The lateral pharyngeal wall also medialized causing transient 
constriction of the nasopharyngeal orifice despite the medial rotation of the torus tubarius 
and posteromedial wall.  It was postulated that this contrary constrictive movement could 
be to provide momentary protection of the Eustachian tube against reflux, clearing it just 
prior to dilating with a swallow (Figure 2a,b). 
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2.  The palate remained elevated and the torus tubarius and posteromedial wall remained 
medially rotated as the lateral pharyngeal wall lateralized and caused some initial dilation 
of the nasopharyngeal orifice. 
3.  The TVP began to contract in the anterolateral wall causing dilation of the lumen to 
propagate from the nasopharynx proximally toward the bony isthmus. The dilation 
occurred by excursion of the anterolateral lumen wall laterally.  The elevation of the 
palate and medially rotated position of the torus tubarius and posteromedial wall were 
maintained. 
4.  Tubal opening occurred as the functional valve of the cartilaginous tube dilated 
laterally away from the stable and medially rotated posteromedial wall to create a roughly 
rounded aperture in the lumen.  The convex bulge seen in the resting anterolateral valve 
wall became visibly effaced or concave to produce this final opening (Figure 2c). 
 
 
Figure 2 a- c Transnasal, 4mm, 45 degree Hopkins rod endoscopic view of left normal 
Eustachian tube orifice. A. Resting position (valve closed).  B. Initiation of swallow.  
Levator veli palatini muscle has elevated the palate and medially rotated the torus 
tubarius. C. Tensor veli palatini has contracted dilating the valve to open position. 
 
 
 
Closure of the tube began with the valve area and propagated distally toward the 
nasopharyngeal orifice.  This proximal to distal closure has been previously recognized 
on contrast studies and hypothesized to have a pumping action to expel material from the 
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lumen as a protection against reflux. (Honjo, Hayashi et al. 1985)  Relaxation of the 
anteromedial wall, torus tubarius and posteromedial wall, lateral pharyngeal wall and 
palate occurred in variable order or even simultaneously. 
 
The thin mucosa and subcutaneous tissues of the normal Eustachian tubes permitted 
observation of the muscular contractions of the LVP and TVP. Even the ripples 
representing the contractions of distinct individual fibers were often appreciated in detail.  
 
 
 
5.2.5     Endoscopy of the Dysfunctional Eustachian Tube  
 
Only a few studies have systematically explored the use of endoscopy in the study 
of the Eustachian tube in patients. In one study Eustachian tube dilatory dysfunction has 
been defined as an inadequacy of the dilatory function that results in secondary ear 
pathology (Poe, Abou-Halawa et al. 2001).  It may be caused by anatomical obstruction 
or physiologic failure due to:  1) hereditary factors as suspected in families with strong 
histories of ear disease, 2) mucosal inflammation causing functional obstruction or failure 
of dilation, 3) muscular problems that cause dilatory dynamic dysfunction and lastly 4) 
true anatomical obstruction due to neoplasms or other mass lesions, which are the least 
common cause. 
 
 The etiologies of tubal dilatory failure have been separated into obstructive and dynamic 
dysfunctions.  Most obstructive problems were not due to true anatomical blockage, but 
were instead found to be the result of functional failures to either dilate the tube 
sufficiently widely or sufficiently frequently to adequately aerate the middle ear.   
 
There is increasing evidence that Eustachian tube dilatory and patulous dysfunction 
results from pathology within the cartilaginous portion. (Hopf, Linnarz et al. 1991; 
Chays, Cohen et al. 1995; Poe, Abou-Halawa et al. 2001) Slow-motion video analysis 
was done on fifty-eight ears (in forty adult patients) with pathology suggestive of tubal 
dilatory dysfunction (Poe, Abou-Halawa et al. 2001). All subjects were found to have 
significant pathology and compromise in the tubal dilation process within the 
cartilaginous portion compared to (13%) of normal subjects who had only mild 
inflammatory changes.  The pathological findings are summarized in Table 2.   
 
Table 2 
 
Pathological findings in 58 clinically dysfunctional Eustachian tubes 
 
Mucosal edema    48 (83%) 
Reduced anterolateral wall lateral excursion 43 (74%) 
Functionally obstructive mucosal disease  15 (26%) 
 
Defects were observed in all of the different components of the cartilaginous Eustachian 
tube, including cartilaginous skeleton, tubal muscles, submucosa, and epithelium of the 
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lumen.   Edema of the mucosa and submucosa, the most common findings, reduced the 
diameter of the lumen and decreased the ability to open the valve region.  The torus 
tubarius and posteromedial wall were most affected by the apparent inflammation, which 
could continue into the tubal lumen or sometimes stopped abruptly at the transition into 
the lumen.   The inflammatory changes were often most prominent on the posterior 
surface of the torus tubarius that faced the adenoid.  The mucosa and submucosa of the 
torus tubarius and posteromedial wall is normally thicker and contains more glands than 
the anterolateral wall. (Schuknecht and Gulya 1986; Poe, Abou-Halawa et al. 2001)  It 
may be more susceptible to inflammatory changes and swelling.  In severe inflammation, 
the torus tubarius was observed to become compressed by an enlarged adenoid during 
swallowing causing it to be thrust forward and blocking the tubal orifice during dilatory 
efforts. This type of bulbous torus tubarius has been repeatedly seen in subsequent 
clinical experience, especially in patients with severe allergic or laryngopharyngeal reflux 
disease (Poe, Metson et al. 2003).    Figure 3 shows examples of mild (Fig 3a,b) and 
more severe inflammation (Fig 3 c,d). 
 
 
 
Figure 3.   Transnasal, 4mm, 45 degree Hopkins rod endoscopic view of left inflamed & 
edematous Eustachian tube orifices 
A.  Mildly inflamed torus tubarius in resting position (valve closed). 
B.  Mildly inflamed torus tubarius in dilated position. (same case as 2a) 
C.  Severely inflamed torus tubarius in resting position (valve closed). 
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D.  Severely inflamed torus tubarius in dilated position.  Torus tubarius is so 
edematous that pharyngeal constrictors and adenoids have forced it anteriorly 
during swallow, completely preventing dilation. (same case as 2c) 
 
 
Muscular dysfunction (dynamic dysfunction) as the primary abnormality was seen in 8%.  
Examples were observed in which hypofunction, hypercontraction or lack of coordination 
between the TVP and LVP muscles caused poor dilatory efforts. 
 
Most commonly observed was reduced TVP muscle action with decreased lateral 
excursion of the anterolateral wall. In some cases the TVP showed diffuse weakness or 
focal, apparent dilator tubae weakness, disorganized contractions, or absence of the usual 
dilatory wave that should normally progress from the nasopharyngeal orifice toward the 
isthmus. Hyperactive contraction of the TVP was also seen producing prominent ripples 
and longitudinal ridges of mucosa that paradoxically reduced the lumen diameter instead 
of dilating it.  
 
Observations of LVP muscle dysfunction included premature relaxation of the LVP 
causing the torus tubarius to return to its resting position before or during the contraction 
of the TVP, and double contraction of the muscle which blocked the lumen during 
dilatory efforts.  
 
Dilatory function appeared to depend on the coordinated action of both TVP and LVP 
muscles.  Although LVP function is not important for tubal dilation in other primates 
(Cantekin, Doyle et al. 1983), it appeared to be significant in patients.   The LVP may 
serve as a “scaffold” against which the inefficient dilatory efforts of the TVP, which only 
act on the anterolateral wall, are dependent.    (Poe, Abou-Halawa et al. 2001; Bluestone 
2008)   
 
The authors did not find correlation between the severity or type of middle ear pathology 
and the severity or type of Eustachian tube pathology.  It appeared that changes in the 
tympanic membrane and middle ear took an independent pathophysiological process once 
Eustachian tube dysfunction had passed some critical point. 
 
In patulous Eustachian tubes patients demonstrated a consistent volume defect or 
concavity in the superior cross-sectional half of the anterolateral wall, within the valve 
area. Normal Eustachian tubes have a convex bulge in this location that flattens during 
the final stage of dilation process. 
 
 
5.3  TREATMENT OF EUSTACHIAN TUBE DYSFUNCTION 
 
5.3.1  Differential Diagnosis aspects of Eustachian tube 
 
Chronic fullness in the ear associated with a normal appearing mobile tympanic 
membrane, absence of any retraction or effusion, and a normal tympanogram should not 
25 
 
be interpreted as Eustachian tube dilatory dysfunction, especially if myringotomy fails to 
relieve the symptoms.  Instead, a search for other causes of fullness, blockage, or otalgia 
is indicated and should include evaluation of temporomandibular joint dysfunction, 
superior semicircular canal dehiscence syndrome, patulous Eustachian tube and 
endolymphatic hydrops. 
(Poe 2007) 
 
Table 3 
Differential diagnosis for chronic Eustachian tube dilatory dysfunction 
 
Allergic disease 
Laryngo-pharyngeal reflux (LPR) 
Hypertrophied adenoid contacting torus tubarius 
Chronic sinusitis 
Tubal dynamic dysfunction 
Pneumonia or chronic pulmonary disease 
Primary mucosal disease 
- Immune deficient/suppressed 
- Samter’s (Aspirin sensitivity, Asthma, Nasal polyps) triad 
- Wegener’s or other granulomatous disease 
- Other middle ear or nasopharyngeal inflammation 
Anatomical obstruction with neoplasm or other lesion 
 
 
 
5.3.2  Medical treatment of Eustachian tube dysfunction 
 
Tubal dilatory dysfunction appears to be predominantly due to mucosal 
inflammatory disease, similar to chronic sinusitis, and can be managed in most cases with 
medical treatment.  Identification of the underlying etiology is important for success.    
Laryngopharyngeal reflux should be treated with dietary management, daily or twice 
daily proton pump inhibitors and H2 blockers at bedtime as indicated.  Refractory cases 
may be treated by sleeping on an inclined bed, and lastly, fundoplication can be done if 
necessary.(Koufman 2011) 
 
Symptoms and signs of allergic disease should be thoroughly investigated, doing 
appropriate testing and dietary elimination trials as indicated.  Avoidance of the 
offending allergen, oral antihistamines, leukotriene inhibitors, nasal antihistamines or 
mast cell stabilizers, nasal steroid sprays, and immunotherapy may all be pursued as 
required.(Kushnir 2011) 
 
The possibilities of other underlying pathologies should be carefully considered.  
Recurrent infections should raise the suspicion for underlying nasal or sinus disease, 
immunosuppression or immunodeficiency, or primary mucosal disease (eg. Samter’s 
triad, Wegener’s and other granulomatous disorders).   
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Anatomical obstruction secondary to neoplasm should be ruled out, especially in cases of 
unilateral persistent effusion.  Contrast-enhanced imaging studies are often necessary to 
recognize nasopharyngeal carcinoma and other malignancies.  Functional obstruction due 
to hypertrophic adenoid tissue contacting the torus tubarius can be treated by 
adenoidectomy.   
 
 
5.3.3  Tympanostomy tubes for dilatory dysfunction 
 
Persistent tubal dilatory dysfunction with OME or atelectasis has been successfully 
managed in most cases with tympanostomy tubes with excellent long term outcomes.  
Some patients, however, recur with effusion or atelectasis and require multiple 
tympanostomy tubes over many years.  Alternatively, tympanic membrane perforation or 
progression of atelectasis may develop and result in chronic otitis media with or without 
cholesteatoma.   
 
A number of "permanent" tubes have been developed in an attempt to provide longer 
lasting middle ear ventilation, but they are subject to problems with crusting, infection, 
obstruction, unplanned extrusion and development of unwanted large 
perforations.(Silverstein 1994) 
 
5.3.4  Eustachian tuboplasty on the osseus portion 
 
Numerous surgical procedures have been developed in an attempt to correct chronic 
Eustachian tube dilatory dysfunction.  Because the bony isthmus is the narrowest portion 
of the tubal lumen, all of the operations described historically have involved techniques 
to widen the osseous portion of the Eustachian tube.  (Zollner and Beck 1955) described 
stenting of the tubal lumen with silk threads and in 1963 (Zollner 1963) changed to the 
use of a polyethylene tube.  The stents had problems with extrusion and obstruction as 
well as a risk for internal carotid artery injury during the insertion process through the 
middle ear tubal orifice. (Wullstein 1960) performed the first reported case of drilling the 
osseus Eustachian tube from a middle ear approach and he expressed significant concern 
over the potential for internal carotid artery injury in future such attempts.  House et al. 
(House, Glasscock et al. 1969) reported performing a middle cranial fossa approach for 
exposure to drill and widen the Eustachian tube.  Misurya (Misurya 1975)performed a 
similar widening of the isthmus using a combined transcanal and preauricular approach.  
Jansen (Jansen 1985) focused on widening the posterior-superior aspect of the middle ear 
tubal orifice using endoscopic assistance.  Charachon et al (Charachon, Gratacap et al. 
1986) described a postauricular approach to widen the inferior and lateral tubal walls 
leaving silastic stents indwelling for 18 to 24 months.  Additionally they advocated 
removal of most of the tensor tympani muscle to gain additional width of the bony 
Eustachian tube.  Zini et al (Zini C 1988) performed an even wider tubal drillout 
involving the superior and inferior aspects of the osseous Eustachian tube in addition to 
removal of the tensor tympani muscle.  They also left silastic stents in place for 6 to 12 
months.  There have been no reports of long-term success using any of these above 
techniques. 
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5.3.5  Eustachian tuboplasty on the cartilaginous portion 
 
Given the mounting evidence from endoscopic investigations that dilatory dysfunction 
may commonly result from inadequate opening of the tubal valve within the cartilaginous 
portion, operations were proposed to widen this portion.  Laser Eustachian tuboplasty 
(LETP) was designed to ablate mucosa, submucosa and sometimes cartilage from the 
posterolateral wall of the tubal lumen to widen it and facilitate the dilatory efforts of the 
TVP muscle.  The operation was first performed by Kujawski in patients with varying 
degrees of OME and/or atelectasis, employing a carbon dioxide laser to ablate mucosa, 
soft tissue, and cartilage at the nasopharyngeal orifice.  The ablation extended along the 
posterior wall into the tubal lumen.  A retrospective report of the first 38 patients using 
either a carbon dioxide or 980 nm diode laser demonstrated that 81% remained free of 
Eustachian tube dilatory dysfunction after 36 months of follow-up. (Kujawski 2004) 
A subsequent prospective pilot study was conducted using a similar technique to evaluate 
the safety and efficacy of LETP in conjunction with a tympanostomy tube in patients 
with refractory OME.   The procedure resulted in the absence of effusion in 7/10 (70%) 
patients at 6 months and 3/5 (60%) patients at 12 months.  There were no significant 
complications.  Healing appeared to occur with regrowth of healthier appearing mucosa 
and scar tissue.  The torus tubarius and posteriormedial wall appeared thinner and with 
reduced inflammation compared to preoperatively.(Poe, Metson et al. 2003) 
 
A trial of Eustachian tuboplasty using a microdebrider for tissue ablation was done in 
twenty patients with chronic OME and sinus disease along with their endoscopic sinus 
surgery; 14/20 (70%) improved subjectively and by improvement in tympanogram and or 
pure-tone averages.  Failure correlated with higher preoperative CT sinus disease stage 
and with higher eosinophil counts in the biopsy specimens. (Metson, Pletcher et al. 2007) 
 
Most recently, Eustachian tuboplasty has been done with a KTP (potassium-titanyl-
phosphate) laser fiber making two or three transverse “cross hatch” cuts full thickness 
from the leading edge of the torus tubarius down through the mucosa and transecting the 
medial cartilaginous lamina nearly up to the valve.  The posterior surface perichondrium 
was spared.  The cuts were intended to alter the curvature of the medial cartilaginous 
lamina causing it to bow medially and widen the distal lumen and nasopharyngeal orifice.  
The procedure was retrospectively reported having been performed in 25 patients with 
varying degrees of ear blockage and abnormal tympanograms over an unspecified 
duration.  92% were relieved of fullness symptoms and 96% improved their 
tympanograms (from a baseline of types B, C, or shallow A) after a mean follow-up of 15 
months.  These results are promising, but longer follow-up and additional experience 
from other surgeons will be needed to judge the long-term importance of this new 
technique. (Yanez 2010) 
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5.3.6  Patulous Eustachian tube  
 
The patulous Eustachian tube has been defined as an abnormal patency in the lumen that 
results in autophony, the auditory perception of one’s own internal sounds.(O'Connor and 
Shea 1981) 
 
The symptoms of the patulous Eustachian tube were first described by Jago in 1858 (Jago 
1858) and recognition of the disorder as a clinical entity was reported by Schwartze in 
1864. (Schwartze 1864) Jago later wrote that he had personally experienced autophony 
and patulous Eustachian tube symptoms. (Jago 1867)    Patients typically report a feeling 
that their affected ear is "blocked," leading to confusion between the patulous Eustachian 
tube and tubal dilatory dysfunction.  Autophony is often described as similar to talking 
into a "wind tunnel" or "barrel" and they experience an "echo" or abnormally loud 
perception of their voice and nasal breathing.  It can occur spontaneously or be activated 
by exercise and prolonged talking; nasal or oral decongestants are of no benefit and may 
exacerbate the condition. The autophony can be very disturbing to patients and even lead 
to major depression and suicide.(DiBartolomeo 2009) 
 
Autophony is usually intermittent, although in severe cases the symptoms may persist for 
hours at a time.  It can generally be relieved, at least temporarily, by placing the head 
down into a dependent position or lying supine for some time.  Sniffing inward against a 
closed nostril to generate negative middle ear pressure, ipsilateral internal jugular vein 
compression, and the presence of an upper respiratory infection or allergies are also 
known to give some temporary relief from the condition. 
 
Confirmation of a patulous Eustachian tube on physical examination can only be done if 
the patient has active autophony during the exam. A brisk walk or going up and down 
stairs for several minutes prior to the examination may activate the symptoms.  Most 
commonly the tympanic membrane and middle ear will appear normal, but tympanic 
membrane scarring, atrophy, and retraction may occur from habitual sniffing.  The 
diagnosis can be confirmed by observation of medial and lateral movements of the 
tympanic membrane coincident with regular or forced nasal breathing.  These patulous 
excursions of the tympanic membrane are best observed with the operating microscope 
and with the patient in the sitting position.  Lying supine may cause venous congestion to 
close the patulous tube (Pulec, Kamio et al. 1975) and the excursions may be missed with 
a handheld otoscope. Excursions may be enhanced with obstruction of the contralateral 
nostril. (Doherty and Slattery 2003) A tympanogram may record “sawtoothed” waves 
synchronous with nasal breathing as a more sensitive test than microscopic observation 
and normal tracings should be present with breath-holding.  Tympanometry may also 
show middle ear negative pressure or hypermobility of the tympanic membrane. (Doherty 
and Slattery 2003) Nasopharyngeal endoscopy into the Eustachian tube lumen will reveal 
a concave longitudinal defect in the superior aspect in the anterolateral wall of the tubal 
valve, where it should normally be convex. (Poe, Abou-Halawa et al. 2001)  (Figure 4) 
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Figure 4.  Transnasal, 4mm, 45 degree Hopkins rod endoscopic view of orifice of a left 
patulous Eustachian tube.  Note concavity of antero-lateral wall extending through valve. 
 
    
 
The patulous Eustachian tube is thought to be due to the loss of tissue within the 
cartilaginous portion and it has been commonly reported with weight loss, especially in 
chronic wasting illnesses. (Pulec and Simonton 1964)  Additionally it has been associated 
with pregnancy,  use of high dose oral contraceptives, (O'Connor and Shea 1981) and 
estrogen therapy for carcinoma of the prostate.  (Shambaugh 1938) Associations have 
also been noted with conditions causing atrophy or scarring within the nasopharynx and 
musculature including adenoidectomy, radiation therapy, poliomyelitis, multiple sclerosis 
and other neuromuscular diseases, cerebrovascular accident, temporomandibular joint 
dysfunction, malocclusion, iatrogenic trauma, and craniofacial abnormalities. (PulecJL 
1973; Virtanen 1978; Cox 1980; O'Connor and Shea 1981)  Patulous Eustachian tube  
symptoms have been reported following protracted otitis media, (Tsuji T 2003)especially 
in patients who have developed a habit of excessive nose blowing or Valsalva maneuvers.  
Up to one third of patients have had no identifiable cause. (Doherty and Slattery 2003)  
An occasional association between patulous Eustachian tube and palatal myoclonus has 
been noted. (Hazell 1990) 
 
Numerous medical and surgical treatments have been reported for the patulous 
Eustachian tube.  Patients require reassurance that although the condition may be very 
disturbing, it is in no way dangerous or destructive.  Weight gain has been recommended 
by some, but it is only recommended when the patient is undernourished and 
underweight.  Decongestants and nasal steroid sprays should be discontinued.   Mucous 
thickening agents (Dyer and McElveen 1991), topical estrogen drops (Bluestone CD 
1998), and topical irritants intended to induce mucosal edema (Bezold K 1908) may be 
effective, but usually only temporarily.  Myringotomy with or without a ventilating tube 
has been reported to be helpful in half of the cases, (Pulec and Hahn 1970; Luxford and 
Sheehy 1982) but it appears to be most effective only in relieving the sensation of the 
tympanic membrane moving during breathing. 
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Surgical correction has been attempted by cauterization of the Eustachian tube orifice or 
lumen(Pulec and Simonton 1964) and removal of portions of the tubal 
cartilage(Simonton 1957).  Topical applications with nitric acid, phenol, salicylic 
acid/boric acid(Bezold K 1908), were effective for approximately two weeks and 
required repeated treatments.(O'Connor and Shea 1981)  Peri-tubal injections of paraffin 
caused granulomas(Zollner 1963) and gelatin sponge achieved only success for weeks to 
months(Ogawa, Satoh et al. 1976).  Injection of the tubal orifice with Teflon® paste 
(Pulec and Hahn 1970) could produce enduring benefit, but serious complications 
including cerebral embolism from inadvertent injection into the internal carotid artery 
caused the manufacturer to withdraw the material for this purpose.(O'Connor and Shea 
1981)  
 
Pterygoid hamulotomy in normal cats produced middle ear effusion in 31/43 
animals(Odoi, Proud et al. 1971)  Combining the procedure with transposition or 
transection of the tendon of the tensor veli palatine muscle yielded successful results with 
an average of two year follow-up in 11/16 patients.(Virtanen and Palva 1982) 
 
Lasting relief of autophony has been achieved by complete obstruction of the Eustachian 
tube using an angiocatheter occluded with bone wax (Bluestone and Cantekin 1981) or 
by cauterization of the lumen with insertion of a fat graft. (Doherty and Slattery 2003) 
These procedures generally require long-term middle ear ventilation with a tube.  
Insertion of a cartilage graft into a submucosal intraluminal pocket to add bulk to the 
posteromedial wall of the nasopharyngeal orifice has had some early success. (Kujawski 
2004) 
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6     PURPOSE OF THE STUDY 
 
 
The purpose of this study was to identify and quantify anatomical and physiological 
parameters of tubal dilation observed during video endoscopy.  Based on these findings 
and previous work, surgical procedures were designed to alter the dimensions of the 
functional valve within the cartilaginous Eustachian tube to treat OME or patulous 
disorders.  The following two hypotheses were tested in six studies: 
 
1.  The cartilaginous portion of the Eustachian tube contains a functional valve and 
pathology involving the valve leads to middle ear disease. Surgical dilation of the 
functional valve should improve otitis media with effusion.  
 
2.  The patulous Eustachian tube has a concave shape in the antero-lateral wall causing 
insufficiency in the functional valve. 
 
The specific aims of the study were: 
 
Study 1 To quantify metric and time parameters from video recordings of transnasal 
Eustachian tube endoscopy, establishing normal values and comparing them statistically 
with patients who had OME or patulous dysfunction.    
 
Study 2 To apply a newly invented technology to simultaneously measure sonotubometry 
in synchrony with video endoscopy.  Sonotubometry would provide objective 
measurements of tubal opening and endoscopy would concurrently demonstrate the 
phases of dilation.   
 
Study 3 To evaluate safety, efficacy and long term data from a prospective study of 
Eustachian tuboplasty for medically refractory long-standing OME.     
 
Study 4  To investigate feasibility and safety of  balloon dilation technology to dilate the 
lumen of the Eustachian tube in a cadaver model with CT and dissection analyses of the 
results. 
 
Study 5  To evaluate the safety and potential for efficacy in a prospective study of 
balloon dilation of the cartilaginous Eustachian tube in patients with refractory long-
standing OME. 
 
Study 6  To evaluate the role of a concave defect in the lateral wall of the functional 
valve as the etiology of patulous Eustachian tube with video endoscopy.  Additionally, a 
prospective trial of surgical augmentation of the lateral wall and valve was conducted for 
treatment. 
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7     MATERIALS AND METHODS 
 
7.1 SUBJECTS 
 
Table 4 shows a summary of the study with a breakdown of the interventions performed 
in the six sub-studies that involved normal subjects, patients with OME or patulous 
Eustachian tubes or cadaver heads (without ear or sinus disease). The study progressed 
from studying video endoscopy of Eustachian tubes to the development and application 
of surgical methods for correcting the observed pathology.  
 
Video endoscopy was obtained in all subjects and analyzed for various parameters or 
pathology.  Endoscopy on contralateral normal ears was not performed if the subject 
declined the exam.   Video software was used to make quantitative measurements from 
recorded examinations. (study 1)  Sonotubometry was performed to make additional 
measurements of tubal opening by simultaneously combining it with endoscopy (study 
2).  Patients with long-standing refractory OME who were found on endoscopy to have 
prominent mucosal thickening from inflammation in the functional valve of the 
Eustachian tube underwent laser resection of intraluminal tissue for dilation of the valve 
and orifice (laser Eustachian tuboplasty) (study 3).  An alternative method for dilation of 
the valve using sinus balloon technology was explored in cadaver specimens (study 4) 
and in patients with long-standing refractory OME (study 5). For patulous Eustachian 
tubes, a leak in the functional valve was sought and the antero-lateral wall was surgically 
augmented to close the defect (study 6).   
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Table 4 shows an overview of the interventions and number of subjects investigated.  
All subjects were adults 18 years or older. 
 
Study Interventions Disease n 
(ETs) 
n 
(subjects)  
n 
(Total ETs) 
1 Video endoscopy 
Analysis of timing 
parameters  
Analysis of metric 
parameters 
-  
Normal 
subjects 
24 15 68 
Otitis media 
with effusion 
20 13 
Patulous ET 24 15 
2 Video endoscopy 
sonotubometry 
Normal 
subjects 
18 18 18 
3 Video endoscopy 
Laser Eustachian 
tuboplasty 
Otitis media 
with effusion 
13 13 13 
4 
Video endoscopy 
CT scan 
Balloon dilation of  
Eustachian tube 
Video endoscopy 
CT scan with contrast in 
lumen 
Anatomical dissection 
Normal 
unembalmed 
cadaver 
heads 
 
16 
 
8 
 16 
5 Balloon Dilation of ET Otitis Media 
with 
Effusion 
11 11 11 
6 Video endoscopy 
Patulous ET 
Reconstruction 
Patulous ET 14 11 14 
 
7.2  METHODS 
 
7.2.1  MEASUREMENTS OF EUSTACHIAN TUBE DILATION BY VIDEO 
ENDOSCOPY (STUDY 1) 
 Measurement of torus tubarius and antero-lateral wall timing and movements.  
 
Recorded examinations from Eustachian tube 4 mm Hopkins rod 30 degree (Karl Storz, 
Tuttlingen, Germany) endoscopic examinations in the office were studied and 
measurements were taken by reviewing video and still frames with OsiriX DICOM 
viewer software v.3.7, (Geneva, Switzerland).  Magnification of images increases 
exponentially in proximity with a target and presents a problem for measuring lengths 
without references in the image.  To resolve this issue, measurements were made in 
reference to the height of the torus tubarius, which is an easily recognizable landmark.  
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Lengths were calculated as a percentage of the torus tubarius height.  Torus tubarius 
heights were visualized at roughly similar magnifications between patients and the 
absolute measured lengths were statistically compared.  The height of the torus tubarius 
was measured in pixels in both the resting position and in the maximally medially rotated 
position during dilatory efforts. The average of these values was used as the torus 
tubarius unit of measurement.  
 
The angle of rotation of the torus tubarius was calculated by the software.   The 
maximum lateral excursion of the anterolateral wall (by TVP muscle action) within the 
orifice and the height of maximal palatal elevation (inferior to the torus tubarius) were 
measured as percentages of the torus tubarius unit.  Durations of the dilatory sequence, 
time to rotate the torus tubarius medially and the duration of apparent opening of the 
valve were measured directly from the time line in Final Cut Pro video processing 
software (Apple, Cupertino, CA)   Measurements were evaluated statistically with SPSS 
17.0 statistical software package (IBM, Chicago, IL).  Independent samples Mann-
Whitney U tests were employed using p<0.05 for the level of significance.   
 
 
 
7.2.2  SYNCHRONOUS ENDOSCOPY AND SONOTUBOMETRY OF THE 
EUSTACHIAN TUBE (STUDY 2) 
 
Subjects underwent endoscopic nasopharyngoscopy with sonotubometry.  The 
examination utilized a novel device to record synchronous and simultaneous 
sonotubometer and digital video recordings of transnasal endoscopy (MMS-S10-EV 
Eustachian Tube Analyser, Marchbanks Measurements Systems, Lymington, UK). 
Figure 5 
 
 
Figure 5.  A. Shows Eustachian tube Analyser in the office.  B. Shows the nasal speaker 
and ear transducer in position in a subject. 
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Endoscopy was performed as previously described using a rigid 45 Hopkins rod 
endoscope (Karl Storz, Tuttlingen, Germany) or flexible nasopharyngoscope (Pentax, 
Montvale, NJ) fitted with a single chip analog charge coupled device (CCD) video 
camera (Karl Storz).  Sonotubometry was performed with the speaker placed into the 
nostril contralateral to the Eustachian tube to be studied. A microphone was placed in the 
ipsilateral external auditory canal (EAC) and sealed against the EAC walls.  The 
endoscope was passed through the ipsilateral nasal cavity.   The nasal speaker was set to 
a produce a 7 kHz tone at 100 dB SPL for a duration of 6.0 seconds.  The nasal probe 
tone signal was detected by the EAC microphone, amplified, passed through an RMS 
converter, onto a true log dB amplifier and finally to a 12 bit analog to digital converter.  
Video recording was done at 29.97 frames per second and calibrated to the 
sonotubometer with a measured variance of +/- 20 ms.  Recordings were made during 
swallows to observe physiological dilation of the Eustachian tubes and with forced yawns 
for sustained maximal efforts. During each 6.25 seconds long video clip, subjects could 
typically perform two swallowing efforts, at times three. Normal individuals do not dilate 
their Eustachian tube to open with every swallow.  Dilation of the functional valve was 
observed on endoscopy by the coordinated actions of the LVP contraction holding the 
torus tubarius in a medialized position against which the TVP subsequently dilated the 
antero-lateral wall to produce a rounding of the valve to the fully dilated position.   
Dilation of the valve to the open position was determined by the observation of a 5 dB 
rise in the dB SPL in the microphone signal from the sonotubometer that coincided with 
the muscular effort.  
 
 
7.2.3  EUSTACHIAN TUBOPLASTY TO WIDEN THE EUSTACHIAN TUBE 
ORIFICE AND FUNCTIONAL VALVE (STUDY 3) 
 
Laser debulking of the luminal surface of the torus tubarius and postero-medial wall up to 
or including the valve was performed to widen the aperture in patients with long-standing 
refractory OME.  The study was a prospective continuation of a pilot trial to add longer 
term follow-up in an expanded cohort.  The outcomes were presence or absence of 
effusion on otomicroscopic exam and tympanogram type A, B or C.   
 
13 of 16 patients operated met criteria for the study having had at least a five-year history 
of chronic otitis media with effusion (OME). They had each undergone at least two prior 
tympanostomy tube placements with recurrence of the effusion immediately following 
extrusion of each of the tubes.  8 of the 13 patients were originally presented in the 
preliminary LETP study (Poe, Metson et al. 2003) and their subsequent data is included 
in this report.  The average follow-up was 26 months (range, 14 to 34 months). The 
patients served as their own historical controls. 
 
 All patients underwent preoperative transnasal endoscopic slow-motion video analysis of 
their Eustachian tubes and were found to have disease within the cartilaginous portion 
consistent with a functional obstructive disorder.   
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All patients were treated for a minimum of eight weeks with nasal corticosteroids and 
medical therapy for allergic or laryngopharyngeal reflux disease was given if indicated by 
signs or symptoms.  Failure to show improvement of OME following medical 
management was the final inclusion criterion. Audiograms and tympanograms were 
performed preoperatively. 
 
Surgery was performed unilaterally, on the worse ear if it the condition were bilateral.  
 
The study protocol was approved by the institutional (ethical) review board of the 
Massachusetts Eye and Ear Infirmary, Boston, MA, USA.  All patients were provided 
appropriate information regarding study design and had signed informed consents. 
 
Eustachian tuboplasty surgical technique  
 
Patients were placed in the supine position, maintained with general anesthesia, and 
orally intubated.  Figure 6 
 
 
Figure 6: Operative setup for left-sided LETP with tonsil mouth gag in place and nasal 
endoscope in the left nostril.  An optional endoscope holder is fixed to the mouth gag.   
 
Ventilation of the ipsilateral middle ear was achieved by placing a 0.9-mm-silicone mini-
Baxter tympanostomy tube in 10 cases, or by removing an obstructed permanent 
tympanostomy tube and leaving the tympanic membrane perforation in 2 cases.  
Myringotomy alone was performed in one case. Middle ear effusion was aspirated.  A 
30o 4-mm-diameter nasal endoscope was placed through the ipsilateral nasal cavity to 
visualize the tubal orifice.  A tonsil mouth retractor was placed and surgical instruments 
were passed transorally.  Local infiltration using 1% lidocaine with 1:100,000 
epinephrine was performed in the tubal orifice.  The medial cartilaginous lamina within 
the torus tubarius was identified and palpated as a landmark.  A 980-nm contact-tip diode 
laser (Biolitec, East Longmeadow, MA) with settings of 7 W power, continuous pulse 
mode with 0.2 seconds on and 0.8 seconds off was used in the first six cases.  The diode 
laser was on loan and after its return to the manufacturer, an argon laser (HGM, Medical 
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Laser Systems, Salt Lake City, UT) with settings of 3 W, 0.2 sec pulse duration, 
continuous mode was used in the subsequent five cases.  Vaporization of mucosa and 
submucosa to expose the underlying cartilage was done to create a wedge shaped defect 
on the intraluminal surface of the torus tubarius and postero-medial wall.  Submucosal 
vaporization was done in the valve region sparing the mucosa. Figure 7 
 
 
 
 
Figure 7  LETP.  A. Preoperative image shows significantly thickened inflammatory 
changes in the mucosa of the torus tubarius with bulging into the lumen.  B. Argon laser 
vaporization of mucosa and submucosa of postero-medial wall to expose the medial 
cartilaginous lamina with sparing of the antero-lateral wall.  C.  Resection of 
cartilaginous bulge from torus tubarius. D  Completed resection.  Note intact valve 
mucosa but removal of underlying submucosa. 
 
The resection was confined to the postero-medial wall avoiding injury to the antero-
lateral wall.  The medial cartilaginous lamina was thinned when it protruded into the 
lumen.  The extent of surgical excision was determined by the degree of bulk seen at the 
pre-operative slow-motion video analysis, In two patients, mucosal biopsies of the torus 
tubarius were obtained at the time of LETP and several months postoperatively. 
 
Patients were followed with audiograms, tympanograms, and microscopic examination of 
the ears for 6 months, 1 year, and yearly intervals thereafter.  Two year follow-up is 
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reported as the three year follow-up data was insufficient due to lack of patient follow-up.  
Patients who were suspected of having reflux disease were continued on omeprazole 20 
mg orally daily for at least 6 weeks after surgery.  Failure of LETP was determined if 
OME recurred as diagnosed by oto-microscopic examination.   
 
A tympanostomy tube placement or myringotomy was performed to assure that patients 
had at least the same temporary benefit that had been experienced with previous tubes.  
As a pilot study, the goal was to establish whether the novel procedure could have a 
demonstrable effect in altering patients’ refractory OME history, in which a tube had 
been previously placed at least two times and the effusion had promptly recurred each 
time.   
 
 
7.2.4  FEASIBILITY AND SAFETY EVALUATION OF BALLOON DILATION 
OF THE EUSTACHIAN TUBE IN CADAVERS  (STUDY 4) 
 
Unembalmed adult human cadaver half-heads underwent baseline axial computed 
tomographic (CT) scans (CereTom® OTOscan, NeuroLogica Corporation, Danvers, MA) 
in the supine position with 0.625 mm slice thickness.   Endoscopic photographs of the 
nasopharyngeal orifice of the Eustachian tube were obtained at baseline and at each stage 
of the procedures using 0° and 30° angled, 4mm diameter Hopkins rod endoscopes fitted 
with a three chip CCD video camera (Karl Storz, Tuttlingen, Germany).  Instruments 
were passed through the nasal cavity to simulate an actual surgical procedure to the 
maximum extent possible. 
The sinus balloon dilation system (Acclarent, Inc., Menlo Park, CA) was employed for 
dilation of the cartilaginous portion of each Eustachian tube.  The guide catheter was 
inserted just into the tubal nasopharyngeal orifice and a Relieva Vigor™ sinus guidewire 
was threaded through the catheter into the lumen of the Eustachian tube lumen and 
advanced under fluoroscopic guidance using a C-Arm to reach the bony isthmus.   The 
guiding catheter was removed and imaged again with CT. A 6 or 7 mm diameter x16mm 
length Relieva Solo™ sinus balloon catheter was passed over the guide wire until 
reaching resistance near the bony-cartilaginous isthmus.  The balloon typically protruded 
from the tubal orifice approximately 2 – 3 mm.  The guidewire was removed and the 
balloon was inflated to 12 atm for one minute, after which it was deflated and removed. 
Endoscopic assessment of the dilation was performed immediately after dilation.  CT 
scans were then obtained approximately 15 – 60 minutes afterwards, placing the ½ heads 
into a lateral decubitus position with the tubal orifice facing upwards and the orifice was 
filled with Omnipaque contrast solution, 300mg I-/ml (GE Healthcare, Princeton, NJ) in 
order to accurately visualize and quantify the dimensions and volumes post-dilation. 
 Careful assessments were made to inspect for any adverse effects from the dilation 
including endoscopic inspection, surgical dissection of the cartilage, muscles, soft tissues 
and adjacent temporal bone, basisphenoid, or pterygoid plates, and detailed review of the 
CT scans.   
39 
 
A final trial of dilation was performed in four Eustachian tubes of two unembalmed 
whole cadaver heads under endoscopic guidance to best simulate surgical conditions.    
After  dilation, close endoscopic inspection was done to assess for any evidence of 
adverse effects, including a visual survey of the mucosa and palpation of the posterior 
cushion to inspect for excessive mobility. Figures 8 a-c 
 
 
Figure 8 A.  Endoscopic view of right Eustachian tube in cadaver at baseline.  B. 7mm x 
16 mm sinus dilation balloon is inflated in position.  C. Tubal lumen post dilation. 
 
CT scans were additionally analyzed to determine the dimensions and volume of the 
cartilaginous Eustachian tube pre- and post-dilation.  Cross sectional areas with 
respective major and minor axis diameters at approximately 4 mm intervals, and volumes 
were computed using OsiriX software (OsiriX Foundation, Geneva, Switzerland).  
  
A curvilinear line representing the longitudinal axis of the Eustachian tube was used to 
create 2D Curved MPR (Multiplanar) perpendicular reconstructions from which the 
length of the longitudinal axis could be measured as well as the cross-sectional areas and 
lengths of the major/minor axes of the oval shaped cross sections.  Volumes were 
calculated by manually outlining a region-of-interest on each axial slice and using the 
volume estimation algorithm. 
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7.2.5  BALLOON DILATION OF THE CARTILAGINOUS EUSTACHIAN TUBE 
(STUDY 5) 
 
 
 
Patients with unilateral or bilateral persistent OME for ≥five consecutive years, broken 
only by tympanostomy tubes or tympanic membrane (TM) perforation were evaluated as 
candidates for ET surgery.  None of the subjects could insufflate their ears with a 
Valsalva maneuver.  Otomicroscopy and tympanometry were done bilaterally.  Video 
rigid or fiberoptic endoscopy of the Eustachian tube with slow motion review 
demonstrated mucosal inflammation as the predominant finding, indicating dilatory 
dysfunction of the ET as opposed to dynamic (muscular) dysfunction.  The techniques for 
endoscopic examination and a scoring system for rating mucosal inflammation have been 
previously reported. (Poe, Metson et al. 2003).  The mucosal inflammation score was 
modified to separate mild and moderate disease and remains unvalidated.  The score 
consisted of 1 = normal mucosa; 2 = mild edema and or erythema, with or without 
increased mucus; 3 = moderate edema and erythema with significant compromise of 
dilation of the lumen during swallows and yawns; 4 = severe edema and erythema with 
inability to dilate the lumen open.  Preoperative high resolution computed tomography 
(CT) scans were obtained to rule out anatomical anomalies of the ET or cranial base and 
dehiscence of the internal carotid artery into the tubal lumen. 
 
Candidates for surgery were offered the option of continuing their current management or 
undergoing a procedure consisting of unilateral balloon dilation of the cartilaginous ET.  
In the case of bilateral disease, the side with the worst ear pathology was selected. 
 
Outcomes included the ability to self-insufflate air through the ET with a Valsalva 
maneuver, rating of mucosal inflammation at the tubal orifice as seen by endoscopy, 
otomicroscopic findings of OME/TM retraction/normal and tympanogram curves types 
A/B/C. 
 
Informed consent was obtained and the protocol was approved by the Ethical Committee 
(equivalent to USA IRB) for the Päijät-Häme Central Hospital, Lahti, Finland (Balloon 
Dilation of the ET R09054).  All cases were performed by the second author at that 
secondary referral hospital and some were assisted by the first author. 
 
Surgical technique 
Patients were induced and maintained under general anesthesia with endotracheal 
intubation in the supine position.  Topical Oxymetazoline hydrochloride decongestant 
was applied to the nasal cavities.  A 30 degree Hopkins rod endoscope (Karl Storz, 
Culver City, CA) was introduced through the ipsilateral or contralateral nasal cavity.  
Video images were displayed on a monitor (Karl Storz, Tuttlingen, Germany). 
 
Similar to the rationale in Study 3, as this was a pilot study of safety and exploration of 
possibility for efficacy, a tympanostomy tube was inserted in the two cases with OME at 
the time of the surgery so that patients could experience immediate symptom 
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improvement as with prior tympanostomy tube procedures.  The remaining cases had a 
tube, perforation, or atelectasis. 
 
The sinus balloon dilation system (Acclarent, Inc., Menlo Park, CA) was employed to 
dilate the cartilaginous portion of the ET.  A curved guiding catheter with a tip angle of 
70 degrees was passed through the nasal cavity with the tip placed just into the ET 
nasopharyngeal orifice.  A 7 mm diameter x 16mm length Relieva Solo™ sinus balloon 
catheter was passed through the guiding catheter and atraumatically into the ET orifice 
until reaching the first mild resistance as it approached the narrowest diameter at the 
bony-cartilaginous isthmus.  The balloon typically protruded from the tubal orifice about 
2 – 3 mm. 
 
The balloon catheter lumen was left open to allow for air escape from the proximal 
(toward the middle ear) ET during inflation.  The balloon was inflated with sterile water 
up to 12 atm for one minute after which it was deflated and removed.   
 
The immediate effect on widening of the lumen of the ET was judged qualitatively from 
intraoperative videos reviewed following the surgery and by palpation of the torus 
tubarius.  The degree to which the functional valve was opened by the dilation and 
remained open was estimated by the increase in apparent depth of view into the lumen of 
the ET.  As the mucosal surfaces are normally in apposition in the valve, the length of 
persistent opening of the valve could reflect the immediate result of the dilation.  The 
effectiveness of the dilation was rated as none if there were no visible change, small if the 
apparent increase in distance seen was estimated at < 4 mm, medium for ≥ 4 mm without 
seeing the isthmus, and patent if the valve was dilated open and the isthmus was visible. 
 
All patients were treated on an out-patient basis.  Follow-up exams were scheduled for 
one and six months post-op and were planned to include otomicroscopy, tympanogram, 
endoscopy of the ET, demonstration of attempt to do a Valsalva maneuver and a repeat 
rating of the mucosa of the ET lumen.  Valsalva maneuvers were neither coached nor 
practiced.  Subjects were merely asked to perform these maneuvers during their office 
visits. 
 
Statistical analysis was done with using SPSS 17.0 statistical software package (IBM, 
Chicago, IL) with 2-tailed Fisher’s exact test performed using p < 0.05 for significance.  
The patients were used as their own historical controls, given their long-standing disease. 
 
 
 
7.2.6  IDENTIFICATION OF THE PATULOUS EUSTACHIAN TUBE DEFECT 
AND SURGICAL CORRECTION WITH AUGMENTATION OF THE LATERAL 
WALL.  (STUDY 6) 
 
Patulous Eustachian tube reconstruction (PETR) was performed in patients who had been 
symptomatic for a median of 6 years and had failed conservative management.  Second-
sided procedures were staged.  Slow motion video endoscopy was done to inspect for a 
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defect in the functional valve of the Eustachian tube.  The outcome measure was a self-
reported assessment of the patient’s autophony scored as:  1) complete relief, 2) 
significant improvement, satisfied, 3) improvement, dissatisfied, 4) unchanged, 5) worse.   
 
 
PETR surgical technique 
 
PETR was performed as an outpatient procedure under general anesthesia using a 
combined endoscopic trans-nasal and trans-oral approach similar to that described for 
LETP above. Autologous nasal septal or tragal cartilage or AlloDermTM  acellular 
cadaveric dermal implant (Life Cell Corp., the Woodlands, TX) were used for graft 
materials.  Under endoscopic guidance, a 200 micron fiber-delivered argon ion laser 
(HGM Co) with settings of 3.5 W and 500 ms or a diode pumped KTP laser (Iridex Co.) 
with settings of 1500 milliwatts and 500 ms were used to make the incision and initial 
dissection into the submucoperichondrial plane along the roof of the Eustachian tube 
lumen.  The incision was made circumferentially along the superior half of the 
nasopharyngeal orifice and carried deeply to expose the medial and lateral cartilaginous 
laminae. 
 
Figure 9  PETR in a left Eustachian tube.  The incision and underlying cartilaginous 
landmarks are demonstrated.   
 
Sharp and blunt dissection with curved instruments was done to develop the 
submucoperichondrial flap creating a pocket inferior to the cartilage roof and the pocket 
was dissected up well into the valve. 
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Figure 10  Blunt dissection of the submucoperichondrial flap.   
 
 
 The resultant pocket was filled with multiple wedges of autologous cartilage grafts or 
with Alloderm™ implant measuring between 1 x 1cm to 1 x 2cm. Sufficient graft 
material was placed into the pocket to overcorrect the concave defect in the anterolateral 
wall anticipating a 50 to 60% loss of graft volume postoperatively. The mucosal wound 
was closed with sutures.   
 
 
 
 
Figure 11  Positioning of cartilage graft wedges into the pocket.   
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Figure 12  Positioning of cartilage graft wedges into the pocket.   
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8     RESULTS 
 
8.1  MEASUREMENTS OF EUSTACHIAN TUBE DILATION BY VIDEO 
ENDOSCOPY (STUDY 1) 
 
Heights of the torus tubarius for the unit of measure 
  
There were no statistically significant differences in the heights of the torus tubarius 
between the groups, which consisted of normal controls, patients with OME and patients 
with patulous Eustachian tube.   
 
 
Duration of Eustachian tube dilatory cycle 
 
There were no statistically significant differences between the groups regarding the 
duration of any portions of the tubal opening and closing cycle.  The mean cycle time 
was 995 ms for normal subjects.  There was a trend toward a longer cycle time with 
patulous tubes at 1276 ms. 
Torus tubarius rotation time measured the duration from initiation of its medial rotation 
to its maximally rotated position and there were no significant differences between the 
groups. 
 
Opening time of the valve represented the duration that the functional valve appeared to 
be dilated open or made maximal efforts to dilate.  The opening time for normal subjects 
was 10.5 ms and there was a trend for prolongation of the opening time in dilatory 
dysfunction Eustachian tubes at 15.1 ms.   
 
Linear and angular measurements in the Eustachian tube dilatory cycle 
 
There were no significant differences between groups regarding height of elevation of the 
palate.  Elevation in normal subjects was 34.8% of torus tubarius height. 
 
Lateral excursion of the antero-lateral tubal wall, the distance traveled due to TVP 
contraction, was significantly reduced in dilatory dysfunction (23.9% of torus tubarius 
height, p=0.015) and even more reduced in patulous Eustachian tube (18.7%, p= 0.001) 
in comparison to normals (35.5%).   
 
The mean angle of rotation of the torus tubarius during dilation for normals was 34.2° 
and there was no significant difference from the other groups. 
 
The important results are summarized in table 5 at the end of this section 8 and the 
complete results with statistical analyses are in the Study 1 article (Poe and Pyykkö 2010) 
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Figure 13 shows the parameters measured on the closed and dilated position still frames 
that were grabbed from the video endoscopic exam. 
 
 
8.2  SYNCHRONOUS ENDOSCOPY AND SONOTUBOMETRY OF THE 
EUSTACHIAN TUBE (STUDY 2) 
 
Sonotubometer measurements 
 
Quantitative results of the sonotubometer measurements during swallow or yawn 
maneuvers to open the Eustachian tube are summarized in table 5.  The number of 
subjects that appeared to open the ET, as observed by endoscopy, or objectively opened 
it, as recorded by a ≥ 5 dB signal increase by sonotubometry, is shown in the first column 
for each maneuver.  The duration and amplitude of the sonotubometer signal increases 
are listed within the same cell below the number of subjects that opened their Eustachian 
tubes.   
 
One subject was excluded from data analysis due to increases in sound intensity 
with tubal opening significantly larger than for other subjects. Six out of the remaining 
seventeen (35.3%) subjects failed to demonstrate a voluntary ability to develop objective 
opening with swallowing during the study.  For the 11/17 that did open the Eustachian 
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tube during swallows, successful opening was variable (range 10-100% of openings per 
swallows). Four subjects opened their Eustachian tubes with every swallow (i.e. 100% 
openings per swallows). The average duration of tubal opening during swallows as 
measured by sonotubometry was 0.44 seconds, and the average increase in sound 
intensity reaching the EAC was 9.2 dB.  Yawning resulted in a higher percentage of 
instances of tubal opening compared to swallowing and only four subjects (23.5%) could 
not open the Eustachian tube during a forced yawn. The average opening time was 2.03 
sec and the intensity of sound recorded in the EAC increased by an average of 10.1 dB. 
 
Correlation between sonotubometer results and video endoscopy 
 
There was a 100% correlation between sonotubometric detection of a significant 
rise in dB SPL to indicate tubal opening and endoscopic observation of valve dilation to 
the open position.  On the contrary, endoscopic observations of valve dilation did not 
correlate with a dilation to open on the sonotubometry in 1/11 cases.   Assuming the 
sonotubometry to be the “gold standard,” this yields a specificity of 0.92.    
 
A negative sound pressure wave was recorded in a number of instances, 
immediately preceding a swallow related opening. In figure 14 recorded from subject 8, 
a bubble of nasal secretions is seen in the Eustachian tube orifice; the sonotubometer 
recording reflects a closed Eustachian tube. Upon swallowing figure b shows the bubble 
to be inflated and the sonotubometer records a reduction in the sound intensity reaching 
the EAC.  These findings are compatible with air being pushed from the Eustachian tube 
into the nasopharynx.  
 
The results are summarized in table 5. 
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Figure 14.  Sonotubometer and video endoscopy demonstrating an air bubble 
being forced out of the tubal lumen between resting baseline A and action of the 
pharyngeal constrictor and LVP muscles to initiate a swallow in B.   
 
 
 
8.3  LASER EUSTACHIAN TUBOPLASTY (STUDY 3) 
 
8.3.1  Outcomes of laser Eustachian tuboplasty 
 
The outcomes for LETP are summarized in table 5 .  In the preoperative assessment, 9/13 
cases had effusion filling the middle ear and 4/13 cases had a mixture of atelectasis and 
effusion.  Laryngopharyngeal reflux was diagnosed in 9/13 (69%) and allergic rhinitis in 
10/13 (77%). LETP in combination with tympanostomy tube eliminated OME in 4/11 of 
the patients at 6 months, 3/10 at 1 year, and 3/8 at 2 years. 
 
 
Comorbidities 
 
Comorbidities were associated with failures in the 1 year results.  The difference between 
successful and failed LETP patients showed statistically significant correlation with the 
presence of reflux disease (0% vs. 40%, respectively, p=0.01) or allergic disease (10% vs. 
30%, respectively, p=0.05).  At two years, there was no significant difference between 
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successful and failed LETP patients with the presence of either reflux (10% vs. 30%, 
respectively, p=0.10) or allergic disease (10% vs. 20%, respectively, p=0.20) by chi 
square analysis.   
 
Audiometry results 
 
Successful LETP + tympanostomy tube patients demonstrated a statistically significant 
difference in their mean pre-treatment pure tone average (PTA) (35.3 dB) and post-
treatment PTA at 1 and 2 years (12.9 dB and 20.8 dB, respectively, p=0.028).  There was 
no statistically significant worsening of the PTAs in either the successful or failed groups.   
 
Histology 
 
Pre- and post-operative histological examinations were obtained in two patients.    
Preoperatively there was severe inflammation with hemorrhagic changes.    
The pseudostratified columnar mucosa was hypertrophied and without cilia.  There was a 
severe inflammatory infiltrate within the submucosa and mucosa.  The post-operative 
specimen showed some moderate inflammation and hypertrophy with return of a ciliated 
epithelial border. The inflammatory infiltrate did not involve the mucosa.  There was 
fibrosis in the submucosal layer but the overall thickness of the mucosa and submucosa 
was substantially reduced compared to preoperatively.    
 
Postoperative endoscopy 
 
Comparison of endoscopic examinations preoperatively Figure 15 A,B  and 
postoperatively in Figure 15 C,D showed that the wounds healed with a stellate-shaped 
scar over a scaphoid loss of volume in the postero-medial wall adjacent to the valve. The 
result was a wider tubal orifice and distal portion of the valve in nearly all cases, 
including failures.   
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Figure 15 showing pre LETP and 1 year post LETP office endoscopic exams of the right 
Eustachian tube 
 
 
Complications were insignificant and were limited to one soft intranasal synechia and a 
small synechia between the posterior surface of the torus tubarius and the adjacent 
adenoid mucosa.  Two other patients developed a small red granuloma in the center of the 
resected area of mucosa that were treated with nasal corticosteroid spray for six weeks 
and the granulomas subsided completely.  There were no instances of epistaxis, nasal 
obstruction, significant pain or intraluminal adhesions or strictures.  There were no 
patulous Eustachian tubes as a result of LETP. 
 
 
8.4  BALLOON DILATION OF THE CARTILAGINOUS PORTION OF THE 
EUSTACHIAN TUBE:  INITIAL SAFETY AND FEASIBILITY ANALYSIS IN A 
CADAVER MODEL (STUDY 4) 
Dilation outcomes 
Successful balloon dilation was achieved in all Eustachian tubes without any major 
adverse effects. Dilation of the 12 Eustachian tubes in the ½ heads was accomplished 
with a 7 mm diameter balloon in 8 (66.7%) and with a 6 mm balloon in 4 (33.3%).  In 
most cases, the inflated balloon locked securely into position leaving approximately one-
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third of the 16 mm length protruding distally from the orifice.  In all cases, the dilation 
caused medialization of the torus tubarius, medially rotating the free portion of the medial 
cartilaginous lamina. 
Post dilation measurements 
Average intraluminal volumes of the cartilaginous Eustachian tube increased from pre-
dilation 0.16 cm3 to post-dilation 0.49 cm3 (increase of +357%), (p < 0.001).  
Measurements of the post dilation lengths of the cartilaginous portion of the Eustachian 
tube averaged 26.3 mm (SD 1.7830, range 23.3 – 29.0)   Cross sectional areas were 
measured at approximately 4 mm intervals through the cartilaginous Eustachian tube with 
the results depicted in Figure 16.   
 
Figure 16 shows average cross sectional areas of the post-dilated Eustachian tube at 
distances from the nasopharyngeal orifice specified on the x-axis.  The greatest effects of 
dilation are seen from 4 mm to 16 mm. 
At the Eustachian tube orifice (0 mm distance) and at the bony cartilaginous junction (ave 
26.3 mm), there were no significant differences between pre- and post-dilation areas (p = 
0.61 and p = 0.54 respectively).  At the remaining distances, post-dilation areas were 
significantly larger (p < 0.001 for each distance).  
 Adverse effects 
There were minor adverse effects in three Eustachian tubes, which were limited to 
lacerations of the luminal mucosa.  There were no other soft tissue or bony injuries in the 
½ head or whole head specimens.   
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The results are summarized below in table 5. 
 
8.5  BALLOON DILATION OF THE CARTILAGINOUS EUSTACHIAN TUBE 
 
Demographics 
 
There were 11 patients (5M, 6F) ages 33-76 years (average 51.8) having had previous 
tympanostomy tubes (ave 4.7).  The preoperative status and post operative results are 
summarized in Figure 17 and the Valsalva outcomes are summarized in table 5. 
 
 
 
Figure 17 shows the pre operative status and post-operative results after the balloon 
dilation procedure.  Follow up range 6 – 14 months (mean 9.2) A 
 
Dilation outcomes 
 
Balloon dilation results are summarized in Table 6.   
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Table 6 
 
 
 
 
   
   Balloon Dilation    
       
Case # Side Atm Dilation effectiveness Mucosal tear Adjunctive procedure Comment 
1 R 12 Medium Yes remove tube  
2 L 12 Patent Yes remove tube  
3 L 10 Medium    
4 L 8 Small   Balloon slipped out by end of dilation 
5 L 8 Small  remove tube Balloon protruded 30% 
6 L 12 Patent    
7 L 12 Patent   Balloon protruded 30% 
8 L 12 Medium  insert tube  
9 L 10 Medium Yes  Dilation repeated x1 
10 L 12 Patent Yes   
11 L 12 Patent Yes insert tube  
 
 
The balloon typically protruded out of the orifice by 25 to 30%.  It was monitored during 
inflation and the guide catheter adjusted to hold it in position if it began to slip out more 
than 30%.   
 
Dilation of the ET occurred successfully in all cases.  The dilation effectiveness was 
small in the 2 cases inflated to 8 atm, medium in the 2 cases dilated to 10 atm, and dilated 
to fully open in 5/6 (83.33%) cases inflated to 12 atm.  The full dilation associated with 
12 atm was significant (p = 0.048).  The position of the posterior cushion was not altered 
and there was no increase in flexibility to suggest cartilaginous fractures.  There was no 
persistent bleeding. 
 
 
Complications 
 
A mucosal laceration within the lumen of the ET occurred in 5/11 (45.5%) and 4 of the 5 
had been inflated to 12 atm.  The lacerations were limited to the mucosa, were less than 5 
mm in length, and were considered to be clinically acceptable (minor adverse effect).  
Bleeding from the lacerations was very limited and of brief duration.  All of the patients 
had a mild sore throat after surgery that resolved within two days. 
 
There were no major adverse effects. All mucosal lacerations had healed without 
scarring.  There was no evidence of injuries, synechial bands, narrowing of the lumen or 
patulous ETs.  There was no post-op epistaxis. 
 
A C 6-7 contralateral radiculopathy occurred in one patient thought to be due to the neck 
extension required for endotracheal intubation.  It fully recovered.  There were no 
complications related to the balloon dilation.  No patients developed patulous ET 
symptoms (including autophony), even transiently.  There were no cases of reflux otitis. 
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8.6  DIAGNOSIS OF THE PATULOUS EUSTACHIAN TUBE AND PATULOUS 
EUSTACHIAN TUBE RECONSTRUCTION (STUDY 6) 
 
Patulous Eustachian tube defect in the antero-lateral wall 
 
Slow motion video endoscopy of the cartilaginous Eustachian tube demonstrated a 
concave (scaphoid) defect in the superior aspect of the anterolateral wall within the 
functional valve in all patients, supporting previous findings.  
 
Outcomes of PETR 
 
Nasal septal cartilage was used in the first case but bleeding from the septum drained 
over the tubal orifice slowing the procedure and prompted the use of Alloderm implant in 
the subsequent 12 cases.  Over the course of the study, progressively wider and longer 
submucoperichondrial pockets were created to accommodate larger implants or grafts 
with deeper insertion into the valve region in an attempt to improve the outcomes.  The 
use of tragal cartilage in the last case was intended to minimize the loss of graft volume 
in the healing period.  Results are shown in the table 7.   
 
 
Results of PETR (Table 7) 
N = 14 Eustachian tubes, follow-up 3 – 30 mo, Ave 15.8 mo 
 
Outcome       Number 
Complete relief    1 (7%)  
Significant improvement, satisfied  5 (36%)  
Improvement, dissatisfied                     7 (50 %) 
Unchanged     1 (7%) 
Worse      0  
Total Satisfied    6 (43%)  
 
Complications 0 
 
 
Complications of PETR 
 
There were no significant complications or persistent OME.  One patient developed OME 
for two weeks.  Patients typically experienced two to three days of oro-and 
nasopharyngeal pain that was well controlled by oral analgesics.  All of the patients 
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experienced immediate and complete relief of their autophony postoperatively, but 67% 
developed some recurrence of symptoms over time. Figure 18 shows pre- and 
postoperative images of a patulous Eustachian tube. 
 
 
Figure 18  Endoscopic views of left patulous Eustachian tube before surgery and one year 
post surgery.  Note the reconstructed convexity to the antero-lateral wall of the valve. 
 
Diagnostic confounders: SCD (semicircular canal dehiscence) syndrome - patients with 
autophony 
 
18 adult patients who were referred with symptoms of aural fullness or autophony of their 
voice similar to the complaints with patulous Eustachian tube were confirmed instead to 
have dehiscence of the superior (or in one case posterior) semicircular canal. Most 
patients experienced autophony of their voice but none of them heard their breathing 
sounds similarly amplified.  50% of the patients had significant improvement or 
resolution of their symptoms in the supine position or with Valsalva maneuver.   
 
 
Table 5 shows a summary of the significant results from the above six studies. 
 
56 
 
 
Study Intervention 
Diagnostic and pre-operative results Post procedure results 
n Normal n OME n Patulous No OME OME Patulous symptoms 
1 
 
Dilation cycle 
(ms) 24 995.0 
 
14 
1082.9 
p=.411 
21 1276.2 p=.183    
Torus tubarius 
rotation 
(ms) 
23 175.7 14 154.38 
p=.563 
21 276.29 p=.660    
Valve open 
(ms) 23 10.5 20 
15.1 
p=.563 
24 14.1 p=.930    
Angle of torus 
tubarius medial 
rotation 
(degrees) 
24 34.2 20 
29.9 
p=.875 
 
24 31.0 p=.592    
Excursion of lateral 
wall 
(% torus tubarius 
height) 
24 35.5 20 23.9 
p=.015 
24 18.7 p=.001    
Palatal elevation 
(% torus tubarius 
height) 
24 34.8 20 37.00 
p=.664 
24 30.6 p=.307    
2 
Endoscopy, apparent 
opening with swallow 
 17  
 
 
17        
Sonotubom.swallow 
Time open (sec) 
11open 
0.44        
Sonotubometry yawn 
Time open (sec) 
13open 
 2.03        
3 
LETP + tube/myr 
6 mo follow up   13 
 
 
OME 
present 
 
 
 
  4/11 7/11 0 
12 mo follow up     3/10 5/10  0 
24 mo follow up     3/8 4/8  0 
4 
Balloon dilation 
ave ET volume (cm3) 16 0.1565     0.4944   
Video endoscopy 
 16 Normal     
3 
mucosal 
lacera-
tions 
  
CT scan 12 Normal     No injuries   
Anatomical 
dissection 12      
No 
injuries   
5 
Balloon dilation 
ET+tube/perf 
 ≥6 mo follow up 
  11 OME present   
7 
Able to 
Valsalva 
4 
Inconsis-
tent 
Valsalva 
0 
6 
Patulous ET 
endoscopy -  
Concave defect 
present antero-lateral 
wall 
    14 14 (100%)    
Patulous ET 
Reconstruction       
6 (43%) 
Satisfied 0 
8 (57%) 
Unsatisfied 
or no change 
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9     DISCUSSION 
 
9.1 TESTS OF THE HYPOTHESES 
 
The purpose of this study was to test two hypotheses regarding the functioning of the 
cartilaginous portion of the Eustachian tube. 
 
The Eustachian tube was demonstrated to have postero-medial and antero-lateral wall 
mucosal surfaces which are in opposition in the resting position and dilate open by 
muscular action, functioning as a valve between the nasopharynx and the middle ear.  
This was consistently shown in the endoscopic findings in normal subjects in studies 1 
and 2.  Mucosal inflammation with edema was noted in all of the patients with OME who 
underwent LETP in study 3.  Impairment of the opening of the functional valve was 
demonstrated objectively in the reduction of the lateral wall excursion measured in study 
1.  Opening times were accurately measured by sonotubometry in study 2, but dilation 
efforts seen on endoscopy were not consistently associated with tubal opening by 
sonotubometry.  The cartilaginous portion of the Eustachian tube operates like a 
functional valve and pathology involving the valve may lead to middle ear disease.  
 
LETP results in study 3 indicated that surgical dilation of the functional valve is possible 
and might improve otitis media with effusion.  The results of LETP with a mini short 
duration tympanostomy tube or myringotomy appear to have supported this hypothesis 
with improvement in 4/11 patients in whom repeated tympanostomy alone had previously 
failed.  It is notable that the procedure did produce lasting results in some patients who 
had previously had chronic OME for over five years duration.  The balloon dilation 
procedure in study 4 demonstrated that significant dilation of the tubal valve is feasible 
with that technology. 
 
The second hypothesis, that the patulous Eustachian tube has a concave shape in the 
antero-lateral wall causing insufficiency in the functional valve, was supported by the 
results of studies 1, 2, and 6.  Study 1 found that the lateral wall excursion was markedly 
reduced, probably due to either loss of tissue volume or possible hypertonic contraction 
of the TVP muscle at rest.  Sonotubometry in study 2 effectively simulated a defect in the 
valve during prolonged yawns in which subjects held their valves in the dilated position 
for as much as 2 seconds.  Study 5 found endoscopic evidence for a concave defect in the 
antero-lateral wall in all patients and surgical augmentation of the wall to restore the 
normal convex shape was initially curative in all cases. 
 
The detailed analysis of Eustachian tube function provided further evidence to support 
the hypothesis that the cartilaginous portion of the Eustachian tube contains a functional 
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valve and that pathology involving the valve may lead to middle ear disease.  Previous 
work has failed to show any correlation between otitis media and pathology within the 
osseus Eustachian tube (Hopf, Linnarz et al. 1991; Chays, Cohen et al. 1995), nor has 
surgical enlargement of the osseus tube successfully relieved middle ear 
disease.(Wullstein 1960; House, Glasscock et al. 1969; Charachon, Gratacap et al. 1986; 
Zini C 1988). The function of the valve can be now be quantified by videoendoscopy and 
sonotubometry, which add valuable new tools for future study.  The impaired valve can 
now be modified surgically with tissue reduction or augmentation.  
 
 
9.2 LIMITATIONS OF THE STUDY 
  
This study contained a number of weaknesses.  It introduced a number of new techniques 
for analysis of the functional valve of the Eustachian tube and a number of new 
procedures for treatment.  However, the subject cohort was different for each study which 
reduced the ability to make comparisons across the groups and reduced the statistical 
power of the study.  As the surgical trials were all pilot studies, the small patient numbers 
could be justified to demonstrate safety and potential for clinical efficacy, but there were 
no control groups for these trials and patients served as their own historical controls.  
Larger trials with controls will be necessary to make valid statistical comparisons against 
existing therapy.  A validated rating scale was not available for clinical staging of 
Eustachian tube disease, which makes it difficult for comparison of the present results 
with other studies.  Because the procedures were novel, there was a learning curve with 
improvements and modifications in technique during the course of the study.  As the laser 
Eustachian tuboplasty and balloon dilation procedures were novel, the interventions were 
combined with tympanostomy tubes, myringotomy or existing perforation, all of which 
added a significant confounding factor in the interpretation of the results.  However, the 
patients selected for these pilot studies had long historical courses of OME broken only 
by tympanostomy tubes and always promptly recurring upon extrusion.  Therefore, in 
these very refractory cases, when some benefit appeared to occur, it suggests that the 
novel intervention may have altered the course of the pathology.  The evidence is 
sufficient to justify further controlled trials.  
 
 
9.3  COMMENTS ON MEASUREMENTS OF EUSTACHIAN TUBE DILATION 
BY VIDEO ENDOSCOPY (STUDY 1) 
 
 Findings of decreased lateral wall excursions within the functional valve of the 
Eustachian tube correlated with OME and patulous dysfunction (Study 1).  For dilatory 
dysfunction, reduced lateral wall excursions could be due to increased thickness of the 
wall from inflammation or from muscle weakness.  From previous work, functioning of 
the LVP muscle appears to be a critical factor in successful dilation of the Eustachian 
tube in humans (Poe, Pyykko et al. 2000; Poe, Abou-Halawa et al. 2001; Bluestone 
2008), but the exact degree of LVP movement as seen by the angle of torus tubarius 
rotation or palatal elevation did not correlate with tubal failure.  It appears that LVP 
action is important to fix the torus tubarius as a rigid scaffold against which the TVP 
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muscle action can pull the lateral wall away for tubal opening, but amount of excursion is 
not critical 
 
The highly significant (p=0.001) and markedly reduced excursion of the lateral wall in 
patulous Eustachian tube is most likely due either to lack of the lateral cartilaginous 
lamina combined with a loss of soft tissue volume or hypertonicity of the resting TVP 
muscle.  Loss of the protrusion of the lateral cartilaginous lamina, thin submucosa, and 
loss of Ostmann’s fat were common findings at surgery in Study 5, but not universally 
present, supporting some speculation that TVP hypercontraction may be a factor in some 
cases.  EMG evaluations to evaluate this hypothesis would be useful for further study.   
 
There were several limitations to this study.  The measurements were all limited to 
endoscopic observations and lacking in precise quantification.  The sample sizes could be 
enlarged to improve the statistical analyses.  The study analyzed the maximum excursion 
of the antero-lateral wall and not the excursion of the valve wall itself, which would be 
useful to investigate in the future.  The etiology of decreased lateral wall excursions was 
not analyzed for evidence of muscle weakness versus inflammatory changes. 
 
 
 9.4  COMMENTS ON SYNCHRONOUS ENDOSCOPY AND 
SONOTUBOMETRY OF THE EUSTACHIAN TUBE (STUDY 2) 
 
 
This study was a first attempt to combine endoscopic observation with a device capable 
of quantitative measurements of some aspect of tubal physiology.  Sonotubometry was 
investigated as a means to passively measure tubal opening, avoiding the 
nonphysiological stimuli of tubomanometry, forced air testing and other tests of passive 
opening pressures.  These other tests have not adequately predicted clinical tubal function 
or success and failure of tympanoplasty.  (Manning, Cantekin et al. 1987) 
 
The simultaneous and synchronous measurement of sonotubometry and video endoscopy 
of tubal function proved to be clinically feasible and immediately beneficial in providing 
complementary information not previously available with either technology alone.  The 
test was simple to perform and had no side effects.  The duration of tubal opening by 
sonotubometry averaged 0.44 seconds, which was in agreement with the previously 
published value of 0.43 seconds. (Mondain, Vidal et al. 1997) These numbers were 
longer than the opening time generated by endoscopic visualization alone in Study 1 of 
0.11 seconds, indicating that some opening probably occurs higher in the valve than can 
be observed before the valve becomes fully visibly dilated.  Sonotubometry is likely the 
more accurate means for establishing when the valve truly opens to the middle ear and 
measuring its duration.  Sonotubometry does not provide any information about tubal 
pathology, however, and endoscopy is critical in assessing the quality of the mucosa and 
muscle movements. Endoscopy may be able to shed some light on sonotubometry 
findings that previously have not been understood or were dismissed as artefacts.  The 
negative deflection before opening in some sonotubometer tracings appeared to be caused 
by brief compression of the Eustachian tube lumen by pharyngeal constrictors and palatal 
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elevation just prior to dilation.  It supports the theory of a pumping action of the 
Eustachian tube prior to dilation as a means of minimizing reflux into the middle 
ear.(Honjo, Hayashi et al. 1985; Poe, Pyykko et al. 2000)  There is also a pumping action 
generated by the progressive closure of the functional valve from superiorly (proximal) to 
inferiorly (distal from the ear)(Honjo, Hayashi et al. 1985) that did not correspond to a 
change in sonotubometry, possibly because it is generated by a different mechanism.   
 
Limitations  
The limitations of this study were the small number of subjects tested in this pilot trial 
and the numbers should be expanded for normals and then systematically used to 
investigate patients with tubal dysfunction.  Larger numbers will allow for statistical 
analyses that were not possible in this study.   There remains the problem that people do 
not consistently dilate their Eustachian tubes open with every swallow, nor can everyone 
dilate their tubes voluntarily, even despite strong efforts.  Failure to open the Eustachian 
tube was seen in 6 subjects during swallowing and 4 subjects during yawns, yet none of 
these individuals had any history of tubal dysfunction or ear disease.  Consequently, 
failure to generate voluntary opening during the course of sonotubometry does not imply 
tubal dysfunction by itself. 
 
 
9.5  COMMENTS ON EUSTACHIAN TUBOPLASTY TO WIDEN THE 
EUSTACHIAN TUBE ORIFICE AND FUNCTIONAL VALVE (STUDY 3) 
 
The first hypothesis to be tested in this overall study was that surgical dilation of the 
nasopharyngeal orifice and functional valve should be expected to improve otitis media 
with effusion.  The results supported the hypothesis. Surgical widening of the tubal 
orifice and medial wall of the valve was effective in relieving OME with lasting benefits 
in 3/8 patients that had truly refractory disease preoperatively.  There were three other 
patients who were counted as failures, but had actually improved to the point that their 
effusions were only intermittent and they considered themselves to be substantially 
improved. All of the patients experienced initial benefit but they had tubes or a 
myringotomy with the intervention.  Failures occurred over time, but not necessarily 
immediately after extrusion of the tubes, probably due to recurrence of inflammation 
from their original underlying pathology.  Failures did correlate with allergic and reflux 
disease in the one year follow-up results. The numbers may have been sufficiently small 
by the two year follow-up that the statistics were less meaningful.  It is probable that, 
similar to chronic sinus disease, failure to eradicate the cause of underlying pathology 
will lead to a significant rate of return of mucosal disease.  The patients for this trial were 
intentionally selected for their atypically severe and medically refractory OME, so that 
the low success rate was not surprising.  It is hoped that the results will be improved in 
subsequent trials to include less severely affected patients who may have more 
intermittent OME, atelectasis, or problems with scuba diving and flights. 
 
The reason for success in improving OME is unclear.  It is believed that there could be a 
mechanical advantage in debulking of the postero-medial wall, widening the orifice and 
valve area and thus facilitating the ability of the TVP muscle to dilate the valve open by 
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lateral excursion of the antero-lateral wall.  As seen in Study 1, that excursion may be 
compromised in patients with OME and dilatory dysfunction.  It is also possible that the 
operation is excising irreversibly diseased mucosa and allowing new mucosa to regrow.  
The pathology showed healing with fibrosis (filling in the crater created by the laser) and 
restoration of healthier epithelium with the net thickness of the tissue reduced from 
preoperatively, largely due to the reduction in inflammation and thickness of the 
epithelial layer.  If the underlying etiology for inflammation has been adequately treated, 
the new tissue can be thinner and healthier than the original.  However, if the source of 
inflammation has not been eliminated, the condition can relapse.  The surgeon must 
diligently search for the underlying etiology and maintain treatment as necessary to 
prevent recurrence.   
  
The etiology of disease in the functional valve is not fully understood.  For dilatory 
dysfunction, mucosal inflammation is the most common finding (Poe, Pyykko et al. 
2000; Poe, Abou-Halawa et al. 2001), but the cause of tubal failure can be multifactorial.  
It can be on the basis of hypertrophy causing thickening the walls of the lumen, 
especially in the torus tubarius and postero-medial wall in which the mucosa and 
submucosa are naturally thicker and contain more secretory glands.(Sando, Takahashi et 
al. 1994)  A thicker wall reduces the diameter of the lumen and increases the work 
necessary for the TVP muscle to dilate the lumen to a fully open position.  Furthermore, 
inflammatory mediators may impair mucociliary function, upregulate mucus production, 
and propagate retrograde into the middle ear to directly cause inflammatory changes there 
as well. 
 
Numerous inflammatory mediators have been demonstrated to be upregulated in the 
middle ears and nasopharynges of patients with otitis media, the origin of the 
inflammation is unknown and deserves further research.(Lesmeister, Bothwell et al. 
2006; Matkovic, Vojvodic et al. 2007; Skotnicka and Hassmann 2008) Allergic disease 
has been reported as a possible cause (Luong and Roland 2008) and this was supported 
by the correlation between atopy and failure of LETP in Study 3.  Laryngopharyngeal 
reflux also correlated with failure of LETP in that study.  Biofilms have been identified in 
the middle ears (Hall-Stoodley, Hu et al. 2006) and adenoids (Kania, Lamers et al. 2008) 
of patients with otitis media and should be studied as a possible source of inflammation. 
 
 Adenoid disease could have the effect of harbouring inflammation that spreads to the 
adjacent Eustachian tube, but it also has been shown to directly compress the torus 
tubarius anteriorly and laterally during swallowing with the result of closing the tubal 
orifice during the time it should be dilating. (Poe, Abou-Halawa et al. 2001)  These may 
explain the benefit of adenoidectomy in improving OME and recurrent acute otitis media, 
especially when the adenoid is in close contact with the torus tubarius. (Gates, Avery et 
al. 1988; Nguyen, Manoukian et al. 2004) 
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Indications for LETP surgery 
 
Patients who have had maximal medical therapy for their underlying pathology and who 
benefit from tympanostomy tubes, yet after extrusion continue to have irreversible 
mucosal disease with persistent atelectasis, difficulty with airplane flights or diving, or 
intermittent or persistent OME, may be candidates for Eustachian tuboplasty.  Slow-
motion video endoscopy should demonstrate mucosal disease causing functional 
obstructive dysfunction with inadequate dilation of the lumen.  A trial of LETP in a series 
of dynamic (muscular) dysfunction has not yet been done.   
 
Contraindications for surgery 
 
Primary middle ear disease that is not caused by tubal dysfunction, such as recurrent 
thick proteinaceous “glue” ear that repeatedly occlude tympanostomy tubes, is a 
contraindication to surgery as are radiation therapy for nasopharyngeal cancer and 
extensive nasal or nasopharyngeal mucosal disease with an underlying, uncontrolled 
inflammatory process. 
 
Surgical planning 
 
Video endoscopy is reviewed preoperatively to determine the extent of Eustachian tube, 
nasal, sinus, and nasopharyngeal disease.  Tissues become engorged in the supine 
position intraoperatively and may not accurately reflect the actual disease.  More 
extensive disease or compromise of the lumen warrants more aggressive removal of soft 
tissue medial cartilaginous lamina. 
 
Limitations 
 
The greatest limitation of the study was the small patient size, but this represented a first 
prospective pilot trial intended to demonstrate safety and the possibility for efficacy of a 
new procedure.  Larger numbers of patients will be needed to generate more meaningful 
statistics for analysis.  There was bias in selecting patients with maximum severity of 
disease, which likely led to a poorer success rate than might have been achieved with less 
severely affected patients.  Determination of the area and depth of tissue to be resected 
has not been scientifically studied and needs to be defined.  Laser vaporization of tissue 
was chosen for its precision but was slow and causes thermal injury that could lengthen 
the healing process. 
 
The treatment results were confounded by the concurrent placement of a tympanostomy 
tube or myringotomy in conjunction with the laser Eustachian tuboplasty.  However, 
having established that laser Eustachian tuboplasty may be beneficial, it is now indicated 
to perform a study in which laser Eustachian tuboplasty alone is compared with a control 
group. 
 
Concurrent use of antihistamine or omeprazole for patients with allergic or reflux disease 
respectively could have introduced a confounding factor in interpreting the results of 
63 
 
Eustachian tuboplasty combined with the tympanostomy tube.  However, these 
medications had been used preoperatively for six weeks without altering the effusion and 
the use was felt to be indicated for their chronic underlying disorder. 
 
 
9.6  COMMENTS ON FEASIBILITY AND SAFETY EVALUATION OF 
BALLOON DILATION OF THE EUSTACHIAN TUBE IN CADAVERS  
(STUDY 4) 
 
This study in cadavers looked at the feasibility and probability of safety of performing 
balloon dilation of the tubal orifice and valve before considering proceeding to a clinical 
pilot trial.  The balloon dilation technology was developed to fracture the bone around 
sinus ostea to enlarge them (Bolger and Vaughan 2006; Kuhn, Church et al. 2008; Weiss, 
Church et al. 2008) and the principle of application was different for use in the 
Eustachian tube, where there is no thin bony orifice.  There was no attempt to dilate the 
bony isthmus or any portion of the temporal bone course since it is not the likely source 
of pathology and could risk injury to the internal carotid artery.  Rather, the intent was 
similar to that of soft tissue endovascular or other lumena, in which the vessel is 
expanded, collagen rearranged, and the endothelium stretched or lacerated to heal with a 
wider lumen. (Mestres, Ninot et al. 1985; Ahrendt, Pitt et al. 1998; Ebeid, Sarris et al. 
2001) The balloon was intended to principally expand the valve region in order to 
facilitate dilation to open by the TVP.   
 
The results demonstrated clear success in significantly dilating the Eustachian tubes 
between 4 mm and 16 mm from the tubal orifice, which included the region of the 
functional valve located at approximately 5 to 13 mm.  It did not significantly dilate 
either the flexible nasopharyngeal orifice or the rigid portion as it approached the 
isthmus.  Volume of the Eustachian tubes was increased from an average of 0.1565 to 
0.4944 cm3 which represented an increase in volume of 357%.  
 
 The procedure did not present significant technical challenges and the balloons fit 
reasonably well into the Eustachian tubes during dilation, occasionally protruding out as 
much as 50%.  If a 7mm diameter balloon did not adequately remain in place during the 
dilation, a six mm balloon was satisfactory.   
 
There were no major adverse injuries, such as bony fractures or injuries to the internal 
carotid artery.  Minor adverse injuries were limited to lacerations of the mucosa of the 
lumen in three cases, which is an expected outcome of procedure and may be desirable.  
Potential safety and efficacy of the procedure was demonstrated to be satisfactory to 
proceed with clinical trials. 
 
There was a roughly 15 – 60 minute period between the dilation and the CT scans that 
could have allowed for some relaxation of the tissues.  The cadavers were not fixed and 
had tissues very similar in handling to live patients.  However, the increased resilience of 
the perfused tissues in a live patient would likely tend to relax more after dilation than the 
cadaver tissues.  In practice, there is an impression that the dilation in patients does not 
64 
 
appear to leave as large of a persistent dilation as was seen in the cadaver study, but this 
has not been accurately measured to date. 
 
 
Limitations 
 
Limitations of the study were that it was conducted on cadaver tissue and the results in a 
clinical trial cannot be fully predicted.  The sinus balloons were not manufactured for this 
purpose and could be modified to optimize the instruments for Eustachian tube surgery.  
The possibility for success in a clinical trial is completely unpredictable based on this 
study, which could only be expected to look at the technical ability to do the operation 
and the potential for mechanically induced side effects.  Even if initially successful in 
improving otitis media, there is no ability to predict the duration of the benefits.  The 
balloons carry a significant expense and the duration of clinical success will be important 
in determining if this operation will become clinically acceptable. 
 
 
9.7 COMMENTS ON BALLOON DILATION OF THE CARTILAGINOUS 
EUSTACHIAN TUBE (STUDY 5) 
 
This study applied the lessons learned from Study 4 to a pilot clinical trial and 
demonstrated that balloon dilation of the ET is technically feasible in patients and can be 
performed without significant adverse effects.  The 7 mm sinuplasty balloon fit 
reasonably well into the tubal lumen and dilated the functional valve effectively, tending 
to slip out in a minority of cases.  In the majority, the balloon actually “locked” into 
position fitting to the inside curvature of the medial cartilaginous lamina that is contained 
within the posterior cushion.  Protrusion of the balloon up to 30% was common and of no 
concern.  Slippage of the balloon out of the ET could be limited by bracing the shaft of 
the guiding catheter against the floor of the nose for stability. 
Balloon dilation in this pilot study demonstrated evidence for effectiveness 
intraoperatively, with an immediate widening of the functional valve, and postoperatively, 
with persisting benefits that included improvement in the ability to insufflate the ET and 
ear with a Valsalva maneuver 11/11 (100%), resolution of OME in all of the 5/11 
(45.4%) patients with an intact TM, and a reduction in inflammation of the mucosa of the 
ET from a mean of 2.91 to 1.73. Although tympanostomy tube or perforation was present 
in all cases, the baseline inflammation had been in place despite prior tubes or perforation. 
The mechanism for reduction in inflammation is uncertain.  It could be speculated that it 
may be due to compression injury to the mucosa and submucosa with healing by healthy 
epithelium or perhaps the compression has served to strip out sources of inflammation, 
such as biofilms.  It is also possible that temporary aeration of the middle ear could cause 
downstream reduction in ET inflammation and a future controlled study comparing 
tympanostomy tubes vs. balloon dilation should evaluate the ET for mucosal changes in 
both groups.  Dilation of the cartilaginous ET could widen the lumen thereby reducing 
the work required for the muscles, especially the Tensor Veli Palatini muscle (TVP), to 
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fully open the lumen on demand.  It is known that balloon dilation of vascular stenoses 
creates tearing of the intima and sometimes the media,(McElhinney, Reddy et al. 2000) 
with healing occurring by scar filling in the gaps thus maintaining the widened lumen. 
(van den Brand, Essed et al. 1992)  Compression of irreversibly injured hypertrophic 
mucosa and submucosa may permit healing with thinner and healthier layers.  Histology 
following laser Eustachian tuboplasty showed return of normal ciliated epithelium and 
thinner submucosa. (Poe, Grimmer et al. 2007)  
 
Balloon dilation appeared to most effectively dilate the mid portion of the cartilaginous 
ET, which corresponds to the functional valve, and this is likely due to the combination 
of the tapered shape of the balloon at each end, the flexibility of the loose cartilage at the 
orifice, and the rigid circumferential cartilage at the isthmus.   These results correlated 
well with the cadaver Study 4 (Poe and Hanna 2010)  
 
The targets of 12 atm inflation pressure for one minute duration were taken from previous 
sinus experience and from the preclinical cadaver trial, since, to our knowledge, this was 
the first clinical trial of balloon dilation of the ET.  There was a greater tendency for 
mucosal laceration with the 12 atm pressure and this may actually be a desirable goal, 
given the experience with endovascular dilation. 
 
The cases were done throughout the year so no seasonal bias in results would be 
anticipated in this study. 
Adverse events 
 There were no major adverse events or complications related to the balloon dilation.  
Pain was predominantly related to the endotracheal intubation and there were only 
minimal complaints of pain localized to the nasopharynx or radiating to the ear. 
Potential complications 
The potential for complications is considerable, including fatal injuries to the internal 
carotid artery. (O'Connor and Shea 1981)  Familiarity with the surgical anatomy is 
important.  No attempt should be made to dilate the bony ET, as it is not usually the site 
of pathophysiology and the carotid artery courses to share the infero-medial wall of the 
ET within the temporal bone.  From the nasopharyngeal orifice, the ET lumen takes a 
slight medial curve initially, then courses toward the temporal bone and becomes 
progressively narrow.  Care should be taken to slowly advance the balloon catheter 
atraumatically to follow the lumen without laceration of the mucosa, which could cause 
bleeding or create a false passage toward the carotid injury.   The balloon dilation 
procedure would not be recommended for a patient with an inferior carotid dehiscence 
and a CT scan is currently recommended. 
 
Additional risks could be circumferential stricture, fracture of the medial cartilaginous 
lamina, injury to the TVP or Levator Veli Palatini muscles, hemorrhage into the 
pterygoid space, instrumentation of the middle ear and patulous ET.   Guidewires can 
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pass into the middle ear and should be avoided.(Poe and Hanna 2010)  From the 
nasopharyngeal orifice, the isthmus is 20 mm from the ET and the middle ear orifice 36 - 
38 mm. (Sudo, Sando et al. 1997; Poe and Hanna 2010) The isthmus should be 
sufficiently narrow that the balloon catheter would not normally pass through and 
advancement should cease when meeting gentle resistance.  Entry into the middle ear 
could occur with a widely patent anomalous isthmus or by excessive force of 
introduction.  
Limitations of the study 
There were several weaknesses of this study.  It used the patients as historical controls 
and suffers from that bias.  Insufflation of the ET by Valsalva maneuver is an imprecise 
measure of tubal function that does not necessarily predict sufficiency of middle ear 
aeration.  However, it did reflect a significant change in this study.  There is the 
possibility that there can be a learning curve in performing the maneuver, but these 
patients had five or more years of symptoms and had attempted the maneuver many times 
over the course of their ET dysfunction. 
There was a lack of objective tests for ET function. Although such tests have not been 
shown to have clear clinical correlation (Manning, Cantekin et al. 1987), they would have 
provided additional basis for comparison of pre- and post-operative results.  An ET 
mucosal rating scale was employed, but is only now undergoing validation testing.  Some 
of the patients still had tympanostomy tubes in place at the termination of this study and 
it remains to be seen if they recur with OME in the future.  A tube could have an 
influence on the outcomes, relieving negative pressure, draining effusion and facilitating 
a Valsalva maneuver.   As none of the patients could perform a Valsalva maneuver 
previously while they had tubes, the outcome of ability to perform a Valsalva maneuver 
represented a real change.   
All of the patients expressed an initial improvement in their symptoms in their new 
ability to be able to perform a Valsalva maneuver, which they perceived as a significant 
benefit.  A disease-specific instrument for quantifying quality of life for ET disorders is 
being developed, but is not yet available.  
 The pathogenesis of OME in children is different from adults and is being investigated.  
At present, we have not considered performing this procedure in pediatric patients. 
 
If balloon dilation of the ET were ultimately demonstrated to be effective with sustained 
benefits, it would be a useful and minimally invasive alternative to tympanostomy tubes 
in patients with chronic OME.  Careful selection of patients with medically refractory 
dilatory dysfunction of the ET should be done.  The procedure may also prove to be 
beneficial to patients with atelectasis or scuba or flight barotrauma.  It remains to be 
determined whether the procedure should be performed in children.  
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9.8  COMMENTS ON IDENTIFICATION OF THE PATULOUS EUSTACHIAN 
TUBE DEFECT AND SURGICAL CORRECTION WITH AUGMENTATION 
OF THE LATERAL WALL.  (STUDY 6) 
 
This study added strong evidence to support the second hypothesis of this overall work, 
that the patulous Eustachian tube contains a concave defect in the antero-lateral wall that 
includes the functional valve.  Such a defect was observed in all cases and surgical 
augmentation completely relieved all complaints of autophony, at least initially.  The 
edema from surgical trauma undoubtedly contributed temporarily to the closure of the 
functional valve, but this effect would be expected to have subsided by six weeks post-
operatively.  This operation provides an opportunity to improve or relieve autophony 
without completely blocking the lumen, which typically would mandate long-term 
tympanostomy tube ventilation.  (Bluestone CD 1998; Doherty and Slattery 2003) 
 
This study also supported the findings of reduced lateral wall excursions in the valve seen 
endoscopically in patulous Eustachian tubes as the thickness antero-lateral wall was often 
reduced compared to normals.  A substantial reduction in the bulge of the lateral 
cartilaginous lamina into the lumen and decrease in Ostmann’s fat pad volume were 
commonly noticed.  With the antero-lateral wall chronically positioned laterally, a 
decreased excursion with TVP muscle contraction would be expected.  It could also be 
speculated that chronic hypercontraction of the TVP muscle could be a possible etiology 
in some patients, but there was no direct evidence from the present study to confirm this 
hypothesis.  However, the large lateral excursion observed in Study 1 in patulous 
Eustachian tubes could support this hypothesis.  
 
The procedure was technically challenging to perform initially and required learning new 
techniques for dissecting and suturing with curved instruments under endoscopic 
guidance.  Improved instruments designed for this procedure will be helpful in its 
performance.    
 
The long-term success rate of the procedure was lower than desired and this was thought 
to be principally due to excessive resorption of the AllodermTM implant and early failure 
to make the submucoperichondrial pocket sufficiently deep into the valve.  There is also a 
need to prevent the graft from mobilizing distally toward the nasopharyngeal orifice and 
out of the valve due to gravity and the forces of the muscle action on the valve that tend 
to pump the graft distally. 
 
A similarity between aural complaints of patients with semicircular canal dehiscence 
(SCD) (Minor, Solomon et al. 1998) and patulous Eustachian tube was recognized for the 
first time during the course of this study and prompted a retrospective comparison of their 
presenting signs and symptoms.  SCD syndrome patients will complain of autophony of 
their voice and other bone conducted sounds due to the inner ear mechanics of the “third 
window” phenomenon.  They will not typically complain of hearing their breathing 
sounds grossly amplified as opposed to patulous Eustachian tube patients, who hear their 
breathing sounds equally amplified as their voice.  SCD syndrome patients will also have 
some degree of other components of the syndrome to include conductive hearing loss or 
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lower than normal bone conduction threshold and vertigo, among other possible 
complaints.  Patulous Eustachian tube patients will demonstrate lateral and medial 
excursions of their tympanic membrane with forced nasal breathing as observed by 
otomicroscopy or tympanometry while they have active autophony. 
 
 
 
Limitations 
 
There were several limitations to this study.  The number of patients was small, but again, 
this was an initial report of a trial of a novel procedure, with the main intent to establish 
the safety and efficacy of the concept.  There was a significant bias in using a self-
reporting of autophony for the outcome, but this was necessary as a number of the 
patients came from a distance and did not wish to return for follow-up visits unless 
necessary.  The subjective self rating of “satisfied” or “dissatisfied”, in particular, could 
be biased by placebo effect.  However, these patients tend to be exceedingly sensitive and 
intolerant of their symptoms making it unlikely that there was a significant placebo 
effect.   There was a significant learning curve to the operation and improved success rate 
with later cases. AllodermTM implants underwent a significant amount of resorption over 
time likely leading to late failures.  Cartilage grafts are likely a better choice for a durable 
graft and would be preferred for future use.  Additionally, AllodermTM is from a cadaver 
source and could theoretically carry prions or other pathogens. 
 
9.8 FUTURE ASPECTS 
 
This study provided new methods for the diagnostic evaluation of Eustachian tube 
dysfunction that can be used to advance clinical and research work.  The new operations 
investigated provided some potential surgical relief to patients with medically refractory 
disease, but they also raise new questions about the mechanisms of efficacy and new 
directions for basic research for possible medical therapy.  LETP may be beneficial more 
for removing irreversibly injured mucosa than for widening the lumen.  Study of the 
pathophysiology of the mucosal disease is needed.  Graft augmentation of patulous 
defects may only be adding volume to a progressive local wasting condition or muscle 
hypertonic disorder.  Study of the underlying etiology is needed. 
 
Future research that would add to the endoscopic measurements in Study 1 could use 
EMG to study TVP muscle function as it correlates with lateral valve wall movements.  
This study focused on OME and patulous Eustachian tubes and could be expanded to 
include atelectasis and patients with aero- or barotrauma.  Endoscopic observations could 
benefit from technology to calibrate the field using lasers to measure the distance from 
the objective lens to the target and to project a unit of measure onto the video monitor 
that would continually change as the distance varies.  Correlation between endoscopy and 
other means for assessing tubal function should be studied. 
 
Combined sonotubometry and endoscopy in Study 2 revealed an issue with false positive 
results in which normal Eustachian tubes may fail to open during a testing session. 
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Further study will be needed to determine how frequently this type of false positive 
occurs and whether patients can be quickly taught to generate a good dilatory effort with 
some instruction aided by the video endoscopy for feedback.  There was an instance in 
which endoscopy suggested tubal opening but it was not confirmed by sonotubometry. 
Sonotubometry alone has artefacts that are difficult to sort out in the absence of 
endoscopy.  Therefore, it is likely that the combination of a normal endoscopic exam and 
normal sonotubometry will be more strongly predictive of normal tubal function.  
Continued research with this combination tool will shed more light on the ability to dilate 
open or not when some degree of pathology is found with endoscopy.  It is hoped that 
imaging may become more helpful in the future, especially with cine-MRI, but present 
resolution remains insufficient for detailed examinations. 
 
LETP should be studied in greater numbers with expanded indications to include non-
fixed atelectasis, difficulty with airplane flights or diving, or intermittent or persistent 
OME.  A randomized controlled trial would be preferable with stratification of risk 
factors, such as allergic disease, reflux disease and smoking.  Investigation into the 
pathophysiology of tubal inflammation must continue to help identify possible preventive 
measures or better medical means to treat dilatory dysfunction of the Eustachian tube. We 
are presently looking for evidence of bacterial biofilms within the tubal orifice.  Such 
therapy would be continued as needed following surgery to prevent recurrences.  With a 
better understanding of the etiology of tubal inflammatory disease, LETP on medically 
refractory disease could be more focused on removal of irreversibly diseased mucosa, 
removal of hypertrophic submucosa, or resecting cartilage or weakening the spring of the 
cartilage, whichever would be indicated.  Investigation into the optimal means to 
accomplish the required resection could be better focused. 
 
Balloon dilation of the Eustachian tube, the subject of Studies 4 and 5 is now being 
applied in expanding clinical use in patients with dilatory dysfunction in Finland, 
Germany, UK and USA., although data for efficacy remain lacking.  The long term 
results of these early trials will be anticipated.  A multicenter randomized controlled trial 
is needed before routine clinical use of this technology can be recommended and such a 
trial is currently being organized by the author.  The size of the balloon, atmospheres of 
pressure of inflation, and duration of inflation all need to be studied for optimized results.  
If the procedure shows some success, it will need to be clarified if the benefit would be 
due to widening of the lumen diameter or due to mucosal or submucosal injury and 
regrowth of healthier tissue. 
 
Further investigation for the etiology of the patulous Eustachian tube, the topic of Study 
6, is needed.  In the event of loss of tissue volume, it might be aided with medical 
treatment if the underlying cause could be ascertained.  Hyperactivity of the TVP muscle 
could be investigated with EMG and if present, treated with speech therapy or precise 
botox injections.  In the event of failure after patulous Eustachian tube reconstruction, 
subsequent augmentation of recurrent defects by injections with hydroxyapatite, minced 
cartilage or insertion of shims into the concave defect within the lumen have been 
effective in relieving autophony for some period. Further work needs to be done on the 
long term efficacy of these procedures and possible better materials. 
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10     SUMMARY AND CONCLUSIONS 
 
This study found evidence to support the hypothesis that surgery designed to alter the 
Eustachian tube’s functional valve within its cartilaginous segment may at least 
temporarily influence dilatory or patulous dysfunction. 
 
  New tools for anatomical and physiological assessment of the function of the valve were 
presented that will help to quantify and stage the pathological effects that are observed 
during endoscopy.  Endoscopy has been shown to be most beneficial in demonstrating 
anatomy and pathology, but it has not been accurate in predicting function or severity of 
tympanic membrane or middle ear disease.  This information will be important in 
planning intervention with the new procedures introduced in this study. 
 
Study 1 
Parameters were quantitatively measured from video endoscopy during tubal dilation to 
include lateral excursion of the antero-lateral wall of the valve, medial rotation of the 
torus tubarius, palatal elevation and durations of the dilation cycle, torus tubarius rotation 
time and valve opening time.  Lateral excursion of the antero-lateral wall, which occurs 
due to action of the TVP muscle as the final phase in dilation, was reduced in patients 
with OME and even more reduced in patients with patulous Eustachian tubes.  This 
potentially useful parameter can now be further studied in the search for pathophysiology 
of tubal dysfunction. 
 
Study 2 
A novel instrument to simultaneously record sonotubometry in synchrony with video 
endoscopy was tested in normal subjects and demonstrated that the two different 
technologies provide important complimentary information.  Endoscopy cannot 
accurately identify true opening of the functional valve and underestimated the duration 
of valve opening, which was precisely measured with sonotubometry.  Sonotubometry 
showed failure to open in some subjects despite normal endoscopic dilatory examinations 
suggesting that voluntary opening is not always readily feasible and does not necessarily 
imply tubal dysfunction.  The results using this combination of technology are promising 
for future clinical and research work. 
 
Study 3 
Laser Eustachian tuboplasty, an endoscopic-guided procedure to thin the postero-medial 
wall and widen the tubal orifice and valve was evaluated for effectiveness in treating 
patients with medically refractory OME.  The hypothesis that LETP with tympanostomy 
tubes could improve OME was supported.  The procedure was safe, without significant 
complications and was performed in an outpatient setting.  It can be indicated for OME, 
non-adherent atelectasis, or difficulties with diving and flights after failure of medical 
therapy and tympanostomy tubes.  Failures of LETP were associated with inability to 
control underlying medical conditions such as atopic or reflux disease and idiopathic 
recurrent OME could also be a factor, but this was not specifically analyzed.  The future 
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role of the procedure will depend on studies with long-term follow-up and expanded 
patient numbers.  A randomized controlled trial is indicated. 
 
Study 4 
Balloon dilation of the Eustachian tube was proposed as a new procedure to widen the 
functional valve.  Safety and feasibility issues were tested in a cadaver model and some 
estimates were made of possible efficacy.  Sinus dilation balloons successfully widened 
the valve region in all of the Eustachian tubes tested without any major adverse effects.  
Techniques were worked out to perform the procedure in patients and clinical trials were 
deemed appropriate. 
 
Study 5 
Balloon dilation of the Eustachian tube, along with a perforation or tympanostomy tube, 
demonstrated safety and feasibility in an initial pilot trial in patients with refractory otitis 
media with effusion.  Initial results have been promising and show potential for clinical 
efficacy in these severely dysfunctioning Eustachian tubes, lending more evidence that 
therapy directed at the cartilaginous Eustachian tube may be effective in treating otitis 
media.  A randomized controlled trial with long term follow-up is now indicated. 
 
 
Study 6 
A concave defect in the antero-lateral wall of the Eustachian tube’s functional valve was 
consistently found in all patients with patulous Eustachian tubes.  A surgical procedure to 
augment the defect, restoring a convex bulge was devised and employed in affected 
patients.  The results supported the hypothesis that correction of the concave defect 
would eliminate the patulous symptoms.  The procedure was safe, done on an outpatient 
basis, and without complications. Although complete relief was obtained in all cases 
initially, return of symptoms occurred over time in the majority of cases, likely due to 
resorption of the implant material.  Future surgery will be done with cartilage grafts, 
which would be expected to be a more enduring material.   
 
 
Future aspects: 
New quantitative methods for the assessment of Eustachian tube function have been 
introduced and tested in this study.  They can be used for the assessment of individual 
patients and for further research into the nature of disorders. These tools should now be 
consistently applied to the additional patients with dilatory or patulous dysfunction in 
larger and more comprehensive studies that could also make comparisons with some 
traditional tests of tubal function.  Underlying medical etiologies should be sought, 
treated and repeat testing done to assess for changes in Eustachian tube function.  
Medical failures from this well studied group could then move on to controlled trials of 
interventions.  LETP can be effective, but medical control of inflammation remains 
important for long-term success.  Balloon dilation is a minimally invasive technique with 
significant potential and it remains to be seen whether it is effective in more patients and 
over what duration.  Patulous Eustachian tubes likely evolve over time creating 
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challenges for surgical intervention.  Improved tissue grafts such as cartilage and variably 
sized intra-luminal shims will be important.   
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Measurements of Eustachian Tube Dilation by
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Objectives:
1. To create techniques for measurement of parameters of Eusta-
chian tube (ET) dilation as observed with video endoscopy.
2. To study correlations of the parameters between healthy
subjects and patients with ET dysfunction to determine if they
may be important for clinical or investigational use.
Study Design: Prospective study in an academic center. 3 groups
of adults: healthy subjects, otitis media with effusion (OME),
patulous ET.
Intervention: Video software analyses were performed on video
recordings from subjects’ transnasal endoscopy to measure para-
meters of the tubal dilation cycle.
Results: 24 ETs of 15 healthy subjects, 24 ETs of 15 patulous
ET and 20 ETs of 13 OME patients. Mean values for healthy
subjects: cycle time 995 ms (SD 404.7), valve opening time
10.5 ms (SD 6.34), torus rotation time 176 ms (SD 151.5 and
angle of torus rotation 34.2- (SD 14.3). Palatal elevation, mea-
sured as a percentage of torus height was 34.8% (SD 16.6) and
excursion of the antero-lateral wall 35.5 % (SD 16.3). Lateral
excursion of the antero-lateral wall was significantly less in pat-
ulous ET (18.7%, SD 15.1, p = 0.001) and in dilatory dysfunc-
tion (23.9%, SD 21.7, p = 0.048). The other parameters were not
statistically different between healthy subjects and patients.
Conclusion: Lateral excursion of the ET’s antero-lateral wall
was significantly reduced in OME and patulous ET patients
compared with healthy subjects. Evaluation of the excursion of
the lateral wall of the ET, which is due to TVP muscle action,
may be an important parameter for further clinical and research
study. Key Words: Eustachian tubeVEustachian tube dysfunc-
tionVEustachian tube testVOtitis mediaVOtitis media with
effusionVPatulous Eustachian tubeVTuba aperta.
Otol Neurotol 32:794Y798, 2011.
Anatomic and physiologic dysfunctions of the Eusta-
chian tube (ET) are believed to be major contributing
factors in the pathogenesis of otitis media. Failure of tubal
function should be more precisely divided into two cate-
gories. Dilatory dysfunction refers to inadequacy of the
opening process or insufficiently frequent dilation for pro-
per aeration of the middle ear, and it is thought to be the
principal cause of most chronic ear diseases. Additionally,
failure of the immune defense system may contribute to in-
flammatory changes with upregulation of mediators and
mucus production or lymphoid tissue reactions that lead to
middle ear disease. Patulous dysfunction is the failure of
the ET to assume its normal closed position, resulting in a
chronic dilated state that permits reflux of sounds and mate-
rial from the nasopharynx toward the ear (1). There is evi-
dence that reflux may contribute to otitis media in children
(1), yet adults with patulous ET dysfunction rarely have
active chronic ear disease.
ET dilatory dysfunction was once thought to be due to
restrictions within the osseus portion, which includes
one-third of the tubal length. The bony cartilaginous
isthmus is the site of the narrowest diameter along the
length of the ET (2). However, submillimeter endoscopy
of the ET showed that there is rarely any pathology
within the bony portion, and it is usually patent, even in
cases of otitis media with effusion (OME) (3,4). Trans-
nasal endoscopy into the lumen of the cartilaginous por-
tion of the ET with video recording to permit slow-motion
analysis revealed that the cartilaginous portion of healthy
adult ETs functions as a valve, which is closed in the
resting position and requires muscular action to dilate
open (5). This functional valve represents the approxi-
mately 8-mm length within the midportion of the cartila-
ginous ET in which the mucosal surfaces are in apposition
at rest.
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Tubal dilation is usually associated with strong swal-
lows and yawns and occurs in 2 principal phases beginn-
ing with palatal elevation, including activation of the
levator veli palatini (LVP) muscle. Within the nasophar-
ynx, the palate is seen to elevate with simultaneous ele-
vation and medial rotation of the torus tubarius (posterior
cushion of the tubal orifice). The distal part of the func-
tional valve opens up during this phase, but the lumen
remains closed proximally. The medial rotation is main-
tained as a scaffold against which the relatively inefficient
final dilator of the ET, the tensor veli palatini (TVP) mus-
cle subsequently contracts. TVP action exerts a laterally
directed pull on the anterolateral wall of the tubal lumen
that results in dilating the valve to its fully opened position.
Valve closure occurs initially proximally and is completed
distally in the nasopharyngeal orifice (6).
Systematic endoscopic observations of tubal function
in patients with chronic OME and atelectasis (other than
attic retractions) have found very close correlation with
the presence of significant pathology within the valve of
the ET (7). The types of pathology have been classified
into obstructive versus dynamic disorders. Obstructive
disorders can be caused by mucosal hypertrophy and in-
flammation in the majority of cases but can also be due
to deformities in the ET cartilaginous skeleton, adenoid
hypertrophy impinging on the torus tubarius, and least com-
monly due to anatomic blockage from neoplasms. Dyna-
mic disorders are failures of the muscular actions of the
LVP or TVP muscles principally because of hypoactive
contraction but occasionally from hyperactive contraction
causing a blockage or a failure of the LVP to sustain its
action during TVP contraction (7). Initial attempts at sta-
ging using observed gradations of mucosal hypertrophy,
muscular movements, and overall valve dilation are qua-
litative and remain unvalidated (8). Medical and surgical
therapies for ET dysfunction are being developed and
introduced, raising a need for the ability to quantify the
findings in ET dysfunction and to provide a staging sys-
tem for observed pathology.
In the present work, we sought to measure several para-
meters of tubal dilation that could be observed from video
endoscopic recordings to seek correlations with dilatory or
patulous dysfunction in comparison to healthy subjects.
Quantified measurements of the anatomy would be desir-
able, but magnification varies greatly with the distance of
a target from an endoscope tip. Although direct measure-
ments are currently not practical, measurements relative
to the height of the torus tubarius can be used to provide
some basis for quantification. In this fashion, we mea-
sured palatal elevation, the lateral excursion of the ante-
rolateral wall of the ET due to TVP contraction, and the
medial rotational angle of the torus tubarius. Additionally,
the durations of portions of the dilatory process were
measured.
METHODS
Patients and healthy subjects were examined while awake
and sitting in an office setting of a major tertiary medical center.
The technique for video recording of ET endoscopy has been
previously reported in detail (5,7). Briefly, subjects had topical
spray anesthetic and were examined with fiberoptic or rigid
angled nasal endoscopes fitted with a video camera and a record-
ing system. Subjects were asked to perform a series of swallows
with the endoscopes positioned immediately anterior to the naso-
pharyngeal orifice of the ET and directed into the lumen. As tubal
opening does not occur with every swallow and the strength of
tubal opening varies with individual swallows, analyses were done
on the swallow from the series that demonstrated maximal dilatory
efforts.
Three groups of subjects were examined. One group included
healthy subjects that had no history of recurrent or persistent otitis
media. The second cohort was composed of patients with chronic
OME. The third group included patients with patulous ET com-
plaints, including autophony of their voice and breathing sounds.
These patients had demonstrable tympanic membrane excursions
synchronous with nasal breathing as objective confirmation of the
diagnosis immediately before the endoscopy. Recorded examina-
tions were studied by observers who were blinded to the subjects’
clinical status, and measurements were taken by reviewing video
and still frames with OsiriX DICOM viewer software v.3.7, (Gen-
eva, Switzerland). The height of the torus tubarius was measured
in pixels superiorly, taking the fixed pivot point adjacent to the
basisphenoid and extending along its longitudinal axis to the infe-
rior tip of the medial cartilaginous lamina’s bulge, in the inferior-
most aspect of the torus tubarius. The height was measured in
both the resting position and in the maximally medially rotated
position during dilatory efforts and drawing lines through the
longitudinal axis of the cartilage in both positions (Figs. 1 and 2).
The angle of rotation was calculated by the software. The aver-
age of these heights of the torus tubarius was then used as a unit
of measurement against which additional measurements were
made. Using this relative ‘‘torus’’ unit, errors in absolute mea-
surements that would be introduced from changes in distance
from the endoscope to the ET orifice between video frames
would be eliminated. The maximum lateral excursion of the ante-
rolateral wall (by TVP muscle action) within the orifice and the
height of maximal palatal elevation (inferior to the torus) were
measured as percentages of this torus unit. Lastly, the duration of
the dilatory sequence and the duration of apparent opening of the
valve were measured directly from the time line in Final Cut Pro
video processing software (Apple, Cupertino, CA, USA) that
FIG. 1. Forty-fiveYdegree transnasal endoscopic view of the
right ET nasopharyngeal orifice in resting closed position. Refer-
ence points and lines are created, with measurements taken and
superimposed on the still frame image.
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was used to create Quick-time videos to be imported into OsiriX.
Patients with active patulous ET symptoms during the examina-
tion could demonstrate a failure of the valve to close, so the
‘‘opening’’ time was measured between the initiation of the
anterolateral wall movement and the relaxation of the wall.
Measurements were evaluated statistically using SPSS 17.0 sta-
tistical software package (IBM, Chicago, IL, USA). Indepen-
dent samples 2-tailed t tests were applied using p G 0.05 for the
level of significance.
Patients and subjects gave their informed consent to the study,
which was approved by the institutional ethical review board
(permission number R09021 University of Tampere, KI/1998
Karolinska Institutet).
RESULTS
Patient demographics are summarized in Table 1.
Healthy subjects had no history of any chronic ear dis-
ease or middle ear effusion. There had been no temporary
inflammation or retraction of the tympanic membrane dur-
ing upper respiratory infections within the past 2 years.
There were no statistically significant differences in the
heights of the torus tubarius between groups, despite the
differences between fiberoptic and rigid endoscopic im-
ages and some variations in the distance from the endo-
scope to the tubal orifice.
ET measurement data and statistical analyses are pre-
sented in Table 2. Comparisons of mean time measure-
ments of tubal dilation in healthy subjects and patients
with OME or patulous ET are in Figure 3. Means of the
measured movements with tubal dilation are compared
between healthy subjects and patients with OME or
patulous ET in Figure 4.
Duration of ET Dilatory Cycle
There were no statistically significant differences
between any of the groups regarding the duration of any
portions of the ET opening and closing cycle. The mean
cycle time, the duration from the initiation of dilation to
completion of closure, was 995 ms for healthy subjects.
There was a trend toward a longer cycle time with patu-
lous ET, 1,276 ms (p = 0.067), but it did not rise to
significance.
Torus rotation time measured the duration from the
initiation of the torus’ medial rotation to its maximally
rotated position. This represented the time to achieve full
contraction of the LVP muscle but did not include the
subsequent sustained contraction while the TVP con-
tracted. There were no significant differences between
groups regarding torus rotation times.
‘‘Open time’’ of the valve represented the duration that
the valve seemed to be dilated open or made maximal
efforts to dilate. This measure corresponded to contrac-
tion and relaxation of the TVP muscle. The open time for
healthy subjects was 10.5 ms. There was a trend for pro-
longation of the open time in dilatory dysfunction ETs at
15.1 ms (p = 0.076) that did not reach significance.
Tubal Movements During Dilation
There were no significant differences between groups
regarding height of elevation of the palate, which included
FIG. 2. Same ET as in Figure 1, dilated open position. Lengths
and angle of torus tubarius rotation have been measured and
indicated.
TABLE 1. Demographics
Group No. of Eustachian tube No. of subjects Age range (yr) Mean age (yr)
Healthy 24 (15 right, 9 left) 15 (9 males, 6 females) 30Y64 43.4
Chronic otitis media with effusion 20 (10 right, 10 left) 13 (8 males, 5 females) 18Y75 41.5
Patulous 24 (11 right, 13 left) 15 (7 males, 8 females) 18Y81 41.7
TABLE 2. Eustachian tube measurements
Healthy = 0,
Chronic otitis media
with effusion = 1,
Patulous = 2 n Mean
Standard
deviation
Significance
(2 tailed)
versus normal
Open time of valve (ms)
CSS n = 23
0 23 10.50 6.336
1 20 15.06 9.959 0.076
2 24 14.07 11.913 0.208
Torus rotation time (ms) 0 23 175.65 151.472
1 14 154.28 141.948 0.673
2 21 276.19 336.072 0.201
Cycle time (ms)
CSS n = 11
0 24 995.00 404.722
1 14 1082.85 671.799 0.617
2 21 1276.19 593.148 0.067
Palatal elevation
(% torus height)
CSS n = 18
0 24 34.80 16.573
1 20 36.99 16.969 0.667
2 24 30.64 17.030 0.396
Excursion of the lateral
wall (% torus height)
CSS n = 14
0 24 35.50 16.306
1 20 23.86 21.659 0.048
2 24 18.67 15.056 0.001
Angle of rotation of torus
tubarius (degrees)
CSS n = 11
0 24 34.20 14.350
1 20 29.90 14.323 0.328
2 24 31.02 18.022 0.502
Assumptions > = 0.05 and A = 0.2 and standard deviations are suf-
ficiently large that a 50% minimum difference was applied.
CSS indicates critical sample size for power of statistics.
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the floor of the ET. This movement corresponds to the
action of the palatal muscles initially and is then joined
by the LVP. Elevation in healthy subjects was 34.8% of
the torus tubarius height.
Lateral excursion of the anterolateral wall of the ET,
the distance traveled because of TVP contraction, was
significantly reduced in dilatory dysfunction (23.9% of
the torus height, p = 0.048) and even more reduced in
patulous ET (18.7%, p = 0.001) in comparison to healthy
subjects (35.5%).
Mean angle of rotation of the torus tubarius during dila-
tion for healthy subjects was 34.2 degrees, and there was
no significant difference from the other groups.
DISCUSSION
This study analyzed quantifiable parameters of tubal
movements observed by endoscopy to aid in understand-
ing its pathophysiology and to determine whether these
parameters would correlate with patulous or dilatory dys-
function and provide clinically useful measurements. The
most significant abnormalities occurred with the excur-
sion of the anterolateral wall of the functional valve, which,
in comparison to healthy subjects, was approximately half
the distance in patulous ET patients and about two-thirds
in dilatory dysfunction patients.
Video endoscopy of the ET is a useful tool for studying
the pathology affecting the nasopharyngeal orifice and
lumen of the cartilaginous portion, which likely play roles
in the pathophysiology of otitis media. Ordinary endos-
copy may reveal gross pathology, but when the cause of
tubal dysfunction is not immediately apparent with ob-
servation in real time, slow-motion playback is very help-
ful for recognizing smaller defects and subtle movement
abnormalities.
Insufficient opening of the valve seems to be caused by
mucosal inflammation and thickening in the majority of
cases. Pure muscular abnormalities (dynamic dysfunction)
occur in a much smaller minority (5,7). Some of the dyna-
mic disorders, such as early relaxation of the LVP muscle
before the TVP muscle begins to contract, can be quite
subtle and only discernable with slow-motion video.
The patulous defect is a visible concavity in the usually
convex anterolateral wall of the ET valve. It seems to be
due to the TVP muscle or a deficiency in volume that may
be due to loss of thickness in the mucosa, submucosa,
Ostmann’s fat pad, or lateral cartilaginous lamina (9). In
patulous ET patients, the reduction in the anterolateral wall
movement could be due to several reasons: hypertonic
basal tone of the TVP muscle resulting in little additional
movement with dilatory efforts, weak or thin TVP, loss of
other soft tissue, or cartilage leaving a volume defect that
is already dilated with little additional room for further ex-
cursion. The exact cause may vary between patients, and
further studies, such as electromyogram (EMG) recordings,
will be necessary to clarify the cause in each case. Most of
the patulous patients demonstrated a lack of lateral cartila-
ginous lamina and lack of soft tissue volume in the ante-
rolateral wall. Hypertonic functioning of the TVP muscle
cannot be adequately determined by endoscopic observa-
tion, but the concave contour of the anterolateral wall pro-
vides some support for chronically increased TVP tone
contributing to patulous ET by active retraction.
Dilatory dysfunction cases showed reduced excursions
of the anterolateral wall as well but likely for different
reasons. The wall often was noticeably inflamed and thick-
ened, making it more difficult for the TVP to move the
increased bulk of the wall. There also could be weakness
of the TVP in some cases in which the mucosa seemed
healthy, but the movement was reduced. Direct measure-
ment with EMG would be necessary to confirm such cause.
Movements that were dependent on LVP action, such
as palatal elevation and angle of torus rotation, did not
show any significant differences between healthy subjects
FIG. 3. Mean time measurements of tubal dilation in healthy
subjects and patients with OME or patulous ET. Total duration
of the opening and closing cycle, rotation of the torus tubarius to
its maximum medialized position, and time of valve open are
indicated.
FIG. 4. Means of the measured movements with tubal dilation
in healthy subjects and patients with OME or patulous ET. Pala-
tal elevation and the anterolateral wall lateral excursion measured
in percentage of torus tubarius length and angle of rotation of the
torus measured in degrees.
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and patients with ET dysfunction. It is likely that the LVP
muscle serves to initiate tubal dilation, opening the naso-
pharyngeal orifice of the ET to create the scaffold against
which the TVPmuscle can dilate the valve open (5). Failure
of the LVP action can be associated with the development
of OME (7), but this study demonstrates that the extent of
LVP action is not too critical a factor.
The durations of portions of the dilatory cycle did not
show any significant differences between groups. Initia-
tion of dilation with rotation of the torus was a mean of
176 ms in healthy subjects. Once rotated, the TVP con-
traction commenced, holding the valve in the maximally
dilated or ‘‘open’’ position for a mean of 10.5 ms, which
is a significantly shorter duration than previously reported
of 430 ms (10). Their evaluation was made by sonotubo-
metry as opposed to visual inspection and may indicate
that the sonotubometry is more sensitive in detecting open-
ing before the endoscopic aperture is sufficiently wide to
observe it. As the actual opening of the valve could not be
confirmed endoscopically, further study would be needed
comparing with sonotubometry or other techniques to de-
termine true patency. We observed a trend toward longer
open time in dilatory dysfunction cases with a mean of
15.1 ms. It is possible that there is an increased duration of
effort exerted by the TVP muscle to dilate the valve when it
is compromised by inflammatorymucosa. The overall length
of the ET dilatory and closing cycle was a mean of 995 ms
in healthy subjects. There was a trend for longer duration
in patulous ET cases with 1,276 ms that is of uncertain
importance.
The present study has a number of weaknesses that limit
its interpretations, most important of which was that the
measurements were all limited to endoscopic observations.
The standard deviations were sufficiently large that much
larger sample sizes would be needed to detect small differ-
ences between the healthy subjects and the patients. Mea-
surements of the total cycle time, time to rotate the torus
tubarius to its fully medial position, open time of the valve,
excursion of the palatal elevation, and angle of torus rota-
tion did not show significant differences between groups;
however, these parameters might become significant in a
larger cohort, and this could be studied in the future. Com-
parisons were not made with severity of ear pathology,
although this has previously been shown to lack any corre-
lation with severity of ET pathology (7). This study ana-
lyzed the maximum excursion of the anterolateral wall and
not the excursion of the valve wall itself, which would be
useful to investigate in the future. Correlation with ET
function tests, EMG recordings, sonotubometry, or other
quantitative methods to measure tubal function were not
performed and would be useful for further research. The
ET dysfunction groups had a wider age distribution than
the control group and could add some bias to the results.
A more similar age distribution would be desired in a sub-
sequent study with a larger cohort. However, the strength
of this article is that it provides a new means to make
quantitative endoscopic measurements and used them to
help describe the muscular events in detail in ET during
the dilatory cycle.
This study has highlighted the importance of the TVP
muscle’s action to cause lateral excursion of the ante-
rolateral wall of the valve during dilation of the ET. When
the muscle wall is thick with inflammation or the muscle
action is reduced sufficiently to compromise tubal open-
ing, it may lead to atelectasis or OME. Lateral excursion
of the wall is relatively easy to see with endoscopy and
could be evaluated qualitatively as part of a grading scale
or quantitatively as was done in this study using open
source downloadable software (OsiriX).
CONCLUSION
Measurements were made of ETs from video endo-
scopic recordings taken during the dilatory and closing
process in healthy subjects and patients with either patu-
lous ETs or dilatory dysfunction. Lateral excursion of the
ET’s anterolateral wall was significantly reduced in dila-
tory dysfunction patients and even more reduced in patu-
lous ET patients. Evaluation of the excursion of the lateral
wall of the ET, which is due to the TVPmuscle action, may
be important to observe during clinical endoscopy of the
ET, and it may be quantified for investigational purposes.
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Introduction 
 Eustachian tube (ET) function plays a critical role in the maintenance of homeostasis 
within the normal middle ear cleft.  Tubal dysfunction is a major factor in the etiology of middle 
ear diseases, such as acute and chronic otitis media, the creation and progression of 
cholesteatoma and resultant hearing loss. Great advances have been made in the reconstruction 
of ears injured by chronic pathology, but persistent tubal dysfunction remains a leading cause for 
surgical failure.
1
 
 The ability to record objective measurements of ET function that would be clinically 
relevant is highly desirable, but has yet to be achieved.  Existing tubal function tests are still 
unable to predict failure in tympanoplasty.
2
 Reliable quantitative measurements are critically 
needed to aid in the investigation of pathogenesis of ET disorders and to enhance our ability to 
assess normal and abnormal function.  A clinical ET function test would be useful in the 
preoperative assessment of candidates for ear surgery, aiding in the selection of patients and in 
appropriate tailoring of operations. It is needed to better evaluate responses to medical or 
surgical treatment, as a tool in the investigation of otitis media, and to aid in the evaluation of 
less well defined entities such as otalgia from flight or scuba barometric changes, autophony 
from patulous tubes, and nonspecific otalgia.    
 
 Endoscopy of the nasopharynx allows a direct examination of the pharyngeal orifice of 
the ET and in most cases a view into the tubal lumen. Much has been learnt from endoscopic 
observation of the ET:  The sequence of muscular activity resulting in dilation of the ET has 
*Manuscript (NO AUTHOR INFORMATION)
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been detailed,
3
 and pathologies of the orifice identified.
1
 Video recording and slow motion 
recording has allowed for more detailed examination.
4
 Endoscopy is limited to subjective 
description of the observed structures and motion and a practical grading scale for pathology has 
yet to be produced.  Dilation of the functional valve of the tubal lumen can be reliably observed, 
but actual complete opening of the full length cannot be assessed by endoscopy.  The valve 
refers to the portion of the mucosal surfaces within the ET lumen that are in apposition during 
the resting position and dilate open during tubal ventilation.
3
 
 
Sonotubometry is a technique by which sound emitted by a speaker seated in the nose is 
recorded by a microphone placed in the external auditory canal.  Opening of the ET is recorded 
as an increase in the intensity of the recorded sound.
5-8
 However, the interpretation of 
sonotubometry results is complicated by the presence of uncertain findings and both false 
negatives and positives, thus it does not reliably predict middle ear ventilation.
9
  
In this report we describe for the first time, a method of recording ET function by 
simultaneous and synchronous video endoscopy and sonotubometry. By applying this technique 
to normal volunteers we hope to better elucidate the mechanisms of ET opening and to shed 
some light on the limitations inherent in performing endoscopy and sonotubometry separately.  
Correlation of these synchronized findings would be expected to aid in the interpretation of 
sonotubometry data and add to the understanding of some previously unexplained results.  
Sonotubometry confirmation of dilation of the ET valve to the open position would be compared 
to the endoscopic observation of valve dilation to ascertain the reliability of the endoscopic 
assessment of complete tubal opening.   
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Materials and methods 
 Eighteen healthy subjects underwent endoscopic nasopharyngoscopy with simultaneous 
synchronous sonotubometry. None had a history or findings on physical examination suggestive 
of ET dysfunction, chronic ear or sinus pathology. The group included eleven females and seven 
males, their ages ranging from 23 to 52 years old.  Each subject gave their informed consent to 
the study and it has been approved by the local research ethics committee (Tel-Aviv Sourasky 
Medical Center code 0621-10-TLV). 
 The examination utilized a novel device capable of recording synchronous and 
simultaneous sonotubometer and digital video recordings of transnasal endoscopy (MMS-S10-
EV Eustachian Tube Analyser, Marchbanks Measurements Systems, Lymington, UK). Figure 1 
illustrates the display of the ET analyser. The results from the sonotubometry are shown in the 
bottom panel and, the image from the endoscopic examination is projected in the upper right 
corner. The red cross marks the point of time corresponding to the projected image from the 
endoscopy. For the purpose of review of the test results, short movie clips were made using a 
screen capturing software [CaptureWizPro, Arvada, CO]. The duration of each component of the 
exam and documenting clip (“run”) was 6.25 seconds.    
Endoscopy was performed using a rigid 45 Hopkins rod endoscope (Karl Storz, 
Tuttlingen, Germany) or flexible nasopharyngoscope (Pentax, Montvale, NJ).  The endoscope 
was fitted with a single chip analog charge coupled device (CCD) video camera (Karl Storz, 
Tuttlingen, Germany).  A full screen image of the endoscopy was projected on a video monitor 
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(SONY, Japan) and the video feed was also presented on the LCD display monitor that was 
connected to the combined sonotubometer-endoscope analyzer. Sonotubometry was performed 
as follows: a speaker was placed into the nostril contralateral to the ET to be studied. A 
microphone was placed in the ipsilateral external auditory canal (EAC) and was sealed against 
the EAC walls with appropriately sized tips otherwise used for tympanometry. The endoscope 
was passed through the nasal cavity ipsilateral to the ET studied.  The parameters for the nasal 
speaker were set to a 7 kHz tone at 100 dB SPL for a duration of 6.0 seconds.  The nasal probe 
tone signal was detected by the EAC microphone, amplified, passed through an RMS converter, 
onto a true log dB amplifier and then to a 12 bit analog to digital (A/D) converter.  Video 
recording was done at 30 frames per second. 
Subjects were examined in the office in the sitting position.  The ipsilateral nasal cavity 
was anesthetized with topical spray Oxymetazoline HCl 0.05% mixed in equal parts with topical 
Tetracain 2% (mixed by the pharmacy at Tel Aviv Sourasky medical center). Next, the 
microphone was placed in the ipsilateral EAC and the speaker into the contralateral nostril.  
Using a feature of the ET Analyser, the completeness of the seal between the microphone and the 
EAC wall and between the nasal speaker and the nostril was verified to limit external feedback 
from the nasal speaker to the EAC microphone in order to reduce background noise.  Once 
adequately anesthetized, the rigid endoscope was introduced into the ipsilateral nostril.  In the 
event that the nasal cavity was too narrow to easily accommodate the rigid endoscope, the 
contralateral nostril was also anesthetized and the fiberoptic endoscope was subsequently 
introduced, either through the ipsilateral or contralateral nostril, whichever yielded the better 
view into the lumen of the ET along its long axis.  The rigid endoscope was passed through the 
nasal cavity along the floor until a satisfactory view into the lumen of the ET was obtained and 
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aligned with its long axis.  Care was taken to avoid any disturbance of the nasal mucosa as any 
bleeding could significantly compromise the video examination.   
Each subject was asked to perform 3 sets of maneuvers. The first was repeated 
vocalization of the letter “k”, demonstrating the activity of the levator veli palatini (LVP) 
muscle.  Isolated LVP activation was not expected to dilate the valve to the fully open position 
since that requires the subsequent contraction of the tensor veli palatini (TVP) muscle.  The 
second recording documented efforts of the subject to swallow as an example of normal 
dynamics. Water was provided for an oral bolus as needed. Although the initiation of swallowing 
is under significant voluntary control, subjects have variable and even quite limited control of the 
subsequent amount of reflexive muscular effort applied to dilate the ET valve to the open 
position.  During each 6.25 seconds long video clip, subjects could usually perform two 
swallowing efforts, at times three. Normal individuals do not dilate their ET to open with every 
swallow.  Lastly, a forced yawn was recorded to study maximal muscular effort. Before the 
actual exam the subjects were instructed to experiment with a number of yawns, and to make a 
maximal effort to open the ET. Most commonly, a yawn gives the best chance of producing ET 
dilation and can yield a maximal dilatory effort.  Again, ET dilation to the open position does not 
occur with every swallow, but individuals can be coached to maximize the voluntary effort.  
Subject 2, a scuba diver, had developed significant voluntarily control over the contractions of 
the levator veli palatini (LVP) and tensor veli palatini (TVP). In addition to the standard protocol 
his examination included documentation of the results of his efforts to contract the LVP and TVP 
individually aided by video endoscopic feedback.  Dilation of the valve was observed on 
endoscopy by the coordinated actions of the LVP contraction holding the posterior cushion 
(torus tubaris) of the ET in a medialized position against which the TVP subsequently dilated the 
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antero-lateral wall to produce a rounding of the valve to the fully dilated position.   Dilation of 
the valve to the open position was determined by the observation of a rise in the dB SPL in the 
microphone signal from the sonotubometer that coincided with the muscular effort.  
Results 
Quantitative results of the measurements of the maneuvers to open the ET are 
summarized in table 1. The data for each subject was averaged and represented as a single row in 
the table. This method of data representation was chosen, rather than presenting the result of 
every swallow and yawn, to allow comparison between subjects, who differed in the number of 
efforts recorded, and for the sake of brevity and clarity.  
One subject was tested and excluded from the data analysis. This 34 years old male had 
undergone conchotomy for nasal obstruction several years before being evaluated. His 
examination resulted in the largest increase in sound intensity during swallowing (ranging from 
23 to 26dB). It is possible that this unusually high recording resulted from the surgically 
expanded nasal cavity.   
Six out of the remaining seventeen (35.3%) subjects did not open their ET during 
swallowing. Interestingly, all six were females. As the middle ears of these subjects were 
normally aerated, it is most likely that they did open their ETs on a regular basis, but failed to 
demonstrate a voluntary ability to initiate dilation with swallowing.  For those eleven that did 
open the ET during swallows, opening was recorded with 3 out of 4 of the swallow efforts (range 
10-100% of openings per swallows). Four subjects opened the ET with every swallow (i.e. 100% 
openings per swallows). The average duration of opening of the ET during swallowing as 
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reported from sonotubometry was 0.44 seconds, and the average increase in sound intensity 
reaching the EAC was 9.2 dB.  Yawning resulted in higher instances of ET opening compared to 
swallowing; only four subjects (23.5%) could not open the ET during a forced yawn. The 
average opening time of the ET during yawning was 2.03sec and the intensity of sound recorded 
in the EAC increased by an average of 10.1dB. Hence, the voluntary yawn resulted in longer 
opening of the ET.   
Comparison of the results from simultaneous recordings of the two techniques 
demonstrated a 100% correlation between sonotubometric detection of a significant rise in 5 dB 
SPL to indicate tubal opening and endoscopic observation of valve dilation to the open position.  
On the contrary, endoscopic observations of valve dilation were not consistently associated with 
confirmation of full dilation to open on the sonotubometry.  We documented one case of an 
effort that appeared to dilate the valve open as seen on endoscopy, but lacking sonotubometric 
confirmation (Figure 2).  The lumen of the ET was partially dilated by the posterior displacement 
of the posterior cushion.  Although the nasopharyngeal orifice appeared to be open, no functional 
opening was recorded by the sonotubometer.     
A negative sound pressure wave was recorded in a number of instances, immediately 
preceding a swallow related opening. In figure 3a recorded from subject 8, a bubble of nasal 
secretion is seen in the ET orifice; the sonotubometer recording reflects a closed ET. Upon 
swallowing (Figure 3b) the bubble seems to be inflated and the sonotubometer records a 
reduction in the sound intensity reaching the EAC.  These findings are compatible with air being 
pushed from the ET into the nasopharynx.  
Discussion 
8 
 
 In the search for a better tool to measure the function of the ET, the value of simultaneous 
synchronous recording of endoscopy and sonotubometry was evaluated in this pilot study.  
 The most commonly used tool for real time evaluation of ET function is endoscopy. ET 
allows for detailed studying of the nasopharyngeal orifice in passive and dynamic states. 
However, endoscopic examination of the ET orifice during swallows or yawns can demonstrate 
dilation of the ET without being certain that full tubal opening was achieved.  Hence, it may lead 
to a false assurance of a normally functioning ET orifice (i.e. false negative). Adding a functional 
measurement of ET activity with sonotubometry can eliminate this source of error. In this study, 
in one instance ET dilation efforts were noted on endoscopy but dilation to open failed to occur 
on sonotubometry. (Figure 2)   It is unlikely that this observation was caused by a fixed 
obstruction in other parts of the ET (e.g. the isthmus), as the middle ear was normally aerated. 
Reasons for failure to observe sonotubometric opening despite dilation seen by endoscopy could 
be secretions temporarily within the lumen (Figure 3a), incomplete dilation of the valve rostrally 
or sufficiently small dilation that it is below the sensitivity of the sonotubometer.  Such a small 
dilation might still provide a significant amount of air exchange to be physiologically beneficial.  
Ordinary ET endoscopy will generally see most of the valve and in some cases up to the isthmus, 
but it is not possible to see the full length of the lumen.  Therefore, it cannot reliably confirm true 
dilation to the open position in all cases.   It is possible to pass smaller endoscopes higher into 
the ET lumen, but the low resolution of such microendoscopes and contact of the lens to the 
mucosal walls has not provided practical benefits from this approach.
3
  
Sonotubometry seems to have high specificity (a recording of ET opening most likely 
reflected a true opening), but lower sensitivity (the ET may open without a corresponding 
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recording by sonotubometry). Simultaneous synchronous endoscopy with sonotubometry may 
improve the sensitivity of both isolated exams. The accepted threshold for ET opening in 
sonotubometry is 5dB, assumed to strike a good balance between false negatives and positives.
10
 
In a number of instances we recorded an increase in EAC sound pressure that did not reach this 
threshold, but was clearly a sign of true opening of the ET, as it nicely corresponded with a 
simultaneous opening of the orifice as seen by endoscopy. Sonotubometry by itself would have 
recorded a false negative measurement. However, we suggest that in such instances even a sub-
threshold recording can still be considered as an indicator of ET opening, given the concurrent 
endoscopic dilation. As mentioned, secretions may result in a non-opening pattern 
sonotubometry, but can be recognized as a transient and easily reversible impediment by 
endoscopy. In all efforts documenting opening of the ET by sonotubometry, a corresponding 
opening was observed during endoscopy.  
Sonotubmetry requires proper EAC sealing. Imperfect sealing of the EAC meatus can 
cause a leakage of sound pressure that will decrease the intensity recorded by the microphone or 
allow sound to enter the EAC from outside the head (feedback).  Feedback could cause false 
recordings of elevation in sound pressure. This problem can be addressed by careful fitting of the 
microphone into the EAC.  The analyzer used in the current study was equipped with continuous 
leak monitoring capability. The examiner should both be alert for noticeable changes in the 
intensity of the tone emitted by the sonotubometer as it will normally be just barely audible. 
The combined exam has provided additional information about the normal activity of the 
ET orifice. Subject 2, a scuba diver, has trained himself to open the ET by voluntarily 
contraction of the LVP and TVP, even without swallows or yawns.  With video endoscopic 
10 
 
feedback, he quickly learned to independently contract the LVP, but could not contract the TVP 
without first contracting and sustaining LVP contraction.  The combined recording illustrates 
that contraction of the TVP is the final and necessary stage in the dilatory process of the ET that 
results in opening of the tube.  Contraction of the LVP elevates the palate and medially rotates 
the posterior cushion, which dilates the postero-medial wall of the ET, but does not cause tubal 
opening as is evident by the flat sonotubometer recording (Figure 1a). When the TVP contracted 
(Figure 1b), a corresponding elevation of approximately 8dB in the sonotubometer was recorded. 
The duration of the opening of the ET was dependent on the duration of contraction of the TVP. 
This is adds additional evidence that TVP contraction is the final step for the opening of the ET. 
This conclusion is also supported by the fact that LVP contraction during pronunciation of the 
consonant “K” never resulted in the opening of the ET. The pivotal role of the TVP in opening 
the ET has been established by other techniques, including paralysis with botulinuim toxin.
11-13
 
Interestingly, subject 2 opened the ET with every swallow and helps to substantiate a potential 
role for endoscopic video feedback as a means for training patients with impaired ET dilation.  
The average opening time of the ET during swallows was 0.44 seconds; this is 
compatible with the 0.43+0.138 seconds reported by Mondain et al.
14
 However, these authors 
defined opening of the ET in sonotubometry as an elevation of 6dB and used different sound 
stimulus characteristics that might influence these measurements. Yawns, in contrast to 
swallows, can produce a strong voluntary opening of the ET and can represent a maximal 
opening effort. As such, it is not surprising that with a maximal voluntary effort the ET can be 
maintained opened for longer durations compared with the largely reflexive sequence that occurs 
during swallows. However, the average increase in sound intensity during a yawn was not higher 
11 
 
than during swallow, potentially implying that the ET does not become more patent with the 
voluntary effort of the yawn compared to the swallow.   
In one instance, an air bubble residing in the ET orifice was inflated by the contracture of 
the ET associated muscles (Figure 3a and 3b). Sonotubometry recorded a negative deflection 
wave. These findings may indicate that gas was being pushed from the lumen of the ET towards 
the nasopharynx, potentially serving one of the ET’s functions of middle ear clearance. A 
detailed analysis of the anatomy of the orifice and the timing of muscle contraction
15  
and a 
clinical observation through perforated ear drums
16 
have supported such a notion.  
 In this study efforts to open the ET by swallowing and yawning were studied. Due to the 
equipment set-up studying spontaneous (non-swallow or yawn related) opening could not be 
evaluated; this would require subjecting an examinee to a long duration of instrumentation. As 
spontaneous opening has an important role in middle ear cleft homeostasis it would beneficial to 
devise a method suitable for longer duration of surveillance. This preliminary study was limited 
by the small number of subjects, and its intention was to study the potential application of the 
technique of simultaneous recording of endoscopy and sonotubometry. There is a need for larger 
scale studies of normal subjects as well as patients with pathologies of the middle ear, 
nasopharynx or the ET (such as cleft palate).  
 In conclusion, simultaneous synchronous recording of endoscopy and sonotubometry can 
improve the accuracy of each of these tools separately as a technique for studying ET function. 
In addition, this preliminary study has confirmed the pivotal role of TVP contraction to ET 
opening.   
12 
 
 
 
 
   
13 
 
Bibliography  
 
1. Poe DS, Abou-Halawa A, Abdel-Razek O. Analysis of the dysfunctional 
eustachian tube by video endoscopy. Otol Neurotol. 2001;22(5):590-5. 
2. Choi SH, Han JH, Chung JW. Pre-operative Evaluation of Eustachian Tube 
Function Using a Modified Pressure Equilibration Test is Predictive of Good 
Postoperative Hearing and Middle Ear Aeration in Type 1 Tympanoplasty 
Patients. Clin Exp Otorhinolaryngol. 2009;2(2):61-5. 
3. Poe DS, Pyykkö I, Valtonen H, Silvola J.Analysis of eustachian tube function by 
video endoscopy. Am J Otol. 2000;21(5):602-7. 
4. Mathew GA, Kuruvilla G, Job A. Dynamic slow motion video endoscopy in 
eustachian tube assessment. Am J Otolaryngol. 2007;28(2):91-7. 
5. van der Avoort SJ, van Heerbeek N, Zielhuis GA, Cremers CW. Sonotubometry: 
eustachian tube ventilatory function test: a state-of-the-art review. Otol Neurotol. 
2005 May;26(3):538-43. 
6. van der Avoort SJ, Heerbeek N, Zielhuis GA, Cremers CW. Validation of 
sonotubometry in healthy adults. J Laryngol Otol. 2006;120(10):853-6. 
7. van Heerbeek N, van der Avoort SJ, Zielhuis GA, Cremers CW. Sonotubometry: 
a useful tool to measure intra-individual changes in eustachian tube ventilatory 
function. Arch Otolaryngol Head Neck Surg. 2007;133(8):763-6. 
14 
 
8. van der Avoort SJ, van Heerbeek N, Snik AF, Zielhuis GA. Cremers CW. 
Reproducibility of sonotubometry as Eustachian tube ventilatory function test in 
healthy children. Int J Pediatr Otorhinolaryngol. 2007;71(2):291-5. 
9. Sumi T, Tsunoda A, Shirakura S, Kishimoto S. Mechanical obstruction of the 
eustachian tube by the benign tumor of the parapharyngeal space does not cause 
otitis media with effusion. Otol Neurotol. 2007;28(8):1072-5. 
10. Di Martino EF, Nath V, Telle A, Antweiler C, Walther LE, Vary P. Evaluation of 
Eustachian tube function with perfect sequences: technical realization and first 
clinical results. Eur Arch Otorhinolaryngol. 2010;267(3):367-74. 
11. Cantekin EI, Doyle WJ, Bluestone CD. Effect of levator veli palatini muscle 
excision on eustachian tube function. Arch Otolaryngol. 1983;109(5):281-4. 
12. Casselbrant ML, Cantekin EI, Dirkmaat DC, Doyle WJ, Bluestone CD. 
Experimental paralysis of tensor veli palatini muscle. Acta Otolaryngol. 
1988;106(3-4):178-85. 
13. Ghadiali SN, Swarts JD, Doyle WJ. Effect of tensor veli palatini muscle paralysis 
on eustachian tube mechanics. Ann Otol Rhinol Laryngol. 2003;112(8):704-11. 
14. Mondain M, Vidal D, Bouhanna S, Uziel A. Monitoring eustachian tube opening: 
preliminary results in normal subjects, Laryngoscope. 1997;107(10):1414-9. 
15. Ishijima K, Sando I, Balaban CD, Miura M, Takasaki K. Functional anatomy of 
levator veli palatini muscle and tensor veli palatini muscle in association with 
eustachian tube cartilage. Ann Otol Rhinol Laryngol. 2002;111(6):530-6. 
15 
 
16. Cohen D, Raveh D, Peleg U, Nazarian Y, Perez R. Ventilation and clearance of 
the middle ear. J Laryngol Otol. 2009 Dec;123(12):1314-20.  
16 
 
. Abstract 
Objective: To describe for the first time, a method of recording of Eustachian tube (ET) 
function by simultaneous and synchronous endoscopy and sonotubometry and explore its 
advantages compared to the performance of these tests independently. 
Study Design: Observational study 
Setting: Academic tertiary medical center  
Subjects and Methods: Eighteen healthy subjects underwent endoscopic 
nasopharyngoscopy with simultaneous, synchronous sonotubometry. This pilot study 
utilized a novel device. Each subject was documented performing three maneuvers: 
pronouncing the consonant “k”, swallowing and yawing. 
Results: Six out of seventeen (35.3%) subjects used for data analysis did not open their 
ET during swallowing. Excluding non-openers, the ET opened in 3 out of 4 of the 
swallows. The average duration of opening of the ET during swallowing was 0.44s. The 
ET does not open every time the endoscopic view notes dilation. A negative sound 
pressure wave was recorded in a number of instances, immediately preceding a swallow 
related opening. Contraction of the tensor veli palatini muscle was essential for ET 
opening.  
Conclusions: Simultaneous synchronous endoscopy and sonotubometry may improve the 
accuracy of either performed separately as an ET function measurement tool. 
Sonotubometry may prevent a false positive endoscopy (ET viewed as open, but no 
17 
 
functional patency achieved). Endoscopy can lower the threshold considered as positive 
for sonotubometry. A negative pressure wave recorded by sonotubometry may reflect the 
ET role of clearing the middle ear of secretions towards the nasopharynx. This novel 
measurement technique provided additional evidence that the tensor veli palatini muscle 
provides the final opening action of the ET.  
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Figures’ Legend 
Figure 1 – Combined rigid endoscopic image (in the right upper corner of the figure) and 
sonotubometry (lower half of the image) recording a left Eustachian tube naso-pharyngeal 
orifice.  All figures are screen images from the prototype device. The endoscopic image is 
projected on the right upper corner of the screen. In the lower part of the screen the 
sonotubometer results are shown. The white curved line is the sound pressure measurement in 
the external auditory canal, in a logarithmic scale (y-axis) vs. time (x-axis). The red cross on the 
sonotubometry recording marks the timing when the corresponding endoscopic picture was 
taken. A) Isolated contraction of the levator veli palatine does not result in opening of the 
Eustachian tube (as reflected by the stable recording of sonotubometry depicted with a white 
line). B) Contraction of the tensor veli palatini is seen as a concavity of the anterior (right side) 
wall of the lumen in the Eustachian tube orifice. The combined contraction of these two muscles 
results in opening of the Eustachian tube as measured by an elevation of approximately 8 dB in 
the sonotubometry recording. Contraction of the tensor veli palatini is essential for ET opening.  
Figure 2 – Discordance between the endoscopic view and the recording of the sonotubometer. A 
rigid endoscopic view of the right Eustachian tube (ET) nasopharyngeal orifice seems to show an 
opening of the ET (white arrow); however sonotubometry did not record a compatible elevation 
in the sound recorded at the external auditory canal. This is an example of the improved 
sensitivity of the combined device for evaluating Eustachian tube opening compared with 
endoscopy alone (see legend of figure 1 for details of the image layout). 
Figure 3 – Secretions in the right Eustachian tube orifice and the creation of pressure towards the 
nasopharynx in the orifice during initial stages of swallowing.  A) Endoscopic view of the 
20 
 
nasopharyngeal orifice of the left Eustachian tube. A thin film of secretions covers the orifice. 
This finding may potentially dampen sound transmission from the nose to the external auditory 
canal causing a falsely negative sonotubometry recording. B) With a swallowing effort, evident 
in the elevation of the levator palatini muscle, an air bubble is being pushed from the orifice 
lumen towards the nasopharynx. This observation is compatible with the role of the Eustachian 
tube of clearing the middle ear to the nasopharynx (see legend of figure 1 for details of the image 
layout).   
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 Table 1 – Summary of Eustachian tube opening with dilatory efforts  
 Swallow 
   
Yawn 
    
Subject Fractio
n 
Open 
Duration (sec) Intensity (dB) Numbe
r of 
efforts 
Fraction 
Open 
Duration (sec) Intensity 
(dB) 
Numbe
r of 
efforts 
1 20% 0.2 7 5 0%   1 
2 100% 1.06 12.8 6 100% 2 9.5 5 
3 86% 0.28 11.5 7 100% 0.8 4 1 
4 0%   7 100% 1.5 7 2 
5 10% 0.35 5 10 100% 1.5 6.7 2 
6 80% 0.27 15 5 50% 3 7 2 
7 0%   4 0%   1 
8 0%   5 0%   1 
9 100% 0.48 6 6 100% 1.25 7 2 
10 33% 0.5 9 6 100% 0.55 9.5 2 
11 0%   4 100% 0.55 9.5 1 
12 75% 0.3 7 4 100% 0.62 17.5 3 
13 100% 0.49 15.3 4 100% 3.1 11.2 2 
14 100% 0.35 5.8 2 n/a    
15 0%   5 0%   2 
16 0%   3 100% 5.25 17.5 2 
17 50% 0.63 7 4 100% 4.24 15 2 
Average 44% 0.29 5.6   71.9 1.52 7.6  
Average(excluding 
non-openers) 
68% 0.44 9.2   96% 2.03 10.1   
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Laser Eustachian Tuboplasty: Two-Year Results
Dennis S. Poe, MD; J. Fredrik Grimmer, MD; Ralph Metson, MD
Objective/Hypothesis: Laser eustachian tuboplasty
(LETP) combined with appropriate medical man-
agement will eliminate the chronic presence of mid-
dle ear effusions in selected patients. Methods: The
study population consisted of 13 adults with otitis
media with effusion (OME). Patients underwent
slow-motion video endoscopy to identify the loca-
tion and extent of surgical resection. A diode or
argon laser was used to vaporize areas of hypertro-
phic mucosa and submucosa along the cartilagi-
nous eustachian tube. Patients were evaluated at 6,
12, and 24 months. Successful outcome was defined
as absence of OME. Patients with evidence of reflux
disease or allergic rhinitis were treated with medi-
cal therapy before surgery and throughout the
follow-up period as indicated. Results: LETP com-
binedwithmedical management eliminated OME in
36% (4 of 11) of patients at 6 months, 40% (4 of 10) at
1 year, and 38% (3 of 8) at 2 years. Failure of LETP
correlated with presence of laryngopharyngeal re-
flux (P  .01) or allergic disease (P  .05) for the
results at 1 year but not at 2 years. Conclusions:
LETP combined with appropriate medical manage-
ment may be an effective treatment in select pa-
tients with chronic persistent eustachian tube dys-
function. A controlled trial with a larger number of
subjects will be necessary to determine the efficacy
of LETP and identify those factors predictive of
successful outcome. Key Words: Eustachian tube,
eustachian tube dysfunction, laser eustachian tubo-
plasty, otitis media with effusion, OME.
Laryngoscope, 117:231–237, 2007
INTRODUCTION
Eustachian tube (ET) dysfunction is a common prob-
lem of childhood, which may persist into adult life. The
cause may be chronic infection, allergies, laryngopharyn-
geal reflux, primary mucosal disease, abnormalities of the
dilation mechanism, and anatomic obstruction.1–8 When
tubal dysfunction is refractory to medical therapy, venti-
lation tube insertion into the tympanic membrane can be
effective in aerating the middle ear. Patients with chronic,
persistent ET dysfunction often require multiple sets of
tubes. Long-acting tubes can also be inserted, although they
are subject to crusting, infection, obstruction, and extrusion.
In previous studies,8,9 the authors have shown that
the majority of patients with chronic, persistent ET dys-
function have identifiable bulky mucosal disease within
the cartilaginous ET lumen that appears to interfere with
the dilation process. These functionally “obstructive dis-
orders” are in contrast to the much less common “dynamic
disorders” in which normal-appearing ETs fail to properly
dilate as a result of apparent abnormalities of muscular
movement or coordination between muscles. Obstructive
disorders are generally the result of degrees of mucosal
inflammation and edema that may involve the entire na-
sopharynx or be isolated to the ET. Mucosal disease may
be limited to the posterior cushion or may extend superi-
orly into the area we have termed “the valve.”9,10 The
valve refers to the approximately 5-mm long segment of
the tubal lumen, just inferior to the bony cartilaginous
isthmus, in which the mucosal walls appose to close the
tube in the resting position. Active dilation separates
these mucosal walls under normal circumstances. Patho-
logic conditions that prevent dilation of the valve have
been correlated with middle ear complications of otitis
media with effusion (OME), atelectasis of the tympanic
membrane, and cholesteatoma.8
Surgical correction of ET dysfunction has been at-
tempted using various approaches to perform a eustachian
tuboplasty by enlarging the osseous ET, especially the isth-
mus, which is the narrowest diameter segment of the ET.11
None of these procedures have had any lasting success. Be-
cause it has become evident that the cartilaginous ET may
be an important site of pathology, the authors have made an
attempt to focus a surgical procedure on that portion for
patients with refractory middle ear effusion.
Laser eustachian tuboplasty (LETP) was first per-
formed by Kujawski in 199712 in patients with varying
degrees of OME and/or atelectasis. We subsequently pre-
sented the preliminary results of a prospective pilot study
evaluating the safety and efficacy of LETP in patients
with refractory OME.13 We hypothesized that debulking of
diseased mucosa with the tubal lumen’s posteromedial
wall, in conjunction with appropriate medical manage-
ment, could be effective in eliminating medically refrac-
tory OME. The procedure resulted in the absence of
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effusion in 7 of 10 (70%) patients at 6 months and 3 of 5
(60%) patients at 12 months. The purpose of the present
study is to present the follow-up data from these and
additional patients.
PATIENTS AND METHODS
Patient Selection
A prospective study of the results of a surgical intervention
was undertaken at a tertiary medical center. The patients served
as their own historical controls. The study population consisted of
adult patients with at least a 5-year history of chronic otitis OME.
Eligible patients must have undergone at least 2 prior tympanos-
tomy tube placements with recurrence of the effusion each time
the tube was extruded.
Otitis media with effusion was documented by microoto-
scopy. Patients with cholesteatoma or atelectasis without effu-
sion were not included in the study. All patients underwent a
previously described transnasal endoscopic slow-motion video
analysis of their ETs (Fig. 1) and were found to have disease
within the cartilaginous portion consistent with an obstructive
disorder.8,10 A tubal dysfunction MTV (Mucosal disease, Tensor
and levator veli palatini muscle strength, and Valve dilation)
score was determined for each patient.9
Medical histories included symptoms of seasonal allergies,
food allergies, or reflux disease (Table I). Patients underwent
endoscopic examination of their nasal cavity, nasopharynx, oro-
pharynx, hypopharynx, and larynx looking for evidence of allergic
disease or laryngopharyngeal reflux (LPR). All patients were
treated for a minimum of 8 weeks with nasal corticosteroids.
When allergic disease was encountered, oral antihistamines were
administered for a minimum of 8 weeks. When evidence of laryn-
gopharyngeal reflux was obtained, treatment with 20 mg per day
of omeprazole was prescribed for at least 8 weeks. Failure to show
improvement of OME after medical management was the final
inclusion criterion.
Surgery was performed unilaterally. In the event of bilat-
eral disease, the more severely affected ear was selected and
tympanostomy tube or continued medical management was of-
fered for the contralateral ear. Patients underwent preoperative
evaluation by audiogram and tympanogram. The pure tone aver-
age (PTA) was calculated by averaging the air conduction decibel
hearing level at 500, 1,000, 2,000, and 3,000 Hz. In the event that
3,000 Hz had not been obtained, the 2,000- and 4,000-Hz thresh-
olds were averaged in accordance with the AAO-HNSF criteria.14
Preoperative tympanograms were not available for patient nos. 8
and 10. Audiograms were not available for patient no. 4.
A biopsy of the posterior eustachian tube cushion was per-
formed immediately before LETP and 5 months after surgery in
patient no. 15.
The study protocol was approved by the Institutional Re-
view Board at the Massachusetts Eye and Ear Infirmary. All
Fig. 1. Transnasal view of normal left eustachian tube nasopharyn-
geal orifice in closed and dilated positions. The patient was exam-
ined in the sitting position with a 0° 4-mm endoscope using slow-
motion video endoscopy.
TABLE I.
Preoperative and Postoperative Results for Laser Eustachian Tuboplasty.
Patient
No. Age Sex
Laryngopharyngeal
Reflux Allergies
Preoperative 6-Month Follow Up 1-Year Follow Up 2-Year Follow Up
Examination Tymp Examination Tymp Examination Tymp Examination Tymp
1 36 M Y Y Atelec/OME B N/A N/A sl. Retrac As N/A N/A
2 30 M Y N OME B OME B TT N/A OME N/A
3 44 M Y Y Atelec/OME C sl. Retrac C Retrac B OME B
4 62 F Y Y OME B OME B Atelec B N/A N/A
5 29 M Y N OME B OME B OME N/A TT N/A
6 48 M Y N Atelec/OME C sl. Retrac C N/A N/A Tiny perf N/A
7 50 M N Y OME C OME N/A N/A N/A N/A N/A
8 45 M Y Y Atelec/OME N/A OME B OME B sl. Retrac A
9 40 M N Y OME B N/A N/A sl. Retrac A sl. Retrac C
10 64 M Y Y OME N/A OME B OME B TT N/A
11 41 M N Y OME B Retrac C N/A N/A sl. Retrac A
12 56 M N Y OME B OME N/A OME B N/A N/A
13 33 M Y Y OME B sl. Retrac A sl. Retrac C N/A N/A
Atelec  atelectasis of the tympanic membrane (TM); N  no; N/A  not available; OME  otitis media with effusion; perf  perforated TM; Retrac  TM
significantly medialized but not necessarily contacting the incus or promontory; there were no adherent retractions or pockets; sl. Retrac  slight retraction of the
TM appearing nearly normal but mobile with negative pressure insufflation; TT  tympanostomy tube in the TM; Tymp  tympanogram: A (normal), As (normal
pressure but shallow peak), B ( flat), and C (negative pressure); Y  yes.
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patients were provided appropriate information regarding study
design and signed informed consents.
Surgical Technique
The surgical technique has been described in detail in our
previous work.13 To summarize briefly, patients were placed in
the supine position, maintained with general anesthesia, and
intubated. Ventilation of the ipsilateral middle ear was achieved
by placing a 0.9-mm silicone mini-Baxter tympanostomy tube or
by removing an obstructed permanent tympanostomy tube and
thus creating a tympanic membrane perforation. In one case,
myringotomy alone was performed. The surgery was typically
performed with a 30o 4-mm-diameter nasal endoscope in the
ipsilateral nasal cavity to visualize the tubal orifice. Surgical
instruments were passed transorally with a tonsil mouth gag in
place. Local infiltration with 1% lidocaine with 1:100,000 epi-
nephrine was performed in the ET orifice. The orifice was further
decongested with the topical application of 1:50,000 epinephrine
on a cotton pledget. The medial cartilaginous lamina within the
posterior cushion (torus tubarius) was identified and palpated
as a landmark. A fiber-delivered laser was then passed into the
nasopharynx, usually through the mouth but occasionally
through the ipsilateral nasal cavity. A 980-nm contact-tip diode
laser (Biolitec, East Longmeadow, MA) with settings of 7 W
power, continuous pulse mode with 0.2 seconds on and 0.8 sec-
onds off was used in the initial six cases. An argon laser (HGM;
Medical Laser Systems, Salt Lake City, UT) with settings of 3 W,
0.2-second pulse duration, continuous mode was used in 8 cases.
Vaporization of mucosa and submucosa to expose the underlying
cartilage was done to create a wedge-shaped defect on the intralu-
minal surface of the posterior cushion and posteromedial wall
(Fig. 2). The resection was confined to the posteromedial wall
taking great care to avoid any injury to the opposing anterolateral
wall and the extent of the lesion never exceeded one-third of the
lumen’s circumference. The cartilaginous lamina was thinned
only when it was unusually thick or stiff as seen on preoperative
video endoscopy. The extent of surgical excision was determined
by the degree of bulk seen at the preoperative slow-motion video
analysis as described in previous studies.13Mucosal biopsies of
the ET were obtained at the time of LETP in 2 patients and 5
months postoperatively in one.
TABLE II.
Overall Laser Eustachian Tuboplasty Results.
Follow Up
(months) No.
Normal
TM Percent
Retracted
TM Percent Failure Percent
6 11 0 0 4 36 7 64
12 10 0 0 4 40 6 60
24 8 0 0 3 38 5 62
Failure  presence of otitis media with effusion, perforated; TM 
tympanostomy tube, atelectasis.
TABLE III.
Preoperative and Postoperative Hearing Results for Laser
Eustachian Tuboplasty.
Patient No. Preoperative PTA 6-Month PTA 1-Year PTA 2-Year PTA
1 21.3 N/A 11.3 N/A
2 20.6 43.8 17.5 31.3
3 23.8 18.8 18.8 32.5
4 N/A N/A N/A N/A
5 40.0 N/A N/A 26.2
6 30.0 35.0 N/A 26.3
7 57.5 N/A N/A N/A
8 28.8 55.0 55.0 30.0
9 51.3 N/A 12.5 15.0
10 47.5 38.8 32.5 21.3
11 31.3 16.3 N/A 17.5
12 42.5 N/A 47.5 N/A
13 37.5 N/A 8.8 N/A
PTA  pure tone average; N/A  not available.
Fig. 2. Laser eustachian tuboplasty. (A)
Intraoperative view of the right eustachian
tube nasopharyngeal orifice as seen
through a 0° endoscope passed through
the ipsilateral nostril. The patient contin-
ues to have otitis media with effusion de-
spite medical therapy and the placement
of multiple tympanostomy tubes. The
posterior cushion (Torus tubaris) has hy-
pertrophic mucosa preventing adequate
opening of the tubal valve region. (B) A 30°
endoscopic view of laser vaporization of
the hypertrophic mucosa and submu-
cosa. The suction catheter is medially ro-
tating the posterior cushion to dilate the
tubal valve and allow for precise vaporiza-
tion of valve mucosa. (C) A 30° endo-
scopic view of completed laser eusta-
chian tuboplasty. A Merogel sponge with
sulfacetamide and prednisolone topical
ophthalmic solution has been packed into
the tubal lumen.
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Patients were followed prospectively. Audiograms, tympa-
nograms, and microscopic examination of the ears were planned
for 6 months, 1 year, and yearly intervals thereafter. Patients
who were suspected of having LPR were continued on 20 mg
omeprazole orally per day for at least 6 weeks after surgery.
Failure of LETP was determined if the patient demonstrated
OME on follow-up otomicroscopic examination. Statistical analy-
sis was performed using the Student t test and 2 test.
RESULTS
Sixteen patients were entered into the study since June
25, 2001; however, three were excluded from the present
report. One patient still had an extruding but patent tym-
panostomy tube in place at the time of surgery. A second had
a long history of OME but it had converted to atelectasis
without effusion just before surgery. The third patient had
not yet reached 6-month follow up by the time of this report.
Of the remaining 13 patients who met the criteria for inclu-
sion into the study, 12 were male and one was female. Ages
ranged from 29 to 64 years with an average of 44 years.
Eight of the 13 patients were originally presented in the
authors’ preliminary LETP study13 and their follow-up data
are included in this report. Patients were followed for an
average of 26 months (range, 14–34 months).
The results are summarized in Tables I through III.
In the preoperative assessment, LPR occurred in 9 of 13
(69%) and allergic disease in 10 of 13 (77%). OME with or
without atelectasis of the tympanic membrane was iden-
tified in all patients preoperatively. LETP eliminated
OME in 36% (4 of 11) of patients at 6 months, 40% (4 of 10)
at 1 year, and 38% (3 of 8) at 2 years.
Two patients (nos. 1 and 13) did not return for 2-year
follow up but reported by phone that they are doing well.
Their phone follow up was not included in the 2-year data.
Patient no. 6 was counted as a failure at 2 years as a result
of the presence of a perforation, but most of the previous
interval time, he had had an intact TM without effusion
and was asymptomatic. Patient no. 10 was diagnosed with
Samter’s triad in the postoperative period.
The presence of comorbidities appeared to influence
the surgical outcome of LETP at 1 year but not at 2 years.
At 1 year, the difference between successful and failed
LETP patients showed statistically significant correlation
with the presence of LPR (0% vs. 40%, respectively, P 
.01) or allergic disease (10% vs. 30%, respectively, P .05)
At 2 years, there was no significant difference between
successful and failed LETP patients with the presence of
either LPR (10% vs. 30%, respectively, P  .10) or allergic
disease (10% vs. 20%, respectively, P .20) by 2 analysis.
Successful LETP patients demonstrated a statisti-
cally significant difference in their mean pretreatment
PTA (35.3 dB) and posttreatment PTA at 1 and 2 years
(12.9 dB and 20.8 dB, respectively, P  .028). As expected,
failed LETP patients did not show a statistically signifi-
cant change in their PTA. Before treatment, there was
also no statistically significant difference between the
mean PTA in the failed and successful LETP groups at 1
year (33.4 vs. 37.3 dB, respectively, .xx) and 2 years (37.1
vs. 35.6 dB, respectively, .31). There was no statistically
significant worsening of the PTAs.
On histologic examination of one subject, the LETP
specimen showed severe inflammation with hemorrhagic
changes (Fig. 3). The pseudostratified columnar mucosa
was hypertrophied and no cilia were recognizable. There
was a severe infiltration of inflammatory cells into
the submucosa and mucosa. The postoperative specimen
showed only moderate inflammation and hypertrophy
with return of a ciliated epithelial border. The inflamma-
tory infiltrate did not penetrate into the mucosa. There
was extensive fibrosis throughout the submucosal layer
that was not present preoperatively. Grossly, the healed
wounds showed a stellate puckered scar with a scaphoid
loss of volume in the posteromedial wall adjacent to the
valve (Fig. 4).
There were no significant complications. One patient
developed a soft intranasal synechia between the inferior
turbinate and septum that was lysed during the 1-month
follow-up visit. The cause of this scar band was thought to
be related to the laser fiber that was passed through the
nasal cavity during the procedure. Another patient de-
veloped small synechiae between the posterior cushion
and the adjacent nasopharyngeal mucosa noted at the
1-month postoperative visit. These bands thinned out over
succeeding months and appeared to be of no clinical sig-
nificance. Two additional patients developed a small red
granuloma in the center of the resected area of mucosa.
Both patients were treated with nasal corticosteroid spray
for 6 weeks and the granulomas eventually subsided com-
pletely. There were no cases of epistaxis, nasal obstruc-
tion, or intraluminal adhesions or strictures.
DISCUSSION
Eustachian tube dysfunction remains without a clear
definition and is assumed to be the absence of appropriate
tubal function. The etiology of ET dysfunction appears to
be multifactorial,1,5–8,15 but there is a final common path-
way leading to middle ear disease once tubal ventilation of
the middle ear is sufficiently compromised. The conse-
quences of tubal dysfunction may be OME, atelectasis,
tympanic membrane perforation, cholesteatoma, or com-
plications of chronic ear disease.
In the past, the ET has often been regarded as a
“black box” in which the organ either functions or not. It
has become increasingly clear that there is a spectrum of
dysfunction and that identification and treatment of the
etiology of this dysfunction may provide clinical improve-
ment. Tubal dysfunction appears to occur most commonly
from functionally “obstructive disorders”8 in which the
tube is not anatomically blocked, but there is sufficient
bulky mucosal disease that dilation does not occur ade-
quately to aerate the middle ear. The etiology of the mu-
cosal disease remains uncertain, but there is increasing
evidence that allergic disease,7,15 LPR,5,6 adenoid hyper-
trophy impinging on the posterior cushion,16 and anatomic
factors,17 may play important roles. Additionally in chil-
dren, exposure to tobacco smoke, wood and charcoal
smoke, short-term breast feeding, and overcrowded living
conditions18 correlate with a higher incidence of otitis
media. Less common are purely muscular or “dynamic
disorders”8 in which movement disorders have been iden-
tified in the tensor veli palatihi (TVP) or levator veli
palatihi (LVP) muscles.
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Tympanostomy tubes have provided a very successful
means for ventilating the middle ear in patients with ET
dysfunction. The use of such tubes, however, has been
associated with infection, crusting, obstruction, extrusion,
and the development of perforation or cholesteatoma. For
patients with long-term tubal dysfunction, repeated inser-
tions are sometimes required and “permanent” tubes have
been developed, but they can have problems with crusting
and extrusion as well.
This study has shown a possible correlation between
failure of LETP with the presence of LPR or allergic dis-
ease. Patients with persistent ET dysfunction may benefit
from a diligent evaluation to identify the underlying eti-
ology of their problem and provide some options for effec-
Fig. 3. Mucosal biopsies. (A) The prela-
ser eustachian tuboplasty specimen
shows severe inflammation with hemor-
rhagic changes. The mucosa is hyper-
trophied and no cilia are recognizable.
(B) The 5-month postoperative speci-
men shows only moderate mucosal in-
flammation and hypertrophy. The cili-
ated epithelium has returned.
Fig. 4. Resting and dilated position of
the eustachian orifice at (A) prelaser eu-
stachian tuboplasty (pre-LETP) and (B) 1
year post-LETP. After LETP, the eusta-
chian tube demonstrates a persistent
loss of volume in the posteromedial wall.
The post-LETP dilated figure shows a
strand of mucus bridging the otherwise
open lumen. There are no adhesions.
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tive medical treatment. A thorough history may disclose
the possibility of environmental or food allergies, asthma,
LPR, home/daycare/school/occupational exposures, sinus
or pulmonary disease, and rheumatoid or autoimmune
illnesses. Physical examination, including nasopharyn-
goscopy, may reveal evidence of inflammatory or anatomic
lesions consistent with these disorders. When simple ob-
servation of the ET is insufficient to identify a possible
cause for dysfunction, slow-motion video endoscopy may
be performed for a detailed assessment of tubal dynam-
ics.10 Tubal dysfunction may be identified as an obstruc-
tive or dynamic disorder.9
The possibility of primary mucosal disorders of the
middle ear must also be considered. Wegener disease may
cause a chronic draining ear with pale boggy mucosa that
fails to respond to ordinary topical or oral antibiotic ther-
apy. It may also be associated with pain and a sensorineu-
ral hearing loss component. Samter’s triad may manifest
in the ear as a chronic thick mucoid effusion that often
occludes tympanostomy tubes and is oral or topical
steroid-sensitive. There are a number of patients without
Samter’s who also present with thick mucoid effusions
that frequently occlude tympanostomy tubes. It is possible
that they may have an allergic or immune-mediated basis
for the effusion and many do seem to respond to oral or
topical steroids.
The purpose of the present study was to determine
the safety and efficacy of combining LETP with ongoing
medical management for OME. All enrolled patients rep-
resent failures of medical therapy alone to resolve OME.
Candidates had demonstrated obstructive disorders of
their ET on slow-motion video endoscopy. This pilot study
used patients with long-term refractory OME as their own
historical controls.
The results of this study appear to support the hy-
pothesis that debulking of diseased mucosa within the
tubal lumen’s posteromedial wall in conjunction with ap-
propriate medical management is effective in eliminating
medically refractory OME in some patients. The results
were not static and there was variation in tubal function
that appeared to correlate with exacerbations or remis-
sions of associated medical conditions, most notably LPR
or allergic disease. When patients stopped following their
dietary or medication recommendations, they often had
deterioration of tubal function. Resumption of treatment
was sometimes successful in relieving the effusion,
whereas preoperatively, medical treatment alone had not
been successful. Like in surgery for chronic sinusitis, relief
may only be temporary if underlying etiologies are not
adequately controlled. Formal testing and documentation
of allergic disease and LPR was not performed in this
study and is recommended for future study.
The histologic studies in this and other studies19
along with postoperative endoscopic examinations suggest
that LETP results in a reduction of mucosal volume and
creates submucosal scarring. It may be that the reduction
of soft tissue volume along the posterior ET cushion facil-
itates the dilatory action of the TVP muscle. In some
patients, however, the tissue vaporization stopped short of
the valve itself raising the question of other possible ben-
eficial effects from this procedure such as a reduction in
tissue inflammation or edema, replacement of irreversibly
diseased mucosa with functional epithelium, or perhaps
eradication of adherent bacterial biofilm.
Although there were no significant surgical compli-
cations in this study, it is of utmost importance to recog-
nize that the authors had undertaken a thorough study of
the surgical anatomy in the laboratory before performing
LETP. In addition, great caution was exercised by excising
only limited amounts of excision of mucosa and submu-
cosa as much as deemed necessary based on the preoper-
ative slow-motion video endoscopy. Furthermore, great
care was taken to avoid any thermal or abrasive injury to
the mucosa of the anterolateral wall of the ET. Given the
small diameter of the ET, it would be relatively easy to
injure the opposing wall mucosa and create strictures or
adhesions that could exacerbate ET dysfunction.
The proximity of the internal carotid artery must be
kept in mind at all times to avoid the catastrophic injuries
and deaths that have been anecdotally reported in the past
during patulous ET injection procedures.20 An intimate
knowledge of the relationship between the intervening car-
tilaginous skeleton of the ET and the carotid is necessary
before embarking on surgery within the tubal lumen.
CONCLUSION
Evidence from the present study suggests that LETP
is effective in the treatment of some patients with medi-
cally refractory OME who have had multiple tympanos-
tomy tubes. Failure of LETP correlated with the presence
of LPR or allergic disease in the 1-year results but not in
the 2-year results. Additional studies are necessary to
identify those individuals who are most suitable candi-
dates for this procedure.
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Abstract
Objectives. (1) To translate techniques developed in a previ-
ous cadaver study of balloon dilation of the cartilaginous
eustachian tube (ET) into clinical treatment for refractory
dilatory dysfunction and (2) to study the safety/efficacy of
the technique in a pilot clinical trial.
Study Design. Prospective with subjects as their own histori-
cal controls since June 2009.
Setting. Regional academic center.
Subjects and Methods. Eleven consecutive adult patients with
longstanding otitis media with effusion (OME) who were
unable to autoinsufflate their ET by Valsalva, swallow, or
yawn and who had previous tympanostomies (average, 4.7).
At the time of intervention, 5 of 11 had a tube; 2 of 11 had
a tympanic membrane (TM) perforation. Four of 11 had
intact TMs, 2 with OME and tympanogram type B and 2
with TM retraction and tympanogram types B and C.
Balloon dilation of the cartilaginous ET was performed with
sinus dilation instruments via transnasal endoscopic
approach under general anesthesia in a day surgery setting.
Inflation was to a maximum of 12 atm for 1 minute.
Outcome measures: ability to Valsalva, rating of ET mucosal
inflammation, tympanogram, and otomicroscopy findings.
Results. All cases successfully dilated. Eleven of 11 could
self-insufflate by Valsalva (P\ .001); tympanograms were A
(4/11), C (1/11), or open (6/11). All atelectases resolved.
Procedures were well tolerated, without pain or complica-
tions related to dilation.
Conclusion. Dilation of the cartilaginous ET appeared to be
beneficial and without significant adverse effects in the treat-
ment of ET dilatory dysfunction. Larger controlled trials
with long-term results are now justified and needed.
Keywords
otitis media, OME, eustachian tube dysfunction, balloon dilation
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T
he cartilaginous portion of the eustachian tube (ET)
is the most likely site of pathology that leads to tubal
dilatory dysfunction.1-3 Normally, the middle 8- to
12-mm-long segment within the cartilaginous ET contains
mucosal surfaces in apposition at rest that function as
a valve. Dilatory dysfunction of the ET is most commonly
due to mucosal inflammation that limits dilation of the
valve, causing insufficient ventilation of the middle ear.4
Eustachian tuboplasty consisting of a partial resection of
inflamed mucosa, submucosa, and cartilage, from the intra-
luminal posteromedial wall, where the soft tissue is thickest,
has been beneficial in approximately 50% of cases with
severely persistent otitis media with effusion (OME) with 2-
year follow-up.5 In patients with OME and sinus disease,
tuboplasty combined with endoscopic sinus surgery was
effective in relieving tubal dysfunction symptoms in 70%.6
These early results support the concept that enlargement of
the valve of the ET could facilitate the dilatory efforts of
the tensor veli palatini (TVP) muscle and provide effective
benefit for chronic OME.
Widening of the tubal valve by balloon dilation has been
demonstrated in cadaver studies to have potential for clini-
cal benefit and without any evidence of significant adverse
effects.7,8 In 1 study, dilation was effective in significantly
enlarging the cross-sectional area of the functional valve
with an average increase volume of 357%.
This pilot study was done to test the effectiveness and
safety of employing balloons for dilation of the cartilagi-
nous ET in patients with chronic OME. It was considered
an important first step toward developing a future clinical
trial to test the hypothesis that balloon dilation could have
a beneficial effect on chronic OME.
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Methods
Hypothesis
Sinus balloon dilation catheters could be adapted to safely
and effectively dilate the cartilaginous portion of the ET in
patients with chronic OME.
Aims/End Points
1. To evaluate the effectiveness of using a balloon for
dilation of the cartilaginous portion of the ET in
patients with chronic OME
2. To evaluate the safety of the dilation procedure
with an analysis of any potential adverse effects
Outcomes included the ability to self-insufflate air
through the ET with a Valsalva maneuver, rating of mucosal
inflammation at the tubal orifice as seen by endoscopy, oto-
microscopic findings of OME/TM retraction/normal, and
tympanogram curve types A/B/C.
Patient Selection
Patients with unilateral or bilateral persistent OME for 5 con-
secutive years, broken only by tympanostomy tubes or tympan-
ic membrane (TM) perforation, were evaluated as candidates
for ET surgery. None of the subjects could insufflate their ears
with a Valsalva maneuver. Otomicroscopy and tympanometry
were done bilaterally. Video rigid or fiberoptic endoscopy of
the eustachian tube with slow-motion review demonstrated
mucosal inflammation as the predominant finding, indicating
dilatory dysfunction of the ET as opposed to dynamic (muscu-
lar) dysfunction. The techniques for endoscopic examination
and a scoring system for rating mucosal inflammation have
been previously reported.9 The mucosal inflammation score
was modified to separate mild and moderate disease. The score
consisted of 1 = normal mucosa; 2 = mild edema and/or erythe-
ma, with or without increased mucus; 3 = moderate edema and
erythema with significant compromise of dilation of the lumen
during swallows and yawns; and 4 = severe edema and erythe-
ma with inability to dilate the lumen open. Preoperative high-
resolution computed tomography (CT) scans were obtained to
rule out anatomical anomalies of the ET or cranial base and
dehiscence of the internal carotid artery into the tubal lumen.
Candidates for surgery were offered the option of con-
tinuing their current management or undergoing a procedure
consisting of unilateral balloon dilation of the cartilaginous
ET. In the case of bilateral disease, the side with the worst
ear pathology was selected.
Informed consent was obtained, and the protocol was
approved by the Ethical Committee (equivalent to a US
institutional review board) for the Pa¨ija¨t-Ha¨me Central
Hospital, Lahti, Finland (Balloon Dilation of the ET
R09054). All cases were performed by the second author at
that teaching hospital.
Surgical Technique
Patients were induced and maintained under general anes-
thesia with endotracheal intubation in the supine position.
Topical oxymetazoline hydrochloride decongestant was
applied to the nasal cavities. A 30-degree Hopkins rod
endoscope (Karl Storz, Culver City, California) was intro-
duced through the ipsilateral or contralateral nasal cavity
(Figure 1). Video images were displayed on a monitor
(Karl Storz, Tuttlingen, Germany).
The sinus balloon dilation system (Acclarent, Inc, Menlo
Park, California) was employed to dilate the cartilaginous
portion of the ET. A curved guiding catheter with a tip
angle of 70 degrees was passed through the nasal cavity
with the tip placed just into the ET nasopharyngeal orifice
(Figure 2). A 7 mm (diameter) 3 16 mm (length) Relieva
Solo (Acclarent) sinus balloon catheter was passed through
the guiding catheter and atraumatically into the ET orifice
until reaching the first mild resistance as it approached the
narrowest diameter at the bony-cartilaginous isthmus
(Figure 3). The balloon typically protruded from the tubal
orifice about 2 to 3 mm.
The balloon catheter lumen was left open to allow for air
escape from the proximal (toward the middle ear) ET
during inflation. The balloon was inflated with sterile water
according to the manufacturer’s recommendations to
a target pressure of up to 12 atm for 1 minute (Figure 4),
after which it was deflated and removed (Figure 5). In the
event that a balloon began to slip out of the ET orifice into
the nasopharynx during inflation, it was either maintained at
the maximum pressure attained before beginning to slip or
reinserted and the inflation repeated. Careful endoscopic
inspection was made of the postdilation tubal lumen to
assess the effects and to note whether there was any evi-
dence of an adverse effect (Figure 6). The posterior cush-
ion was manipulated and rotated medially, before the
dilation and afterward, looking for any change in the flexi-
bility or increase in angle of rotation.
Figure 1. Intraoperative photo of left eustachian tube (ET) naso-
pharyngeal orifice in a patient with otitis media with effusion prior
to balloon dilation. The lumen (arrow) is closed in the resting posi-
tion, and the posterior cushion is edematous. Images were taken
through a 30-degree 4-mm-diameter Hopkins rod endoscope.
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The immediate effect on widening of the lumen of the
ET was judged qualitatively from intraoperative videos
reviewed following the surgery. The degree to which the
functional valve was opened by the dilation and remained
open was estimated by the increase in apparent depth of
view into the lumen of the ET. As the mucosal surfaces are
normally in apposition in the valve, the length of persistent
opening of the valve could reflect the immediate result of
the dilation. The effectiveness of the dilation was rated as
none if there was no visible change, small if the apparent
increase in distance seen was estimated at\4 mm, medium
for 4 mm without seeing the isthmus, and patent if the
valve was dilated open and the isthmus was visible.
All patients were treated on an outpatient basis. Follow-
up exams were scheduled for 1 and 6 months postoperative-
ly and were planned to include otomicroscopy, tympano-
gram, endoscopy of the ET, demonstration of an attempt to
do a Valsalva maneuver, and a repeat rating of the mucosa
of the ET lumen.
Statistical analysis was done using SPSS 17.0 statistical
software package (SPSS, Inc, an IBM Company, Chicago,
Illinois) with 2-tailed paired samples t tests performed using
P \ .05 for significance. The patients were used as their
own historical controls, given their longstanding disease.
Results
Eleven patients (5 men, 6 women) aged 33 to 76 years
(average, 51.8) having had previous tympanostomy tubes
Figure 3. The balloon catheter has been inserted through the
guide catheter and into position within the lumen of the eustachian
tube until meeting slight resistance from the isthmus (bony-cartilag-
inous junction). The band on the catheter indicates the proximal
end of the balloon.
Figure 4. The balloon has been fully inflated to 12 atm for 1
minute. Approximately one-third of the balloon protrudes from
the eustachian tube orifice.
Figure 2. Guide catheter has been placed into the eustachian tube
orifice.
Figure 5. The balloon remains in position but has been fully
deflated.
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(average, 4.7) underwent unilateral balloon dilation of the
cartilaginous portion of their ET since June 2009.
Preoperative findings are summarized in Table 1.
Two patients had OME with type B tympanograms, 2
had generally retracted TMs with type B or C tympano-
grams, 5 had tympanostomy tubes in place, and 2 had TM
perforations. ET mucosal inflammation scores were 2 in 4
of 11 (36.4%), 3 in 4 of 11 (36.4%), and 4 in 3 of 11
(27.2%), with a mean (SD) of 2.91 (0.83). None of the
patients could insufflate air into their ears with a Valsalva
maneuver. Middle ear mucosa seen through tympanostomy
tubes was mildly inflamed with some mucus in 1 case, mod-
erately inflamed (significant hypertrophy reducing the
middle ear space) in 2, and severely inflamed (hypertrophy
nearly filling the middle ear space) in 2 cases, including
a small polyp in one of those. In the 2 cases with perfora-
tions, mucosal inflammation was mild in one and moderate
in the other.
Adjunctive Procedures
At the time of surgery, tympanostomy tubes were placed in
the 2 patients with OME, and tubes were removed from
3 patients with moderate to severe middle ear mucosal
inflammation. Balloon dilation results are summarized in
Table 2.
Dilation was done at 12 atm in 7 cases and 8 to 10 atm
in the remainder. Reinsertion and repeat dilation due to slip-
page were done in 1 case. The balloon typically protruded
out of the orifice by 25% to 30%. It was monitored during
inflation and the guide catheter adjusted to hold it in posi-
tion if it began to slip out more than 30%. The balloon
began protruding in 1 case as the pressure reached 8 atm,
and this pressure was maintained for the 1-minute duration,
but the catheter slipped out at the end of the minute. Repeat
dilation was not deemed to be necessary in this case.
Dilation of the ET occurred successfully in all cases.
The dilation effectiveness was small in the 2 cases inflated
to 8 atm, medium in the 2 cases dilated to 10 atm, and
dilated to fully open in 5 of 6 (83.33%) cases inflated to
12 atm. The full dilation associated with 12 atm was sig-
nificant (P = .004). The position of the posterior cushion
was not altered, and there was no increase in flexibility to
suggest cartilaginous fractures. There was no persistent
bleeding.
Adverse Effects
A mucosal laceration within the lumen of the ET occurred
in 5 of 11 (45.5%), and 4 of the 5 had been inflated to 12
atm. The lacerations were limited to the mucosa, were
under 5 mm in length, and were considered clinically
acceptable (minor adverse effect). Bleeding from the lacera-
tions was very limited and of brief duration. All of the
patients had a mild sore throat after surgery that resolved
within 2 days. There were no major adverse effects.
Postoperative results are summarized in Table 3.
Follow-up duration ranged from 6 to 14 months (median
7.0). All patients could perform a Valsalva maneuver post-
operatively (P \ .001). At the time of the last follow-up
visit, 7 of 11 (63.6%) could still consistently perform the
maneuver, and 4 of 11 (36.4%) could perform it but incon-
sistently. Otomicroscopy demonstrated that 5 of 11 (45.4%)
tympanic membranes now appeared normal, although 1 of
these cases had a type C tympanogram but normal hearing.
Mucosal inflammation scores of the ET lumen were 1 in 4
of 11 (36.4%), 2 in 4 of 11 (36.4%), and 3 in 2 of 11
(18.2%) with a mean (SD) of 1.73 (0.79). Improvement in
mucosal inflammation scores was statistically significant
(P = .003). All mucosal lacerations had healed without scar-
ring. There was no evidence of injuries, synechial bands,
narrowing of the lumen, or patulous ETs. There was no
postoperative epistaxis.
Complications
A C6-7 contralateral radiculopathy occurred in 1 patient
thought to be due to the neck extension required for endo-
tracheal intubation. It fully recovered. There were no com-
plications related to the balloon dilation. No patients
developed patulous ET symptoms (including autophony),
even transiently. There were no cases of reflux otitis.
Discussion
This study demonstrated that balloon dilation of the ET is
technically feasible and can be performed without signifi-
cant adverse effects. The 7-mm sinuplasty balloon fit rea-
sonably well into the tubal lumen and dilated the functional
valve effectively, tending to slip out in a minority of cases.
In the majority, the balloon actually ‘‘locked’’ into position,
fitting to the inside curvature of the medial cartilaginous
lamina that is contained within the posterior cushion.
Protrusion of the balloon up to 30% was common and of no
concern. Slippage of the balloon out of the ET could be
Figure 6. Postdilation, the entire length of the cartilaginous eusta-
chian tube has been dilated by the balloon. The isthmus is not
directly seen because of blood from a small mucosal laceration.
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Table 1. Preoperative Findings
Preoperative Findings
Case No. Age, y Sex
No. of
Tubesa
Type of
Effusion
Associated
Diagnosis
Previous
Adenoidectomy TM Statusb Tympanogram
Mucosal
Inflammation
1 55 M 5 Serous Chronic rhinitis No Tube Open 3
2 36 F 1 Mucoid Atelectasis, OME Yes Tube Open 3
3 76 M 3 Mucoid Chronic rhinitis No Perforated Open 3
4 33 F 4 Mucoid Chronic rhinitis, polyps Yes Retracted C 3
5 63 F 5 Mucoid Chronic rhinosinusitis, asthma No Tube Open 4
6 48 F 2 Serous Isolated OME Yes Perforated Open 2
7 48 M 5 Mucoid Chronic rhinitis No Tube Open 2
8 49 M 6 Mucoid Chronic rhinitis, polyps Yes OME B 4
9 49 F 6 Mucoid Isolated OME Yes Tube Open 4
10 71 M 5 Mucoid Skull base fracture No Atelectasis B 2
11 35 F 10 Mucoid Isolated OME No OME B 2
Abbreviations: F, female; M, male; OME, otitis media with effusion; TM, tympanic membrane.
aNo. of tubes = number of previous tympanostomy tubes.
bTM status = otomicroscopic exam of the tympanic membrane.
Table 2. Balloon Dilation Results
Balloon Dilation
Case No. Side atm Dilation Effectiveness Mucosal Tear Adjunctive Procedure Comment
1 R 12 Medium Yes Remove tube
2 L 12 Patent Yes Remove tube
3 L 10 Medium
4 L 8 Small Balloon slipped out by end of dilation
5 L 8 Small Remove tube Balloon protruded 30%
6 L 12 Patent
7 L 12 Patent Balloon protruded 30%
8 L 12 Medium Insert tube
9 L 10 Medium Yes Dilation repeated 13
10 L 12 Patent Yes
11 L 12 Patent Yes Insert tube
Abbreviations: atm, atmosphere; L, left; R, right.
Table 3. Postoperative Findings
Postoperative Findings
Case No. Follow-up, mo Valsalva TM Status Tympanogram ET Mucosal Inflammation
1 14 Yes, inconsistent Normal C 3
2 14 Yes Normal A 1
3 11 Yes, inconsistent Perforated Open 2
4 10 Yes Normal A 3
5 11 Yes Normal A 1
6 6 Yes, inconsistent Perforated Open 1
7 7 Yes Tube Open 2
8 7 Yes Tube Open 2
9 7 Yes, inconsistent Tube Open 2
10 7 Yes Normal A 1
11 7 Yes Tube Open 1
Abbreviations: ET, eustachian tube; TM, tympanic membrane.
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limited by bracing the shaft of the guiding catheter against
the floor of the nose for stability.
Balloon dilation in this pilot study demonstrated evidence
for effectiveness intraoperatively, with an immediate widen-
ing of the functional valve, and postoperatively, with per-
sisting benefits that included improvement in the ability to
insufflate the ET and ear with a Valsalva maneuver in 11 of
11 (100%), resolution of OME in all of the 5 of 11 (45.4%)
patients with an intact TM, and a reduction in inflammation
of the mucosa of the ET from a mean of 2.91 to 1.73.
Dilation of the cartilaginous ET could widen the lumen,
thereby reducing the work required for the muscles, espe-
cially the TVP muscle, to fully open the lumen on demand.
It is known that balloon dilation of vascular stenoses creates
tearing of the intima and sometimes the media,10 with heal-
ing occurring by scar filling in the gaps, thus maintaining
the widened lumen.11 Compression of irreversibly injured
hypertrophic mucosa and submucosa may permit healing
with thinner and healthier layers. Histology following laser
eustachian tuboplasty showed return of normal ciliated epi-
thelium and thinner submucosa.5
Balloon dilation appeared to most effectively dilate the
mid-portion of the cartilaginous ET, which corresponds to
the functional valve, and this is likely because of the combi-
nation of the tapered shape of the balloon at each end, the
flexibility of the loose cartilage at the orifice, and the rigid
circumferential cartilage at the isthmus. These results corre-
lated well with a cadaver study.7
The targets of 12 atm inflation pressure for 1 minute
duration were taken from previous sinus experience and
from the preclinical cadaver trial because, to our knowledge,
this was the first clinical trial of balloon dilation of the ET.
There was a greater tendency for mucosal laceration with
the 12 atm pressure, and this may actually be a desirable
goal, given the experience with endovascular dilation.
There were no major adverse events or complications
related to the balloon dilation. Pain was predominantly
related to the endotracheal intubation, and there were only
minimal complaints of pain localized to the nasopharynx or
radiating to the ear.
The potential for complications is considerable, including
fatal injuries to the internal carotid artery that were experi-
enced with ET surgery in the past.12 To perform the proce-
dure safely, surgeons must become familiar with the
surgical anatomy. No attempt should be made to dilate the
bony ET, as it is not usually the site of pathophysiology,
and the carotid artery courses to share the inferomedial
wall of the ET within the temporal bone. From the nasopha-
ryngeal orifice, the ET lumen takes a slight medial curve
initially, then courses toward the temporal bone and
becomes progressively narrow. Care should be taken to
slowly advance the balloon catheter atraumatically to follow
the lumen without laceration of the mucosa, which could
cause bleeding or create a false passage toward the carotid
injury. The balloon dilation procedure would not be recom-
mended for a patient with carotid dehiscence, and a CT
scan is currently recommended.
Additional risks of balloon dilation could be circumferen-
tial stricture, fracture of the medial cartilaginous lamina,
injury to the TVP or levator veli palatini muscles, hemor-
rhage into the pterygoid space, instrumentation of the
middle ear, and excessive widening to cause a patulous ET.
Techniques to repair a persistently patulous ET are now
available.13 Guidewires can pass into the middle ear and
should be avoided.7 The isthmus should be about 20 mm
from the ET nasopharyngeal orifice, and the middle ear ori-
fice occurs at about 36 to 38 mm.7,14 The isthmus should be
sufficiently narrow that the balloon catheter would not nor-
mally pass through, and advancement should cease when
meeting gentle resistance. Entry into the middle ear could
occur with a widely patent anomalous isthmus or by exces-
sive force of introduction.
There were several weaknesses of this study. It used the
patients as historical controls and suffers from that bias.
Insufflation of the ET by the Valsalva maneuver is an impre-
cise measure of tubal function that does not necessarily pre-
dict sufficiency of middle ear aeration. However, it did
reflect a significant change in this study. There was a lack of
objective tests for ET function. Although such tests have
not been shown to have clear clinical correlation,15 they
would have provided additional basis for comparison of pre-
and postoperative results. An ET mucosal rating scale was
employed but is only now undergoing validation testing.
Some of the patients still had tympanostomy tubes in place at
the termination of this study, and it remains to be seen if they
recur with OME in the future. A tube could have an influence
on the outcomes, relieving negative pressure, draining effu-
sion, and facilitating a Valsalva maneuver. As none of the
patients could perform a Valsalva maneuver previously while
they had tubes, the outcome of being able to perform
a Valsalva maneuver represented a real change.
All of the patients expressed an initial improvement in
their symptoms, either by relief of effusion or by ability to
be able to perform a Valsalva maneuver, which they per-
ceived as a significant benefit. A disease-specific instrument
for quantifying quality of life for ET disorders is being
developed but is not yet available.
The pathogenesis of OME in children is different from
adults and is being investigated. At present, we have not
considered performing this procedure in pediatric patients.
If balloon dilation of the ET were ultimately demonstrat-
ed to be effective with sustained benefits, it would be
a useful and minimally invasive alternative to tympanost-
omy tubes in patients with chronic OME. Careful selection
of patients with medically refractory dilatory dysfunction of
the ET should be done. The procedure may also prove to be
beneficial to patients with atelectasis or scuba or flight baro-
trauma. It remains to be determined whether the procedure
should be performed in children.
Conclusion
This study demonstrated that balloon dilation of the cartilag-
inous portion of the ET was feasible and without significant
adverse effects in a pilot clinical trial. There was a reduction
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in the rate of OME and improvement in the ability to con-
sistently perform a Valsalva maneuver (100% postoperative-
ly, 63.6% at 6 months). Intraluminal mucosal inflammation
was reduced. A controlled clinical trial study to determine
the efficacy of balloon dilation of the ET in patients with
medically refractory dilatory dysfunction of the ET is now
indicated.
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Diagnosis and Management of the Patulous
Eustachian Tube
Dennis S. Poe
Department of Otolaryngology, Children’s Hospital Boston; and Department of Otology and Laryngology,
Harvard Medical School, Boston, Massachusetts, U.S.A.
Objective: The patulous eustachian tube (ET) seems to be
caused by a longitudinal concave defect in the mucosal valve
at the superior aspect of its anterolateral wall and causes trou-
blesome autophony of one’s own voice and breathing sounds.
Patulous ET reconstruction was evaluated to analyze whether
submucosal graft implantation to fill in the concavity within the
patulous tubal valve may produce lasting relief of symptoms.
Study Design: Prospective trial.
Setting: Tertiary referral center, ambulatory surgery.
Patients: Fourteen ETs in 11 adults with 1 or more years of
confirmed continuous patulous ET symptoms refractory to
medical care.
Intervention: Endoluminal patulous ET reconstruction was
performed in 14 separate cases using a combined endoscopic
transnasal and transoral approach under general anesthesia. A
submucosal flap was raised along the anterolateral wall of the
tubal lumen up to the valve and mobilized superiorly off of the
basisphenoid. The pocket was filled with autologous cartilage
graft or Alloderm implant, restoring the normal convexity and
competence to the mucosal lumen valve.
Main Outcome Measure: Autophony symptoms were scored
as 1) complete relief; 2) significant improvement, satisfied;
3) significant improvement, dissatisfied; 4) unchanged; or
5) worse.
Results: All 14 cases reported immediate complete relief of
autophony. Results with an average follow-up of 15.8 months
are as follows: 1 (7%) case had complete relief; 5 (36%) had
significant improvement, satisfied; 7 (50%) had significant
improvement, dissatisfied; and 1 (7%) was unchanged. There
were no complications. Correlation between patulous ET and
other conditions was strongest with previous tubal dysfunction.
Autophony of voice, but not breathing sounds, was also found
to be experienced by 17 (94%) of 18 patients with superior
semicircular canal dehiscence syndrome and could be easily
mistaken for patulous ET autophony.
Conclusion: Patulous ET seems to be caused by a concave
defect in the tubal valve’s anterolateral wall. Submucosal
graft implantation to restore the normal convexity to the
valve wall seems to provide lasting relief of symptoms.
Long-term study is needed. It is important to differentiate
between the autophony of semicircular canal dehiscence syn-
drome and patulous ET. Key Words: PatulousVEustachian
tubeVPETRVSuperior semicircular canal dehiscenceVSSCD.
Otol Neurotol 28:668Y677, 2007.
The eustachian tube (ET) has the function of aiding in
the maintenance of middle ear gas exchange, clearing of
middle ear secretions, and protection of the ear from
reflux of material and sounds from the nasopharynx
(1). The tube is ordinarily closed in the resting position
and dilates to the open position typically with swallows,
yawns, and with other voluntary or involuntary efforts
(Figs. 1 and 2). Tubal opening typically lasts less than
one-half second (2). Closure of the tube is maintained by
a valve-like function of the opposing mucosal surfaces,
submucosal tissue, fat, muscle, and cartilage. The valve
measures approximately 5 mm in length and lies within
the cartilaginous portion of the ET located about 10 mm
distal into the tube from the nasopharyngeal orifice’s
posterior cushion or torus tubarius (3). The patulous
ET has been defined as an abnormal patency that results
in autophony (4).
The symptoms of the patulous ET were first described
by Jago in 1858 (5), and recognition of this clinical entity
was reported by Schwartze in 1864 (6). Jago later de-
scribed that he personally experienced autophony and
patulous ET symptoms (7). Patients typically report a feel-
ing that their affected ear is blocked, leading to confusion
between the patulous ET and tubal obstruction or dysfunc-
tion. On further questioning, they often describe the sensa-
tion of talking into a wind tunnel or barrel and experience
an echo or abnormally loud perception of their voice and
nasal breathing. It can occur spontaneously or can be acti-
vated by exercise, prolonged talking, and using nasal or
Address correspondence and reprint requests to Dennis S. Poe, M.D.,
Department of Otolaryngology, Children’s Hospital Boston, 300 Longwood
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oral decongestants. This autophony can be very disturbing
to patients and even lead to major depression and suicide.
Most patients report that their autophony is intermit-
tent, although in severe cases, the symptoms may per-
sist for hours at a time. The autophony can generally be
relieved, at least temporarily, by placing the head down
into a dependent position or lying supine for some time.
Sniffing inward against a closed nostril to generate
negative middle ear pressure, ipsilateral internal jugular
vein compression, and the presence of an upper respira-
tory tract infection or allergies are also known to provide
some temporary relief from the condition.
Confirmation of a patulous ET on physical examina-
tion can only be done if the patient has active autophony
during the examination. If the symptoms are absent, hav-
ing the patient take a brisk walk or go up and down stairs
for several minutes before the examination may activate
them. Most commonly, the tympanic membrane and
middle ear will seem normal. Evidence of tympanic
membrane scarring, atrophy, and retraction are some-
times observed. The diagnosis can be confirmed by
visualizing medial and lateral movements of the tympa-
nic membrane coincident with regular or forced nasal
breathing. These patulous excursions of the tympanic
membrane are best observed with the operating micro-
scope and with the patient in the sitting position. Lying
supine may cause venous congestion to close the patu-
lous tube (8), and the excursions may be missed with a
handheld otoscope. Excursions may be enhanced with
obstruction of the contralateral nostril (9). Nasopharyn-
geal endoscopy into the ET lumen will reveal a concave
longitudinal defect in the superior aspect in the antero-
lateral wall of the tubal valve (Fig. 3A). This wall of the
valve is normally convex and bulges into the posterome-
dial wall to close the valve in the resting position (10).
Although autophony symptoms are active, impedance
tympanometry may be successful in documenting fluc-
tuations in the tracings synchronous with breathing and
normal tracings with breath-holding (11). Tympanome-
try may also show middle ear negative pressure or hyper-
mobility of the tympanic membrane (9).
The patulous ET is thought to be caused by the loss of
tissue within the cartilaginous portion of ET. The con-
dition has been commonly reported with weight loss,
especially in chronic wasting illnesses (12,13). It has
also been associated with pregnancy (14), use of high-
dose oral contraceptives (4), and estrogen therapy for
carcinoma of the prostate (15,16). Additional associa-
tions are conditions causing atrophy or scarring within
the nasopharynx and musculature, including adenoidec-
tomy, radiation therapy, poliomyelitis, multiple sclero-
sis, and other neuromuscular diseases, cerebrovascular
accident, temporomandibular joint dysfunction, maloc-
clusion, iatrogenic trauma, and craniofacial abnormal-
ities (4,17,18). Patulous symptoms have been reported
after protracted otitis media (19), especially in patients
who have developed a habit of excessive nose blowing
or Valsalva maneuvers. Up to one third of patulous ET
patients have had no identifiable cause (9). Occasional
association between patulous ET and palatal myoclonus
has been noted (20).
Numerous medical and surgical treatments have been
reported for patulous ET. Patients need reassurance that
although the condition may be very disturbing, it is in no
way dangerous or destructive. Weight gain has been
suggested, but it is only recommended when the patient
is undernourished and underweight. Discontinuation of
decongestants and nasal steroid sprays may be indicated.
Mucous-thickening agents (21), topical estrogen drops
(11), and topical irritants to induce mucosal edema (22)
may be effective, but usually only temporarily. Myrin-
gotomy with or without a ventilating tube has been
reported to be helpful in 50% of cases (23,24), but it
seems to be most effective in relieving the sensation of
the tympanic membrane moving during breathing.
Surgical correction of the patulous ET has been
attempted by cauterization of the ET orifice or lumen
and removal of portions of the tubal cartilage. Peritubal
injections of various materials have usually achieved
FIG. 1. Image showing normal ET in resting closed position.
FIG. 2. Image showing normal ET in active open, dilated position.
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only temporary success. Lasting relief of autophony has
been achieved by complete obstruction of ET using a
catheter and bone wax (25) or by cauterization of the
lumen with insertion of a fat graft (9), but these proce-
dures generally require long-term middle ear ventilation
with a tube. Insertion of a cartilage graft into a submuco-
sal intraluminal pocket to add bulk to the posteromedial
wall (distal to the posterior cushion or torus tubarius) has
had some early success (26).
This report tested a hypothesis that the endoscopically
observed longitudinal defect in the anteromedial wall is
responsible for the patulous ET, and that surgical closure
of the defect would relieve the patulous symptoms in
patients. A patulous ET reconstruction (PETR) technique
is presented for augmentation of the specific concave or
scaphoid defect within the tubal valve. Grafting material
was introduced into a submucosal pocket within the tubal
lumen to obliterate the space in the anterolateral wall in
an attempt to restore it to the normal convex shape and
reestablish the valve’s competence without necessitating
a ventilating tube or creating tubal dysfunction and otitis
media. Autologous cartilage or AlloDerm implant (Life
Cell Corp.; the Woodlands, TX, USA) were used for graft
materials.
AlloDerm is human acellular dermis stripped of the
epidermal layer and processed with salts and detergents
to remove all cellular immunogenic components. The
remaining graft material is an acellular matrix that retains
a basement membrane and vascular channels. When
implanted, the matrix serves as a scaffold for ingrowth
of the host fibroblasts and vascular endothelial cells
(27,28). AlloDerm has been successfully used in plastic
and reconstructive surgery and more recently in otologi-
cal surgery for tympanoplasty (29) and neurotological
surgery for dural and skull base reconstruction (30).
This report will also present a series of patients diag-
nosed with the superior semicircular canal dehiscence
(SSCD) syndrome. Most of these patients experienced
autophony of their voice that they self-described in
terms identical to the patulous ET syndrome. Given
the apparent similarity in presenting symptoms between
these two very different conditions, an analysis of signs
and symptoms in this series of SSCD patients was
undertaken and compared with those of the patulous
ET patients. Recommendations to differentiate between
these two syndromes are made.
MATERIALS AND METHODS
A prospective trial of PETR was undertaken in adult patients
with medically refractory patulous ET symptoms for 1 or more
years. The hypothesis was that surgical obliteration of an
endoscopically recognized concave defect in the tubal valve
would relieve the patient’s autophony. It was hoped that the
relief is of lasting benefit. Candidates for the procedure were
required to demonstrate persistent patulous ET signs and
symptoms, despite appropriate medical therapy. Patulous
excursions of the tympanic membrane and a visible character-
istic patulous defect in the ET lumen had to be identified.
All candidates had failed medical therapy with mucous
thickening agents, topical estrogen drops, or topical irritants.
Most had undergone previous myringotomy with or without
placement of a ventilating tube and even other ET procedures.
An assessment for possible risk factors was done in the history
and physical examination, looking for evidence of weight loss,
rheumatologic or autoimmune conditions, laryngopharyngeal
reflux (LPR), pregnancy, allergic rhinitis, ET dysfunction or
FIG. 3. Image showing PETR. A, Left preoperative patulous tube. B, Dissection of the submucosal pocket along the TVP muscle.
C, Cartilage graft is inserted into the pocket. D, Completed operation with suture closure of wound.
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otitis media, habitual sniffing or Valsalva, and other possible
factors.
All candidates underwent a thorough head and neck exam-
ination, including micro-otoscopy, flexible fiberoptic naso-
pharyngoscopy, and rigid nasal endoscopy with slow-motion
video endoscopy of the ETs, the technique for which has been
previously presented (10). All of these patients were examined
while they had active autophony. In the event that a patient
initially presented with absence of autophony, they were reex-
amined after taking a brisk walk or going up and down stairs
for several minutes until their symptoms were activated.
Micro-otoscopy was initially attempted in the supine position,
but if the autophony was not present while supine, the patient
was raised and examined in the sitting position. All patients
exhibited patulous excursions of the tympanic membrane
while the patient did quiet and forceful nasal breathing. The
larynx was carefully inspected for any evidence of LPR. Slow-
motion video endoscopy of the cartilaginous ET demonstrated
a concave (scaphoid) defect in the superior aspect of the ante-
rolateral wall in the tubal valve in all patients. Candidates for
PETR were offered the options of ongoing conventional treat-
ment, ET obliteration along with a ventilating tube, and the
new unproven PETR procedure. Informed consent for PETR
was obtained in all patients, including a discussion of neuro-
logical complications and deaths that had occurred in the past
with ET surgery (4).
During this study, 18 patients with SSCD were identified,
and their signs and symptoms were retrospectively analyzed
because of the newly recognized similarity of autophony
symptoms between patulous ET and SSCD. The diagnosis of
SSCD was confirmed by an identifiable dehiscence in the
superior or posterior semicircular canal on computed tomo-
graphic (CT) scan, and/or identification of abnormally low
thresholds on Vestibular-evoked Myogenic Potential (VEMP)
testing (31Y35). When CT scans were obtained at our institu-
tion, a noncontrasted temporal bone protocol was used with
0.5-mm collimation reformatting images in axial, coronal, and
modified Poschel’s and Stenvers’ projections (34).
PETR was performed on 14 ETs of 11 patients. Bilateral
cases were done as separate procedures.
The patient’s self-reporting of presence or absence of auto-
phony was used as the outcome measure. Patients were inter-
viewed postoperatively to assess their amount of autophony and
symptoms were scored as 1) complete relief; 2) significant
improvement, satisfied; 3) significant improvement, dissatisfied;
4) unchanged; or 5) worse. BComplete relief^ required that the
patient no longer experienced any autophony at all. BSignificant
improvement, satisfied^ meant that patients no longer experi-
enced autophony under normal circumstances, but could experi-
ence it with prolonged exercise or talking. The symptoms were
easy to control by placing the head in a dependent position for a
short time or by sniffing inward. The patients no longer felt the
desire for further medical or surgical intervention. BSignificant
improvement, dissatisfied^ was reported when the patients felt
that they had gained significant benefit from the operation but
continued to have sufficient autophony that further medical or
surgical intervention was desired. A second procedure was done
in one patient, making an injection of hydroxylapatite micro-
spheres into the ET valve.
Surgical Technique
PETR was performed as an outpatient procedure under gen-
eral anesthesia using a combined endoscopic transnasal and
transoral approach. The patient was placed in the supine posi-
tion, and adequate general anesthesia was administered. The
oral endotracheal tube was taped midline to the lower lip.
Patients intending to fly home postoperatively initially had
placement of a soft silicone mini-Baxter button, a 0.91-mm-
diameter ventilating tube in the ipsilateral tympanic membrane
(Gyrus Co.; Memphis, TN, USA). A nasal septal cartilage graft
was harvested in the first patient. Alloderm implant was used
as the graft material in the subsequent 12 patients. A tragal
cartilage graft was used in the last patient. If cartilage grafts
were to be used, these were harvested first through standard
techniques. The nasal cartilage graft did not contain any peri-
chondrium. The tragal composite graft was harvested including
the posterior surface perichondrium. Topical nasal deconge-
stant spray was applied to both nostrils. A 4-mm-diameter,
45-degree, rigid Hopkins rod nasal endoscope with video moni-
toring (Karl Storz, Inc.; Culver City, CA, USA) was used to
visualize the ET from the nasopharynx. A tonsil mouth gag
was placed, and the mouth was partially opened sufficiently to
view the oropharynx. Using a 45-degree angled nasal sinus
needle, lidocaine 1% with epinephrine 1:100,000 was infil-
trated into the anterior and superior aspects of the anterolateral
wall (anterior cushion), and topical cocaine 4% solution was
placed in the ipsilateral nasal cavity for hemostasis. A red
rubber catheter was placed in the contralateral nasal cavity to
retract the soft palate, and a nasopharyngeal suction catheter
was placed alongside it into the nasopharynx for smoke eva-
cuation of laser plume. The cocaine pledget was subsequently
removed, and the endoscope was reintroduced into the naso-
pharynx and held in position with a mouth gagYmounted endo-
scope holder (Karl Storz, Inc.; Culver City, CA, USA) assisted
by manual support. An argon ion laser (HGM Medical Lasers;
Salt Lake City, UT, USA) with settings of 3.5 W and 500 ms or
a diode pumped KTP laser (Iridex Corporation; Mountain
View, CA, USA) with settings of 1,500 mW and 500 ms
were used to make the laser incision and dissection. The endo-
scope was left in place throughout the procedure to minimize
the possibility for nasal trauma and resultant bleeding that
would obscure the ET orifice. The endoscope lens was peri-
odically defogged by irrigation with saline introduced through
the ipsilateral naris and cleaned with a curved olive-tip max-
illary antral suction from within the nasopharynx. All instru-
ments were passed through the oropharynx to reach the ET.
Standard otologic fiberoptic 200-Km-diameter laser probes
were used, and the probes were fashioned into a curved
shape to reach the tubal orifice. While visualizing the tubal
orifice, a laser incision was made from the 11-o’clock to the
5-o’clock position on the anterior cushion. The incision was
carried down until the tensor veli palatini (TVP) muscle was
visualized, and this plane was followed superiorly and distally
into the level of the tubal valve using a combination of sharp and
blunt dissection with curved instruments (Fig. 3B). Hemostasis
was achieved via watchful waiting, laser cauterization, or mono-
polar electrocauterization with curved probes (Karl Storz, Inc.;
Culver City, CA, USA). This submucosal flap was developed
along the anterolateral wall of the tubal lumen into the valve
and mobilized superiorly off of the basisphenoid bone. In ear-
lier cases, the flap was separated off of the cartilage superiorly,
but in later cases, the cartilage itself, with its attached mucosa,
was delivered off of the basisphenoid bone to inferiorly
depress the tubal roof and reduce its lumen. In the event that
the cartilage was very thick, the inferior cartilage-mucosa flap
was mobilized by filleting the cartilage superiorly with sharp or
laser dissection. The resultant submucosal-subcartilaginous
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pocket was filled with autologous cartilage graft or Alloderm
implant measuring between 1  1 cm to 1  2 cm. Sufficient
graft material was placed into the pocket to overcorrect the
concave anterolateral wall defect, anticipating a 50 to 60%
loss of graft volume postoperatively. The mucosal wound
was closed with three interrupted 4-0 Vicryl (Ethicon, Inc.;
Somerville, NJ, USA) sutures passed and tied through the
oropharynx. At least one of the sutures was passed through
the underlying graft (Fig. 3D). Patients were subsequently
discharged after satisfactory recovery from general anesthe-
sia. Follow-up examinations were done when possible, and
phone follow-up was done when necessary. Of the patients who
flew home, the ventilating tube was removed by a local oto-
laryngologist a few days postoperatively.
The first patient opted to undergo a second procedure 10
months after the cartilage graft PETR. The patient was
administered general anesthesia, and an identical operating
setup was used. Radiesse (BioForm Medical Co.; Franksville,
WI, USA) injectable calcium hydroxyapatite (HA) was used as
an implant. It is composed of 25-Km-diameter microspheres
of HA in an aqueous gel carrier and is U.S. Food and Drug
AdministrationYapproved for craniofacial and oral-maxillofa-
cial defect reconstruction as well as vocal cord implantation.
While visualizing the ET lumen, the Radiesse was injected
through a 20-gauge nasal sinus 45-degree angled needle. A
series of 3 injections were made longitudinally into the sub-
mucosal layer of each side, including the remaining concave
defect in the anterolateral wall and also in the opposing
posteromedial wall. A total of 0.9 mL was injected.
RESULTS
PETR was performed in 14 ETs of 11 patients. There
were 5 males and 6 females. Seven patients had bilateral
patulous ETs and 4 were unilateral. Of the 14 patients, 7
were on the left side and 7 were on the right. The dura-
tion of preoperative autophony symptoms ranged from 1
to 38 years, with an average of 8.5 years and a median of
6 years. Preoperative risk factors based on history and
physical examination are presented in Table 1. All
patients had failed medical therapy. Eight (73%) of
11 had a myringotomy or ventilating tube trial. Two
patients had undergone previous ET procedures at
other centers without success. One patient had botuli-
num toxin (Botox) tubal injection and then cartilage
implantation into the posterior cushion, and the other
received tubal injection of collagen.
The initial procedure took approximately 32 hours
to complete, and the most recent procedures have
taken between 12 and 2 hours. Nasal septal cartilage
was used in the first patient, but bleeding from the
septum drained over the ET orifice, slowing the pro-
cedure, and prompted the subsequent use of Alloderm
implant. Over time, a progressively larger submucosal
and subcartilaginous pocket was used to accommo-
date larger and deeper placement of the implant or
grafts in an attempt to improve the outcomes. The
use of tragal cartilage in the last patient was intended
to minimize the loss of graft volume in the healing
period.
Outcomes for relief of autophony after PETR are
presented in Table 2. There were no complications.
No one experienced persistent otitis media with effu-
sion (OME), and only one patient had OME for 2
weeks. Patients experienced 2 to 3 days of oropharyn-
geal and nasopharyngeal pain that was well controlled
by oral analgesics. All patients experienced immediate
and complete relief of their autophony postoperatively.
They were limited to light activities for 2 weeks post-
operatively. Follow-up duration ranged from 3 to 30
months, with an average of 15.8 months. The patient
who had a secondary HA injection has had complete
relief of autophony for 22 months. In the 2 patients
with palatal myoclonus, those symptoms remained
unchanged postoperatively.
Results from a retrospective analysis of 18 adult
patients diagnosed with dehiscence of the superior or
posterior semicircular canal are tabulated in Table 3.
The CT scan confirmed the dehiscence of the superior
semicircular canal in 15 (83%) of the patients and a
dehiscence of the posterior semicircular canal in one
(5.6%). The CT scan was equivocal in one patient,
and no dehiscence was demonstrated in one patient.
The VEMP, however, was strongly abnormal in both
of these patients. The VEMP was performed in 12 of
TABLE 1. Risk factors in patulous eustachian tube
reconstruction patients
Risk factor No. Percentage
Eustachian tube dysfunction/otitis media 5 45
Rheumatoid/autoimmune 3 27
Laryngopharyngeal reflux 3 27
Allergic rhinitis 3 27
Weight loss 2 18
Sniff/Valsalva habit 2 18
Palatal myoclonus 2 18
Pregnancy 1 9
Cocaine abuse 1 9
Lactose intolerance 1 9
n = 11 patients.
TABLE 2. Outcome scores for patulous eustachian
tube reconstruction
Initial outcomes Primary procedure only
Final outcomes after
hydroxyapatite injection
Autophony score No. % Complications No. % Complications
1 1 7 0 2 14 0
2 5 36 0 5 36 0
3 7 50 0 6 43 0
4 1 7 0 1 7 0
5 0 0 0 0 0 0
No. satisfied
(overall)
6 43 7 50
n = 14 patients.
Autophony scores: 1 = complete relief; 2 = significant improvement,
satisfied; 3 = significant improvement, dissatisfied; 4 = unchanged; 5 =
worse.
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18 patients, and all 12 were abnormal and consistent
with the dehiscence syndrome.
DISCUSSION
Patients with patulous ET may present with a wide
spectrum in severity of symptoms ranging from asymp-
tomatic (4) to severe disturbance in quality-of-life and
suicidal tendencies. Most patients can be helped simply
with reassurance. Symptoms can often be relieved by a
swallow or yawn. Placing one’s head between their legs
or lying supine for a few minutes is very effective for
most patients. Good hydration, nasal saline spray, and
discontinuation of unnecessary decongestants or nasal
steroid sprays may be helpful. When the symptoms
recur too frequently or become excessively persistent,
patients typically request additional medical interven-
tion. Most of these interventions are only of temporary
benefit. Premarin nasal solution, prepared as 25 mg of
intravenous Premarin in 30 mL of isotonic sodium chlo-
ride solution, is taken as 3 nasal drops 3 times daily (9).
It may have side effects of epistaxis or nasal irritation.
SSKI, an expectorant, has been used to thicken mucus
secretions and is dispensed as 1 g/mL of saturated potas-
sium iodide oral solution in a 30-mL dropper bottle.
Seven to 10 drops in 8 ounces of juice or water are
taken orally 3 times daily (9,21).
Numerous methods for causing irritation and inflam-
mation of the tubal orifice have been described, but
results are generally very temporary, and no long-term
successes have been reported (11). Salicylic and boric
acid in a 1:4 ratio has been instilled as a solution through
an ET catheter (22) or insufflated as a powder into the
nasopharynx (9) for temporary relief.
Myringotomy with a ventilating tube has been reported
to provide some improvement in approximately 50%
of patients (13,21,24). In the author’s experience, it is
unusual for patients to experience relief from their
autophony with a ventilating tube, but they do find sig-
nificant relief from the variations in the middle ear pres-
sure and tympanic membrane movements that can be
quite distracting while talking and breathing.
Monopolar electrocauterization of the tubal orifice
(35) and the tubal lumen (36) has met with some suc-
cesses, but injuries to the middle cranial fossa dura and
the mandibular division of the trigeminal nerve have
been reported (4). Application of 20% silver nitrate solu-
tion into the tubal lumen has achieved temporary suc-
cesses, but repeated applications were usually required.
Surgical closure of the tubal orifice was attempted by
Simonton (36), making a superior incision to separate the
medial and lateral cartilaginous laminae and remove a
portion of the medial lamina. Complete occlusion of the
ET with middle ear effusion was sometimes achieved, but
many patients had no improvement. Doherty and Slattery
(9) reported lasting success in three patients using mono-
polar electrocautery in the proximal tubal lumen and
occlusion with an autologous fat graft. These patients
required ventilating tubes.
Surgery on the tensor veli palatini muscle has been per-
formed. Stroud et al. (37) transposed the muscle tendon off
of the hamulus in 10 patients and reported improvement in
90% after 6 months’ follow-up. Virtanen and Palva (38)
fractured or removed the hamulus with 70% complete suc-
cess. When these procedures were performed in monkeys
by Cantekin et al. (11), they were initially effective, but the
success abated over time.
Various substances have been injected into the ET
with mixed results. Zollner (39) was the first to attempt
infiltration in 1937 using paraffin around the tubal ori-
fice and achieving temporary improvements. Ogawara
et al. (40,41) injected a mixture of absorbable Gelfoam
(Upjohn Co.; Kalamazoo, MI, USA) and glycerin in
saline with initially good results but a high rate of recur-
rence after 1 month. O’Connor and Shea (4) injected
polytetrafluoroethylene (Teflon paste) into both sides
of the tubal orifice with temporary success. Brookler
and Pulec (42) injected Teflon into dogs to analyze the
optimal location for the paste to maximally increase
resistance to applied opening pressures without causing
OME. They found that injection in the anterolateral
wall, just anterior to the tensor veli palatini muscle
gave the optimal results. Injection of 0.5 ml posterior
to the torus tubarius (posterior cushion) in the poster-
omedial wall consistently produced a serous effusion
without any measurable increase in opening pressures.
Pulec (43) was subsequently successful in 19 of 26
patients injected with Teflon paste into the orifice of
the anterolateral wall. He acknowledged that patients
often required repeated injections, but most had long-
lasting benefit, and there had been no complications in
his experience (J. L. Pulec, personal communication,
October 2003). Unfortunately, several cases of cerebral
thrombosis and death have been reported with Teflon
injection in the ET, and the practice was discontinued
(4). The material was possibly injected directly into the
TABLE 3. Signs and symptoms of superior or posterior
canal dehiscence syndrome patients
No. Percentage
Symptoms
Autophony of own voice 17 94
Autophony of bone conducted soundsa 9 50
Symptom relief with strain/supine 9 50
Tullio symptom 9 50
Vertigo/disequilibrium 7 39
Vertigo with strain/Valsalva 7 39
Hyperacusis 2 11
Auditory distortion 1 6
Autophony of nasal breathing 0 0
Signs
Conductive hearing loss 13 72
Objective positive fistula test 6 33
Tullio sign (torsional nystagmus) 2 11
n = 18 patients.
aPatients report hearing amplified perception of sounds presumably
transmitted through bone conduction. Examples are unusually loud
perception of chewing, pulsatile tinnitus, an elbow hitting a table,
and footsteps striking the ground during normal walking.
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internal carotid artery, which runs immediately posterior
to the posteromedial wall at the level of Rosenmu¨ller
fossa.
The patulous ET seems to be caused by loss of tissue
in the superior aspect of the anterolateral wall within the
tubal valve. This tissue loss can be cartilage and/or soft
tissue, and the exact mechanism for the loss is unclear.
Chronic inflammation with tissue atrophy is suspected
in many patients. This is supported by the associated
potential risk factors presented in Table 1. Chronic
tubal dysfunction with a long history of otitis media
was the most prevalent possible risk factor and then
rheumatoid or autoimmune connective tissue disorders,
LPR, and allergic rhinitis. Weight loss and pregnancy
were minor risk factors in this series. These results are
consistent with the potential risk factors identified in the
patulous ET patients who were evaluated and treated
without surgery.
Identifying the patulous defect within the tubal valve
allows for more precise surgical correction with the goal
of restoring the tubal valve’s competence and avoidance
of overcorrection and OME. The author initially tried
submucosal injections of autologous fat, collagen, and
injectable HA. Injections of as little as 0.3 mL were
immediately effective in all patients, but most experi-
enced the recurrence of symptoms within 1 month. This
helped to confirm that the endoscopically observed defect
in the anterolateral wall was most likely the cause of the
incompetence in the tubal valve. The next challenge was
to find a suitable filler material that would provide lasting
benefit. The work of Brookler and Pulec (42) seems to
support this hypothesis when they found that even small
amounts of injected Teflon into the tubal valve region
uniformly caused persistent OME. The goal of trying to
place enough material to raise the opening pressure resis-
tance for the whole length of the tube is probably un-
necessary and requires an excessive volume of material.
Injectable HA provided a convenient opportunity for
subsequent CT scan evaluation. It was found that when
the material was injected into the posteromedial wall, it
remained in place, but when injected into the patulous
defect of the anterolateral wall, it gained access to the
tensor veli palatini muscle fascial plane and dissected
superiorly to the basisphenoid and inferiorly into the lat-
eral hypopharynx (Fig. 4). This excessively wide distri-
bution of material probably accounted for the short-lived
results in most patients and necessitated installation of
more volume than desired. It was difficult to obliterate
the patulous defect by injecting the posteromedial wall,
and there remains the danger that should the needle
penetrate the medial cartilaginous lamina, the internal
carotid artery lying immediately posterior to the carti-
lage would be in jeopardy. The author no longer
recommends ET injections as a primary method for
closure of a patulous defect.
The first patient in this PETR series underwent a
small injection of Radiesse HA with long-term complete
relief. Injection of material as a secondary procedure
once the tensor veli palatini muscle fascial plane has
been operated on and scarred may be a useful technique
when a small amount of incompetence of the valve per-
sists after PETR.
FIG. 4. Axial CT of the temporal bone demonstrating bone density injected with HA in the TVP fascial plane extending from the basi-
sphenoid to the parapharyngeal space in the hypopharynx (arrows).
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The first patient in this PETR series had a septal carti-
lage graft for the initial procedure. Oozing from the septal
incision drained over the tubal orifice and made the sub-
sequent PETR procedure more difficult. The submucosal
pocket was probably too small and made it difficult to
secure the cartilage graft into position. It was found that
the subsequent Alloderm grafts were easier to handle, but
because of the 57% rate of dissatisfied or unchanged
results, cartilage grafts from the tragus are now being
used. Alloderm proved to be initially effective, but recur-
rence of symptoms in some patients began as early as 1
month postoperatively, presumably because of resorption
of the graft. Postoperative endoscopic examination of the
ET in satisfied patients demonstrated an appropriate con-
vex bulge to the wall that nicely contacted the poster-
omedial wall (Figs. 5 and 6). Even in patients with
recurrence of symptoms, the preoperative concave defect
in the anterolateral wall remained nicely convex, except
for a very small residual defect.
In performing the PETR procedure, it is important to
dissect along the TVP muscle plane all the way super-
iorly to the valve area and dissect a cartilage-mucosal
flap off of the basisphenoid to appropriately position the
graft and have it remain in place deep to the valve. With
a sufficiently broad and deep pocket, it is much easier to
wedge the cartilage graft into position and have it stay in
place even before it is sutured. It is anticipated that the
resorption of cartilage is significantly less than with
Alloderm. There were no complications with the
PETR procedure. Closure of the patulous defect within
the tubal valve does seem to support the original hypoth-
esis. Further experience and long-term follow-up are
important to analyze if the results are lasting.
The PETR procedure is currently performed princi-
pally with nasal sinus instruments, especially long
curved frontal sinus instruments that can readily reach
the ET when passed through the oral cavity. There is a
need for dedicated instrumentation that will facilitate
PETR in the future.
Caution is advised when beginning to attempt the
PETR procedure because it is technically challenging
to operate in the nasopharynx, and surgeons are gener-
ally less familiar with the surgical anatomy of the
region. It is extremely important to be thoroughly famil-
iar with the location of the internal carotid artery and its
relationship with the ET to avoid the disastrous conse-
quences of tubal surgery in earlier years. The surgeon
should keep the dissection along the tensor veli palatini
muscle and the basisphenoid bone. The internal carotid
artery runs just deep and posterior to the medial cartila-
ginous lamina in the posteromedial wall. Maintaining
awareness of the location of the cartilage and staying
anterior to it at all times will help protect the carotid
artery.
Making the diagnosis of patulous ET is not always
straightforward, especially because the patients uni-
formly complain of Bblockage^ in their ears. The condi-
tion is often confused with ET dysfunction and negative
middle ear pressure. Patulous ET is probably underdiag-
nosed. In addition, there has been confusion in diagnosis
because of a great similarity with the autophony observed
in the superior semicircular canal dehiscence (SSCD)
syndrome. Amplification of somatosounds that are car-
ried through bone conduction seems to occur nearly uni-
formly in this syndrome. Ninety-four percent of the
patients with the syndrome in the author’s series had a
significant complaint of autophony of their voices. None
of them experienced autophony of their breathing, with
the exception of one patient who had both SSCD and a
patulous ET. This patient had chronic baseline autophony
of his voice but not breathing. During exercise or pro-
longed talking, he could develop true patulous ET symp-
toms with a much more dramatic autophony of his voice
and breathing sounds that was clearly different from the
SSCD autophony. SSCD patients also frequently hear
other bone-conducted noises, such as their footsteps hit-
ting the ground (50%), and have measurable conductive
hearing loss (72%).
FIG. 6. Image showing PETR of same patient as in Figure 5 at 1
year postoperative.
FIG. 5. Image showing preoperative left PETR. Patulous ET
with characteristic concave defect in anterolateral wall.
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The apparent conductive hearing loss in SSCD has
been theorized by Minor et al. (31) and Mikulec et al.
(44) to be a Bpseudoconductive hearing loss^ because of
the effect of a Bthird window^ in the labyrinth. There is
a better than normal conduction of bone-transmitted
sounds creating autophony of one’s own voice but not
of breathing sounds that are transmitted through the air.
Most patients did not complain of vertigo, and only
50% had signs or symptoms of Tullio phenomenon. For
these reasons, the diagnosis of SSCD has probably been
missed in many patients or erroneously diagnosed as a
patulous ET on the basis of their autophony.
It was observed that 50% of the 18 SSCD patients
experienced relief of their autophony with the head in
a dependent position or when supine. One patient had
autophony and an objective torsional nystagmus with a
fistula test challenge when sitting, but it completely
ablated with his head between his legs. It is postulated
that increased intracranial pressure or increased intrala-
byrinthine pressure may reduce the Bthird window
effect,^ perhaps by stiffening the dehiscent window.
This ablation of symptoms with the head in a dependent
position also increases the possibility for confusion with
patulous ET autophony that characteristically is relieved
similarly in head-dependent or supine positions.
It is proposed that SSCD syndrome be called Minor’s
syndrome. It should be suspected when a patient pre-
sents with complaints of chronic persistent autophony of
their voice but not breathing sounds. The autophony
tends to be unremitting from the time of onset, except
for some very occasional hours or days of relief. There
may or may not be accompanying vertigo or dysequilib-
rium, vertigo with pressure changes in the ear or with
Valsalva and straining, or Tullio phenomenon. Torsional
nystagmus may be observed with a loud tuning fork or
Barany masker in the ipsilateral ear. An objectively
positive fistula test may be present. There may be a
conductive hearing loss, yet intact stapedial reflexes.
Importantly, the patient will show no evidence of patu-
lous excursions of the tympanic membrane under micro-
otoscopy, despite experiencing active autophony during
the examination. Ultimately, the diagnosis of SSCD is
best made with a combination of high-resolution CT
scan and VEMP. The CT is optimally done with recon-
structed Poschel’s and Stenvers’ views to visualize the
superior semicircular canal in its own cross-sectional
and longitudinal planes (44). The VEMP will show
abnormally low thresholds to elicit the responses, that
is, the spinovestibular reflex is triggered at lower than
expected levels of auditory stimulation. Ordinarily,
VEMP thresholds are anticipated to be at higher than
normal levels in the presence of conductive hearing loss.
Patulous ET should be suspected when patients com-
plain of loud autophony of their voice and equally loud
autophony of their breathing sounds. The author has
occasionally experienced a patulous ET with heavy
exercise and prolonged speaking. To appreciate the
loudness of the autophony, it can be accurately simu-
lated by speaking and breathing into the diaphragm of
one’s own stethoscope held close to the mouth. Patients
will often say that the autophony is constant, but on
careful questioning, they will admit to relief, even
briefly, throughout the day with sniffing, head down,
or supine position. They should not have vertigo or dys-
equilibrium complaints as a result of a patulous ET. Past
descriptions of a relationship between patulous ET and
vertigo (15,23) may have been caused by misdiagnosis
of SSCD patients before the condition had been
described by Minor et al. (31). Most importantly, the
patient should be examined while they have active
autophony, and there should be patulous excursions of
the tympanic membrane with normal or forced nasal
breathing, especially if the contralateral nostril is closed.
It may be necessary to examine the patient in the sitting
position with micro-otoscopy to appreciate the move-
ments. Nasopharyngeal endoscopy should demonstrate
a longitudinal patulous concave or scaphoid defect in the
valve area of the anterolateral wall within the tubal
lumen. This is best visualized during forced yawns,
which maximally dilates the lumen. The endoscopy is
not pathognomonic because it is not always possible to
visualize all the way up distally into the tubal valve.
Because the autophony often occurs intermittently, tym-
panometry may miss the patulous sawtooth excursions
overlying the impedance tracing that might be expected.
One patient who received the PETR procedure also
had severe palatal and tensor tympani muscle myoclo-
nus. The tympanic membrane moved with strong nasal
breathing and with strong facial muscle contractions and
could easily be misinterpreted as patulous excursions
from air exchange. She had successful relief of her
autophony but continued to show tensor muscle move-
ments of the tympanic membrane on postoperative Day
1. PETR was not effective in relieving myoclonus.
CONCLUSION
It was hypothesized that the patulous ET was caused
by a loss of tissue volume within the anterolateral wall
of the tubal lumen in a region referred to as the valve,
where the mucosal surfaces are in opposition in the
closed resting position. Incompetence of this valve
was thought to cause reflux of air and somatosounds
from the nasopharynx that result in a spectrum of symp-
toms from asymptomatic to profoundly disturbing. It
was hypothesized that filling in the specific concave
defect within the valve would resolve the patulous ET
symptoms, and the results seem to support this hypoth-
esis. It remains to be observed whether improvements in
graft technique and materials, such as with the current
use of cartilage, will result in improvements in outcomes
with a higher complete relief of vertigo that is enduring
long-term.
When reassurance and medical treatments are not
adequately effective for symptomatic patients, they
may be offered a tubal obliteration procedure that will
require a ventilating tube and subsequent monitoring
or a PETR procedure that will likely preserve tubal
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function. This pilot study of PETR found the operation to
be effective in 43% of patients with the primary proce-
dure and overall in 50% after one patient had a secondary
tubal injection of HA. There were no complications.
Long-term evaluation of the PETR procedure in larger
numbers is needed to analyze whether the operation is
ultimately effective. A secondary touch-up procedure
with HA may be effective in correcting small defects,
and this will need to be studied further. Dedicated instru-
ments for PETR are being designed in the hopes of facil-
itating the operation.
Minor’s syndrome of superior semicircular canal dehis-
cence has many symptoms that are similar to patulous ET
symptoms, and careful assessment of these patients is
needed to differentiate between these conditions.
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doi:10.1016/j.amjoto.2and safety in the treatment of chronic sinus disease with 2 years of follow-up. Similar to sinus
surgery, initial studies of partial resection of inflamed mucosa from within the cartilaginous
eustachian tube (ET) have demonstrated efficacy and safety in the treatment of medically refractory
otitis media with effusion. Therefore, balloon dilation of the cartilaginous ET was investigated as a
possible treatment modality for otitis media.
Methods: A protocol for sinus balloon catheter dilation was evaluated in each of the cartilaginous
ETs in 8 fresh human cadaver heads. Computed tomographic scans and detailed endoscopic
inspections with video or photographic documentation were performed pre- and posttreatment, and
gross anatomical dissections were done to analyze the effects of treatment and to look for evidence of
undesired injury.
Results: Catheters successfully dilated all cartilaginous ETs without any significant injuries. There
were no bony or cartilaginous fractures, and 3 specimens showed minor mucosal tears in the
anterolateral or inferior walls. Volumetric measurements of the cartilaginous ET lumens showed a
change from an average of 0.16 to 0.49 cm3 (SD, 0.12), representing an average increase of 357%
(range, 20–965%).
Conclusions: Balloon catheter dilation of the nasopharyngeal orifice of the ET was shown to be
feasible and without evidence of untoward injury. A significant increase in volume of the
cartilaginous ET was achieved. A clinical study is now indicated to determine whether balloon
dilation will demonstrate lasting benefits and safety in the treatment of otitis media.
© 2010 Elsevier Inc. All rights reserved.1. Introduction
Advances in technology, combined with expanding
knowledge of pathophysiology, are facilitating the develop-
ment of minimally invasive interventions that are increasinglye authors have no financial relationship or conflict of
t, Inc.
a poster at the Triological Society Annual Meeting,
, 2009.
author. Department of Otolaryngology, Children's
od Ave LO 367, Boston, MA 02115, USA. Tel.: +1
ennis.poe@childrens.harvard.edu (D.S. Poe).
nt matter © 2010 Elsevier Inc. All rights reserved.
009.11.008important and efficacious means of therapy that in most cases
also reduce morbidity and expenses. Balloon dilation of
stenotic or occluded lumina, although simplistic in concept,
has contributed to remarkable advances in the fields of
urologic, gastrointestinal, neurologic, vascular, and cardiac
procedureswith effective and remarkably durable results [1-3].
Balloon dilation of sinus ostia and recesses was
introduced in 2005 with the hypothesis that it could provide
lasting patency of ostia along with the advantages of
minimizing tissue trauma, bleeding, and scarring [4]. Using
the balloon dilating catheter (Acclarent, Inc, Menlo Park,
CA), 1-year patency rates of 91.6% [5] and 2-year patient
satisfaction results of 85%, with significant symptom
improvement (Sino-Nasal Outcome Test 20 scores reduced
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MacKay score reduced from 9.66–2.69), have been reported.
Revision sinus surgery rates for patients were 9.2% [6]. As of
2008, the rate of major complications in patients treated with
balloon sinuplasty technology, with or without accompa-
nying endoscopic sinus surgery, was 0.01% [7].
It is possible that balloon dilation of the cartilaginous
portion of the eustachian tube (ET) could produce similar
benefits in the treatment of chronic otitis media with effusion
(OME). Under normal circumstances, there is a roughly 8- to
12-mm segment in the middle of the cartilaginous ET that is
closed at rest, with mucosal surfaces in apposition, and
therefore functioning as a valve. The cartilaginous ET dilates
to the open position on demand, particularly with swallows
and yawns, because of the action of, first, the levator veli
palatini (LVP) muscle, which rotates and maintains the
posterior cushion (torus tubarius) medially, followed by
tensor veli palatini (TVP) contraction that distracts the
anterolateral wall laterally to open the valve for approxi-
mately 0.4 seconds [8]. Tubal dilatory dysfunction is most
commonly due to mucosal inflammation with swelling that
limits or prevents dilation of the valve, causing insufficient
ventilation of the middle ear [9]. Partial resection of inflamed
luminal mucosa, submucosa, and occasionally bulges in the
cartilage, from the posteromedial wall, where the soft tissue
is thickest, has been beneficial in approximately 50% of
cases with severely persistent OME with 2-year follow-up
[10]. In patients with OME and sinus disease, this eustachian
tuboplasty technique, combined with endoscopic sinus
surgery, was effective in relieving symptoms in 70% [11].
These early results support the concept that enlargement of
the valve of the ET may facilitate the dilatory efforts of the
TVP muscle and provide effective benefit for chronic OME.
Widening of the tubal valve could be accomplished by
balloon dilation. It would be expected to deflect the posterior
cushion medially, stretching the cartilaginous “hinge”
between the mobile medial cartilaginous lamina, within the
posterior cushion, and the roof of the ET, which is firmly
fixed to the basisphenoid bone. The balloon would
circumferentially compress and stretch the mucosa and
submucosa. No attempt would be made to dilate the bony-
cartilaginous isthmus because it is usually patent, even when
OME is present [8]. Furthermore, the dense temporal bone
most likely would not be affected by the balloon; and the
internal carotid artery comes to within a millimeter of the
mucosa or can even be dehiscent within the bony portion of
the ET. The purpose of this study was to investigate the
feasibility and safety of performing balloon dilation of the
cartilaginous ET before consideration of a human trial.2. Methods
2.1. Hypothesis/research questions
Sinus balloon dilation catheters could be adapted to safely
and effectively dilate the cartilaginous portion of the ET.2.2. Aims/end points
Sinus balloon catheter technology was applied to human
cadaver heads in a prospective acute procedural study with
the following aims:
1. To evaluate the feasibility of using the system for
dilation of the cartilaginous portion of the ET.
2. To evaluate the safety of the dilation procedure with an
analysis of any potential adverse effects.
The primary end point of the study was the success or
failure of tubal dilation and the occurrence of any adverse
effects from the process.
2.3. Procedure design
Initial feasibility analyses were performed on embalmed
human cadaver half heads, sagittally split in the midline, and
computed tomography (CT) scans of patients with normal
ears, patients with OME, and a fresh cadaver one-half head.
From this work, a dilatory procedure was conceived using
existing sinus balloon technology through a transnasal
approach in which the catheter would be advanced into
position over a guide wire. The trial procedures would be
done first on one-half head specimens to facilitate post-
procedure CT imaging and dissections. The procedure would
then be evaluated in whole cadaver heads.
2.4. Procedure methods and study
Six frozen unembalmed adult human cadaver heads were
divided in the midline sagittal plane and thawed for the
procedure. Initial screening CT scans confirmed the absence
of any ear or nasal pathology. Baseline CT scans (CereTom
OTOscan; NeuroLogica Corporation, Danvers, MA) were
obtained of each one-half head, placing it in the supine
position and acquiring images in the axial plane with 0.625-
mm slice thickness. Baseline endoscopic photographs of the
nasopharyngeal orifice of the ET were obtained. Endoscopic
visualization was performed with 0°- and 30°-angled, 4-
mm–diameter Hopkins rod endoscopes fitted with a 3-chip
CCD video camera (Karl Storz, Tuttlingen, Germany) and
observed on a monitor with video and photographic capture
capability. Instruments were introduced through the nasal
cavity to simulate an actual surgical procedure to the
maximum extent possible.
The sinus balloon dilation system (Acclarent, Inc) was
used to dilate the cartilaginous portion of each ET. A curved
guiding catheter with a tip angle of 70° was passed through
the nasal cavity, and the tip was placed into the ET
nasopharyngeal orifice. A Relieva Vigor sinus guide wire
was inserted through the catheter into the ET lumen; and
once engaged within the ET, it was advanced slowly under
fluoroscopic guidance using a C-arm (GE OEC 9800,
Fairfield, CT) through the bony isthmus approximately 5
mm into the temporal bone portion of the ET. The guiding
catheter was removed, and another CT scan was performed
Fig. 1. Right ET nasopharyngeal orifice in fresh cadaver head viewed
through a 30°, 4-mm–diameter Hopkins rod endoscope. Predilation.
ig. 3. The balloon has been fully inserted until meeting slight resistance
om the bony-cartilaginous junction.
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cartilaginous tubal lumen and postprocedure image recon-
struction. A 6- or 7-mm–diameter × 16-mm–length Relieva
Solo sinus balloon catheter was slipped over the guide wire
into the ET orifice until it reached resistance near the bony-
cartilaginous isthmus. The balloon typically protruded from
the tubal orifice about 2 to 3 mm. The guide wire was then
removed. Once in position, the balloon was inflated to 12
atm for 1 minute, after which it was deflated and removed. In
the event that a 7-mm balloon slipped out of the ET orifice
into the nasopharynx during inflation, it was replaced with a
6-mm balloon; and the inflation was repeated. Careful
endoscopic inspection of the postdilation tubal lumen for any
evidence of injury was done with photographic documenta-
tion immediately after the procedure, and a CT scan was
subsequently performed. The one-half head was then placedFig. 2. Guide catheter has been placed into the ET orifice, and the balloon
and guide wires are protruding from the catheter into the tubal lumen.F
frin a lateral decubitus position with the ET orifice facing
upward; and the orifice was filled with Omnipaque contrast
solution, 300 mg I− per milliliter (GE Healthcare, Princeton,
NJ), to accurately visualize and quantify the final dilation
dimensions and volumes. A final CT scan was obtained in
this position.
Each specimen was carefully evaluated for any adverse
effects from the dilation. Inspection of the lumen was done
with the endoscope; and a complete survey of the mucosa
was done, looking for any evidence of injuries. The posterior
cushion was manipulated and rotated medially, looking for
any unusual flexibility or increase in range of mobility. A
careful and systematic gross dissection was performed
making a circumferential mucosal incision around the tubal
orifice and making a longitudinal cut along the inferior freeig. 4. The balloon has been fully inflated in position. Approximately one
ird of the balloon protrudes from the ET orifice. The guide catheter is left
position to help stabilize the inflated balloon.F
th
in
Fig. 5. The entire length of the cartilaginous ET has been dilated by the
balloon.
Fig. 6. (A) Axial CT scan through a right cadaver half head; predilation. (B) Axial
into the ET lumen.
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were elevated extra- and intraluminally to reveal the entire
medial and lateral cartilaginous laminae up to the bony-
cartilaginous junction. Integrity of the cartilage and soft
tissues was noted. Inspection was made of the TVP and LVP
muscles, Ostmann fat pad, and pterygoid fossa.
A final feasibility trial of balloon dilation of the
cartilaginous ET was performed in 2 unembalmed whole
cadaver heads under endoscopic guidance. The dilation
procedure was executed on each of the 4 ETs using a
protocol modified from that in the one-half heads and
without CT scans or postdilation dissections. It was found
that it was easiest to place the guide wire into the balloon
catheter, such that the wire protruded 5 mm from the distal
tip of the catheter, and to introduce them together through the
guide catheter. Once in position, the guide wire was
removed; and the guide catheter was maintained in position
to stabilize the balloon. After dilation, close endoscopic
inspection was done to assess for any evidence of adverseCT scan through a right cadaver half head; postdilation, with contrast placed
Fig. 7. 3-Dimensional volume reconstruction from CT scans postdilation,
viewed inferiorly. Eustachian tube has been filled with contrast that has
passed into the middle ear and mastoid. Cross-sectional slices constructed
perpendicularly to the longitudinal axis of the ET were used to orient the CT
reconstructed images from which luminal cross-sectional areas were
measured.
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palpation of the posterior cushion to inspect for excessive
mobility (Figs. 1–5).
Postprocedure CT scans from the one-half heads were
reviewed in extensive detail for any evidence of bonyFig. 8. Computed tomographic reconstructions as described in Fig. 7 yielding crossfractures in the temporal bone, basisphenoid, or pterygoid
plates. For the cartilaginous portion of the ET, lengths, cross-
sectional areas with respective major and minor axis
diameters at approximately 4-mm intervals, and volumes
were computed using OsiriX software (OsiriX Foundation,
Geneva, Switzerland) (Fig. 6). In predilation scans, the ET
was identified based on the location of the guide wire, which
was left in place for the initial set of predilation scans. Once
the location had been determined, measurements were
completed on an identical set of predilation scans taken
with the wire removed. For the postdilation scans, the ET
was identified based on the radiopaque contrast that had been
poured into ET orifice. Measurements were also completed
on the postdilation scans with the contrast present. For both
the pre- and postdilation scans, the midpoint of the ET was
identified on each axial slice and tagged in OsiriX. The ET
lengths were determined from the anterior-inferior–most
point of the posterior cushion (torus tubarius) to the bony
isthmus as the ET entered the temporal bone. A curvilinear
line representing the longitudinal axis of the ET was created
by following the identified midpoints from the orifice to the
bony-cartilaginous junction. The curvilinear lines became
the basis to create 2-dimensional curved multiplanar
reconstructions containing the line, from which the length
of the longitudinal axis could be measured, and perpendic-
ular to the line, from which cross-sectional areas and major/
minor axes were measured (Figs. 7 and 8). Volumes were
calculated by manually outlining a region of interest on each
axial slice and using the volume estimation function to
interpolate between slices.
Statistical analysis was done with SPSS 16.0 statistical
software (Espoo, Finland) with 2-tailed paired-samples tests
performed using P b .05 for significance.-sectional slices of postdilated ET. Contrast has been placed into the lumen.
Table 1
Eustachian tube balloon dilation results and intralumenal volumes
Specimen Balloon(s)
diameter (mm)
Final balloon
protrusion (mm)
Mucosal tear
(mm, location)
Volumes
Predilation (cm3) Postdilation (cm3) % Increase
1L 7, 6 6 0 0.0576 0.3627 530
1R 6 8 b1, inf 0.1463 0.4297 194
2L 6 b5 0 0.2758 0.6631 140
2R 6 5 0 0.2442 0.5343 119
3L 6, 7, 7 5 6 × 2, lat 0.0831 0.6828 722
3R 7 5 3 × 2, lat 0.1129 0.5767 411
4L 7 b5 0 0.1116 0.3922 251
4R 7 5 0 0.0846 0.3922 364
5L 7 b5 0 0.2414 0.6498 169
5R 7 b5 0 0.4099 0.4915 20
6L 7 5 0 0.0361 0.3845 965
6R 7, 7, 7 b5 0 0.0745 0.3730 401
Average 0.1565 0.4944 357
SD 0.1124 0.1227
Final balloon protrusion = distance balloon protruded from ET orifice when inflated. Specimen 1R had a partial-thickness mucosa laceration in the inferior wall,
superiorly. Specimens 3R and L had oval full-thickness lacerations in the lateral wall, superiorly.
able 2
ustachian tube straight line and curvilinear lengths
Postdilated length (mm)
verage 26.32
D 1.7830
ax 28.96
in 23.34
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Successful balloon dilation was achieved in all ETs
without any major adverse effects (Table 1). The guide
catheter, guide wires, and balloon catheters were all inserted
into the ET without difficulty. Dilation of the 12 ETs in the
one-half heads was accomplished with a 7-mm–diameter
balloon in 8 (66.7%) and with a 6-mm balloon in 4 (33.3%).
In most cases, the inflated balloon locked securely into
position, leaving approximately one third of the 16-mm
length protruding distally (inferiorly) out of the orifice, but
stable. In one specimen (1L), the ET was dilated initially
with a 7-mm balloon; but it slipped distally out of the orifice
excessively and was replaced by a 6-mm balloon that
partially slipped but stabilized with 6 mm protruding from
the orifice (∼37%), which gave a satisfactory dilation. The
contralateral ET from the same head was dilated with a 6-mm
balloon that slipped inferiorly, but stabilized with 8 mm
(50%) protruding and yielding a satisfactory dilation. During
the dilation of one ET (specimen 4R), a 7-mm balloon began
to distract distally but was successfully maintained in
position by stabilizing the catheter against the floor of the
nose. In the event that a balloon slipped out more than 50%,
the dilation was repeated. In all cases, the dilation caused
medialization of the posterior cushion, rotating the free
portion of the medial cartilaginous lamina.
Average intraluminal volumes of the cartilaginous ET
increased from predilation of 0.16 cm3 to postdilation of 0.49
cm3 (increase of +357%), which was statistically significant
(P b .001).
Measurements of the lengths of the cartilaginous portion
of the ET are presented in Table 2. Cross-sectional areas
were measured at approximately 4-mm intervals through the
cartilaginous ET, with the results depicted in Fig. 9. At the
ET orifice (0-mm distance) and at the bony-cartilaginous
junction (average of 26.3 mm), there were no significantdifferences between pre- and postdilation areas (P = .61 and
P = .54, respectively). For the remaining distances,
postdilation areas were significantly larger (P b .001 for
each distance).
Cross-sectional major and minor axis dimensions in pre-
and postdilated ETs are presented in Table 3.
There were minor adverse effects in 3 one-half head
specimens, all of which were lacerations of the luminal
mucosa. Specimen 1R had a partial-thickness mucosal tear of
no significance. Specimen 3L had a full-thickness tear
superiorly in the anterolateral wall near the bony-cartilagi-
nous isthmus (Fig. 10). The contralateral ET from the same
head sustained a smaller tear in the same location. There
were no other soft tissue injuries, no fractures of the cartilage
of the ET or separation from the basisphenoid, and no bony
fractures detected on palpation or on postdilation CT images.
There were no adverse effects noted in the 4 ETs dilated in
the whole head specimens.4. Discussion
Recurrent and chronic OMEs are common problems in
children and adults. Attempts are made to ascertain the
underlying etiology in each case and to treat it with medical
therapy as indicated. Refractory cases are typically managed
with the insertion of tympanostomy tubes, but there is aT
E
A
S
M
M
Fig. 9. Plot of average cross-sectional areas along the cartilaginous ET
length; pre- and postdilation.
ig. 10. A 30°, 4-mm–diameter Hopkins rod endoscopic view of left ET
ostdilation. A mucosal tear in the anterolateral wall is noted (arrow).
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extrusion of the tubes. Multiple or prolonged tube place-
ments are associated with an increased risk of tympanic
membrane atrophy at the tympanostomy site or persistent
perforation. Eustachian tuboplasty has shown some early
effectiveness in reducing the rate of OME in otherwise
refractory cases [10,11].
Balloon dilation of the cartilaginous portion of the ET has
been proposed as a novel, minimally invasive method for
treating refractory OME. ET dilation with a sinus balloon
dilation catheter is not indicated on the labeling of the device.
The present study has demonstrated that the procedure is
feasible and safe to the best extent that can be judged from a
cadaver trial. There was significant dilation of the lumenTable 3
Cross-sectional major and minor axis dimensions in pre- and postdilated ET
Average distance from
ET orifice (mm)
0.00 4 8 12 16 20
Predilation
Major axis ave (mm) 1.11 0.77 0.55 0.56 0.32 0.26
SD 0.2115 0.4723 0.3062 0.0644 0.0922 0.0000
Max 1.436 1.73 1.092 0.65 0.427 0.258
Min 0.794 0.109 0 0 0 0
Minor axis ave 0.38 0.22 0.14 0.15 0.13 0.08
SD 0.0951 0.1086 0.0441 0.0344 0.0314 0.0000
Max 0.593 0.42 0.2 0.185 0.166 0.081
Min 0.266 0.086 0 0 0 0
Postdilation
Major axis ave 1.04 1.03 1.01 0.74 0.57 0.53
SD 0.2364 0.1455 0.2593 0.2530 0.1612 0.1563
Max 1.529 1.284 1.61 0.74 0.805 0.746
Min 0.656 0.809 0.707 0.191 0.291 0
Minor axis ave 0.47 0.46 0.33 0.36 0.24 0.21
SD 0.1454 0.1917 0.1103 0.1945 0.1124 0.0776
Max 0.657 1.019 0.527 0.906 0.559 0.345
Min 0.23 0.299 0.18 0.19 0.148 0F
pwithout any significant adverse effects. There was no
significant effect at the tubal orifice, where the medial
cartilaginous lamina is most mobile, or near the bony-
cartilaginous junction, where the cartilage becomes circum-
ferentially fixed. The greatest dilatory changes occurred
between 4 and 16 mm from the orifice, where the cartilage is
less mobile; and the balloon was forced to expand into the soft
space of the anterolateral wall, toward Ostmann fat pad, TVP
muscle, and pterygoid fossa. Our measurements of the length
of the adult cartilaginous ET were similar to the average
length of 26.6 mm previously reported by Sudo et al [12] in
measurements from reconstructions of histologic sections.
Unlike with dilation of sinus ostia, there was no
intentional fracturing of bone. However, soft tissue balloon
dilation of stenotic vessels, biliary tree, urinary strictures,
and other tubular organs has been demonstrated to have
lasting benefits. It is known that one of the mechanisms of
successful balloon dilation of vascular stenoses is tearing of
the intima and sometimes the media [13]. In a histologic
study of balloon-dilated aortic valves, there was evidence of
young-appearing scar tissue that filled the small tears and
lacerations observed in the dense collagenous tissue stroma
rather than healing by regrowth of the collagen. The scar
tissue consisted of a cell-rich pattern of fibroblasts,
capillaries, and an inflammatory infiltrate composed of
lymphocytes, plasma cells, and histiocytes that was present
even at 24 months [14]. In the present study, endoscopically
observed tears occurred in the mucosa in 3 (19%) of 16
dilated ETs; and it is likely that microscopic examination
would reveal an even higher number of tears. Although the
mucosa, submucosa, and cartilage are all flexible, it is
possible that similar submucosal and intracartilaginous
injury or tears may result. It is also possible that compression
of irreversibly injured hypertropic mucosa and submucosa
may cause them to regrow with thinner and healthier layers.
Histology after laser removal of posteromedial mucosa and
submucosa has shown such a healing pattern with return of
normal ciliated epithelium, reduced inflammatory infiltrate,
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submucosa [10]. Therefore, it is possible that balloon
dilation could cause some permanent changes in the
cartilaginous ET that could provide lasting benefit in
widening the lumen and facilitating the dilatory action of
the TVP muscle.
Risks of the balloon dilation could be development of a
circumferential stricture, fracture of the medial cartilaginous
lamina, injury to the TVP muscle, hemorrhage into the
pterygoid space, and excessive widening to cause a patulous
ET. Circumferential strictures have been predicted since the
introduction of balloon dilation procedures, but vast
experience has shown that it rarely occurs because of the
permanent histologic changes that are induced. Gross
fracture of the cartilage could theoretically cause the
posterior cushion to flail loosely, which could be detrimental
to the action of the TVP; but no fractures occurred at all in
this trial, and the cartilage would be expected to be more
flexible in live patients. There was no evidence of muscle
tears in the TVP or LVP in any of the specimens, and it
would therefore be unlikely for hemorrhage to occur.
Patulous ET could theoretically occur, even on a temporary
basis. Although physiologically harmless and likely to
resolve a patient's OME, it could cause significant disturbing
symptoms of autophony that would be undesirable. Patients
selected for the procedure would have considerable mucosal
swelling as an indication for dilation such that the risk of
causing an incompetent, patulous valve would be minimized.
Techniques to repair a persistently patulous ET are now
available [15].
Another risk of the procedure would be with the
introduction of the guide wire. Excessively deep insertion
could pass the wire into the middle ear, causing injury to the
ossicles, tympanic membrane, or inner ear. It could also
present a risk to an internal carotid artery that would be
dehiscent into the floor of the bony ET. In the course of this
study, we found that the C-arm fluoroscopy was unneces-
sary. Inserting the wire with only 5 mm protruding from the
balloon catheter should absolutely minimize the risk of entry
into the middle ear, keep the wire within the cartilaginous
ET, and prevent any proximity to the internal carotid artery.
A preoperative CT scan to ensure that the carotid is covered
with bone would be initially prudent until more experience is
gained with the procedure. The guide wire should be
removed before inflation to prevent any potential overpres-
sure from occurring in the proximal ET and middle ear.
It is important to monitor the balloon for movement
during the dilation. The optimal position for the balloon
appeared to be protruding by about one quarter to one third
out of the tubal orifice. A deeper insertion, such as occurred
in specimen 3L with the initial 6-mm balloon, was the likely
cause of the largest mucosal tear. If the balloon were to begin
to slip out during the inflation, it may be possible, as was
done in one case, to maintain it in place by allowing the
catheter to rest on the nasal floor to provide some
counterpressure. If the balloon were to slip out more than50%, the dilation could be repeated with the same size
catheter if it appears that some dilation has successfully
occurred, or a smaller balloon could be used.
If balloon dilation of the ET were ultimately demonstrated
to be effective with the benefits sustained over time, it would
be a useful and minimally invasive alternative to tympa-
nostomy tubes in patients with chronic OME. Careful
selection of patients with medically refractory tubal dilatory
dysfunction should be done. A thoughtful evaluation of the
risks and potential benefits of the procedure should be made
in every case. In the future, it may also be beneficial to
patients with atelectasis or scuba or flight barotrauma. After
accumulating experience in adults, it would have to be
determined whether the procedure should be performed in
children, in whom the mechanisms of OME remain less clear
than for adults.5. Conclusions
This study demonstrated that balloon dilation of the
cartilaginous portion of the ET was feasible and appeared
to be safe in a cadaver trial. The hypotheses for this study
were supported by the significant dilation of intraluminal
volumes and cross-sectional areas within the middle
section of the cartilaginous ET. No significant adverse
effects were encountered.
On the basis of this study, it is reasonable to proceed with
a human pilot study to judge safety and efficacy in patients
with medically refractory dilatory dysfunction of the ET.
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